Sentence,class,file
SUPPLEMENTAL INFORMATION Supplemental Information contains Supplemental Discussion and can be found with this article online at http://dx.doi.org/10.1016/ j.celrep.2014.10.029 .,Non-OADS,/arxiv_data1/oa_pdf/68/64/nihms779740.PMC4844007.pdf
http://dx.doi.org/10.7150/ijbs.3836 .,Non-OADS,/arxiv_data1/oa_pdf/68/64/nihms779740.PMC4844007.pdf
http://dx.doi.org/10.1016/j.jclinepi.,OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
: CD005594 http://dx.doi.org/ 10.1002/14651858.CD005594.pub2 7.,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/10.1097/CCM.0000000000000863 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/10.1214/08-AOAS187 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/ 10.1001/archinte.167.15.1629 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/10.1097/00003246-200107000-00012 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/10.1001/archinte.161.8.1099 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/10.1007/ s00228-013-1499-3 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/10.1146/annurev.publhealth.21.1.193 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
http://dx.doi.org/10.1001/jama.297.3.278 .,Non-OADS,/arxiv_data1/oa_pdf/dd/3f/nihms751372.PMC4844076.pdf
Temperature 2015; 2(3):346-52; http://dx.doi.org/10.1080/23328940.2015.1039190.,OADS,/arxiv_data1/oa_pdf/36/1d/ktmp-02-03-1050156.PMC4844093.pdf
"© Shaun F Morrison *Correspondence to: Shaun F Morrison; Email: morrisos@ohsu.edu Submitted: 05/05/2015Accepted: 05/05/2015http://dx.doi.org/10.1080/23328940.2015.1050156 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecom mons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution,and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/1d/ktmp-02-03-1050156.PMC4844093.pdf
Nat Neurosci 2008; 11:62-71; PMID:18084288; http://dx.doi.org/10.1038/nn2027 5.,Non-OADS,/arxiv_data1/oa_pdf/36/1d/ktmp-02-03-1050156.PMC4844093.pdf
Ann N Y Acad Sci 2011; 1225:72-82; PMID:21534994; http://dx.doi.org/10.1111/j.1749- 6632.2011.05990.x 6.,OADS,/arxiv_data1/oa_pdf/36/1d/ktmp-02-03-1050156.PMC4844093.pdf
PLoS ONE 2006; 1:e1; PMID:17183631; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/36/1d/ktmp-02-03-1050156.PMC4844093.pdf
Cell Metab 2014; 19:741-56; PMID:24630813; http://dx.doi.org/10.1016/j.cmet.2014.02.007 www.tandfonline.com 333 Temperature,OADS,/arxiv_data1/oa_pdf/36/1d/ktmp-02-03-1050156.PMC4844093.pdf
"8,9The ﬁrst modern seminal trials of thera- peutic hypothermia have demonstrated that maintaining the © Viktor V Feketa and Sean P Marrelli *Correspondence to: Sean P Marrelli; Email: marrelli@bcm.eduSubmitted: 12/03/2014; Revised: 02/25/2015; Accepted: 02/25/2015 http://dx.doi.org/10.1080/23328940.2015.1024383 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Science 1952; 116:231-2; PMID:17770935; http://dx.doi.org/10.1126/ science.116.3009.231 2.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care Med 2005; 33:414-18; PMID:15699847; http://dx.doi.org/10.1097/01.CCM.0000153410.87750.53 3.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Brain 2007; 130:3063-74;PMID:17478443; http://dx.doi.org/10.1093/brain/ awm083 4.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
The effects of mild induced hypo- thermia on the myocardium: A systematic review.Anaesthesia 2010; 65:505-15; PMID:20151956; http://dx.doi.org/10.1111/j.1365-2044.2009.06237.x 6.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care 2012; 16:R41; PMID:22397519; http://dx.doi.org/10.1186/cc11235 7.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Acta Neurochir (Wien) 2006; 148:565-70;; PMID:16489500; http://dx.doi.org/ 10.1007/s00701-006-0747-z 8 .,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Circulation 2003; 108:118-21; PMID:12847056; http://dx.doi.org/10.1161/01.CIR.0000079019.02601.90 9.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
N Engl J Med 2002; 346:557-63; PMID:11856794; http://dx.doi.org/ 10.1056/NEJMoa003289 11.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
N Engl J Med2002; 346:549-56; PMID:11856793; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
N Engl J Med 2005; 353:1574-84;PMID:16221780; http://dx.doi.org/10.1056/ NEJMcps050929 13.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
N Engl J Med 2009; 361:1349-58; PMID:19797281; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Tri- als 2011; 12:8; PMID:21226939; http://dx.doi.org/ 10.1186/1745-6215-12-8 15.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Int J Stroke2014; 9:117-25; PMID:24206528; http://dx.doi.org/ 10.1111/ijs.12151 16.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Int J Stroke 2014; 9:642-5; PMID:24828363; http://dx.doi.org/10.1111/ ijs.12294 17.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Am Coll Cardiol 2002; 40:1928-34; PMID:12475451; http://dx.doi.org/10.1016/S0735- 1097(02)02567-6 18.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
The Neurohospitalist 2014; 4:153-63; PMID:24982721; http://dx.doi.org/10.1177/1941874413519802 19.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
N Engl J Med 2010; 363:1256-64; PMID:20860507; http://dx.doi.org/10.1056/NEJMct1002402 20.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care Med 1991; 19:379-89; PMID:1999100; http://dx.doi.org/ 10.1097/00003246-199103000-00017 21.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Brain Res 1994; 654:265-72; PMID:7987676; http://dx.doi.org/10.1016/0006-8993(94)90488-X 22.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Acad Emerg Med 2007; 14:293-300; PMID:17296802; http://dx.doi.org/10.1111/j.1553-2712.2007.tb02010.x23.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
N Engl J Med 2013; 369:2197-206; PMID:24237006; http://dx.doi.org/10.1056/NEJMoa1310519 24.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care Med 1993; 21:1348-58;PMID:8370299; http://dx.doi.org/10.1097/ 00003246-199309000-00019 25.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
"Circula- tion 2010; 122:737-42; PMID:20679551; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.906859 2 6 .K i mF ,N i c h o lG ,M a y n a r dC ,H a l l s t r o mA , Kudenchuk PJ, Rea T, Copass MK, Carlbom D,Deem S, Longstreth WT, et al.",OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
JAMA 2014; 311:45-52; PMID:24240712; http://dx.doi.org/10.1001/jama.2013.282173 27.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Funct Ecol 2007; 22: 58–67;http://dx.doi.org/10.1111/j.1365-2435.2007.01341.x 28.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Annu Rev Phys- iol 1995; 57:69-95; PMID:7778882; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Acta Physiol 2014; 210:498-507; http://dx.doi.org/10.1111/apha.12231 32.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Anesthesi- ology 1995; 82:662-73; PMID:7879935; http://dx.doi.org/10.1097/00000542-199503000-00008 33.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
"Philos Trans R Soc Lond B Biol Sci 1990; 326:669- 85, discussion 685-6; PMID:1969651; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Curr Atheroscler Rep 2010; 12:336-42; PMID:20589482; http://dx.doi.org/10.1007/s11883-010-0119-2 www.tandfonline.com 255 Temperature,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care Med 2009; 37:S211-22; PMID:19535949; http://dx.doi.org/10.1097/CCM.0b013e3181aa5bad 37.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Resuscitation 2007; 75:76-81; PMID:17462808; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Resuscitation 2008; 77:331-8; PMID:18314248; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Cardio-vasc Med 2014; http://dx.doi.org/10.2459/ JCM.0000000000000130 40.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Neurocrit Care 2004; 1:201-3; PMID:16174915; http://dx.doi.org/ 10.1385/NCC:1:2:201 42.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Resuscitation 2003; 56:9- 13; PMID:12505732; http://dx.doi.org/10.1016/S0300-9572(02)00276-9 43.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Am J Physiol Regul Integr Comp Physiol 2011; 301:R1207-28; PMID:21900642; http://dx.doi.org/10.1152/ajpregu.00109.2011 47.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Ann Emerg Med 2008; 51:153-9; PMID:18045737; http://dx.doi.org/10.1016/j.annemergmed.2007.07.012 50.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Anesthesiology 2002; 96:467-84; PMID:11818783; http://dx.doi.org/10.1097/00000542-200202000-00036 52.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Anesthesiology 1997; 86:1046-54; PMID:9158353; http://dx.doi.org/10.1097/ 00000542-199705000-00007 54.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Anesth Analg 2001; 93:1233- 9; PMID:11682404; http://dx.doi.org/10.1097/00000539-200111000-00038 55.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Neurol Sci 2007; 261:47-54; PMID:17512551; http://dx.doi.org/10.1016/j.jns.2007.04.038 57.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Lancet Neurol 2013; 12:275-84;PMID:23415567; http://dx.doi.org/10.1016/S1474- 4422(13)70013-9 58.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Physiol 2004; 555:503-13;PMID:14578483; http://dx.doi.org/10.1113/ jphysiol.2003.053215 59.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Am J Physiol Regul Integr Comp Physiol 2007; 292:R127-36; PMID:16931649; http://dx.doi.org/10.1152/ ajpregu.00427.2006 60.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Neurosci Lett 2004; 357:58-62; PMID:15036613; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Am J Physiol Regul Integr Comp Physiol 2008; 295:R343-54; PMID:18463193; http://dx.doi.org/10.1152/ajpregu.00115.2008 62.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Physiol2011; 589:3641-58; PMID:21610139; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Am J Phys- iol Regul Integr Comp Physiol 2006; 291:R518-29;PMID:16690776; http://dx.doi.org/10.1152/ ajpregu.00039.2006 67.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Annu Rev Neurosci 2006; 29:135-61; PMID:16776582; http://dx.doi.org/10.1146/annurev.neuro.29.051605.112958 68.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Pharmacol Rev 2009; 61:228-61;PMID:19749171; http://dx.doi.org/10.1124/ pr.109.001263 69.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Neurosci 2012; 32:2086-99; PMID:22323721; http://dx.doi.org/10.1523/JNEUROSCI.5606-11.2012 70.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
PLoS One 2011; 6:e25894; PMID:21984952; http://dx.doi.org/10.1371/ journal.pone.0025894 71.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care Med 2014; 42:e355-63; PMID:24595220; http://dx.doi.org/10.1097/CCM.0000000000000229 72.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Nature 2007; 448:204-8;PMID:17538622; http://dx.doi.org/10.1038/ nature05910 73.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Neuron 2007; 54:379-86; PMID:17481392; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Neuron 2007; 54:371-8;PMID:17481391; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Nature 2002; 416:52-8;PMID:11882888; http://dx.doi.org/10.1038/ nature719 76.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Cell 2002; 108:705-15;PMID:11893340; http://dx.doi.org/10.1016/S0092- 8674(02)00652-9 77.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Am J Physiol Regul Integr CompPhysiol 2011; 300:R1278-87; PMID:21411765; http://dx.doi.org/10.1152/ajpregu.00631.2010 78.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Neurosci 2008; 28:566-75; PMID:18199758; http://dx.doi.org/10.1523/ JNEUROSCI.3976-07.2008 79.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
PLoS One 2011; 6:e17504; PMID:21407809; http://dx.doi.org/10.1371/journal.pone.0017504 80.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Shivering and tachycardic responses to external cooling in mice are substantially suppressed by TRPV1 activation but not by TRPM8 inhibition.Am J Physiol Regul Integr Comp Physiol 2013; 305: R1040-50; PMID:24005250; http://dx.doi.org/ 10.1152/ajpregu.00296.2013 81.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
92:425-37; PMID:23159643; http://dx.doi.org/ 10.1016/j.lfs.2012.10.032 82.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Anesthesiology 1995; 82:1160-8; PMID:7741291; http://dx.doi.org/10.1097/ 00000542-199505000-00011 83.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Anesthesiology 2001; 95:1089-95; PMID:11684976; http://dx.doi.org/10.1097/ 00000542-200111000-00011 84.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care 2007; 11:R29; PMID:17316456; http://dx.doi.org/10.1186/cc5709 85.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Crit Care Med2009; 37:1893-7; PMID:19384208; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Neuron 1998; 21:531-43; PMID:9768840; http://dx.doi.org/ 10.1016/S0896-6273(00)80564-4 88.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Neuropharmacol- ogy 2014; 85:151-7; PMID:24887171; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Pharmacol Ther 1984; 26:389-416; PMID:6085515; http://dx.doi.org/10.1016/0163-7258(84)90041-X 91.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
BMC Cardiovasc Disord 2010; 10:51; PMID:20932337; http://dx.doi.org/10.1186/1471-2261-10-51 92.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Am J Physiol Regul Integr Comp Physiol 2014; 306:R149- 56; PMID:24305062; http://dx.doi.org/10.1152/ ajpregu.00329.2013 93.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Cereb Blood Flow Metab 2012; 32:978-82; PMID:22434066; http://dx.doi.org/10.1038/jcbfm.2012.36 94.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Curr Pharm Biotechnol 2011;12:130-44; PMID:20932253; http://dx.doi.org/ 10.2174/138920111793937844 95.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
PharmacolRev 2012; 64:939-71; http://dx.doi.org/10.1124/ pr.112.006163 96.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Pain 2000; 84:407-12; PMID:10666547; http://dx.doi.org/10.1016/S0304-3959(99)00231-6 97.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Neurology 2008; 70:2305- 13; PMID:18541884; http://dx.doi.org/10.1212/01.wnl.0000314647.35825.9c 98.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Cell 2003; 112:819-29; PMID:12654248; http://dx.doi.org/10.1016/S0092- 8674(03)00158-2 99.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Neurosci 2014; 34:4445-52; PMID:24671991; http://dx.doi.org/10.1523/JNEUROSCI.5387-13.2014 101.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
FEBS J 2013; 280:5471-87; http://dx.doi.org/10.1111/febs.12302 102.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Exp Dermatol 2013; 22:447-52; PMID:23800054; http://dx.doi.org/10.1111/exd.12163 103.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Prog Biophys Mol Biol 2010; 103:2-17; PMID:19835908; http://dx.doi.org/ 10.1016/j.pbiomolbio.2009.10.002104.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Neurosci 2005; 25:1304-10; PMID:15689568; http://dx.doi.org/10.1523/JNEUROSCI.4745.04.2005 105.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Mol Pain 2011; 7:37; PMID:21586160; http://dx.doi.org/10.1186/ 1744-8069-7-37 107.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Neurosci 2011;31:11425-36; PMID:21832173; http://dx.doi.org/ 10.1523/JNEUROSCI.1384-09.2011 108.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Mol Pharmacol 2009; 75:1262-79; PMID:19297520; http://dx.doi.org/10.1124/mol.109.055624 109.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Biosci Biotech- nol Biochem 2009; 73:1021-7; PMID:19420725;http://dx.doi.org/10.1271/bbb.80796 110.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
FASEB J 2012; 26:2799-810;PMID:22459147; http://dx.doi.org/10.1096/fj.11- 201822 111.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
Resuscitation 2012; 83:232-7; PMID:21803015; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Neurosci2013; 33:14512-25; PMID:24005302; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Cereb Blood Flow Metab 2013; 33:171-4; PMID:23211965; http://dx.doi.org/10.1038/ jcbfm.2012.181 114.,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
J Med Chem 2010; 8:233-47; http://dx.doi.org/10.1021/ jm101075v www.tandfonline.com 257 Temperature,Non-OADS,/arxiv_data1/oa_pdf/96/24/ktmp-02-02-1024383.PMC4844121.pdf
"Epige-netic regulation is central to the control of gene expression,genomic imprinting, X chromosome inactivation, and cell © R C Huang, E S Garratt, H Pan, Y Wu, E A Davis, S J Barton, G C Burdge, K M Godfrey, J D Holbrook, and K A Lillycrop *Correspondence to: K A Lillycrop; Email: kal@soton.ac.ukSubmitted: 12/04/2014; Revised: 07/27/2015; Accepted: 08/01/2015 http://dx.doi.org/10.1080/15592294.2015.1080411 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
"Given the high correlation between the methylation status of TAOK3 andPIWIL4 , we run Gapped Local Alignment of Motifs (GLAM2), which is part of the moti f-based sequence analysis suite MEME (http://meme.nbcr.net/meme),22to determine whether there was any commonality between the s equences surrounding these CpG sites.",OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Am J Clin Nutr 2010; 92:1257-64; http://dx.doi.org/10.3945/ajcn.2010.29786 2.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Circulation 2005; 111:1999-2012; PMID:15837955; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
N Engl J Med 2004; 350:855-7; http://dx.doi.org/ 10.1056/NEJMp048008 4.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Pediatr 2001; 108:712-8; PMID:11533341; http://dx.doi.org/10.1542/peds.108.3.712 6.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Epidemiol 2007; 18:167-78; http://dx.doi.org/10.1097/01.ede.0000239647.26389.80 8.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Annu Rev Nutr 2010; 30:315-39; PMID:20415585; http://dx.doi.org/10.1146/annurev.nutr.012809.104751 9.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Br Med Bull2001; 60:103-21; PMID:11809621; http://dx.doi.org/ 10.1093/bmb/60.1.103 10.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Early Hum Dev 2006; 82:485-91; PMID:16876341; http://dx.doi.org/10.1016/j.earlhumdev.2006.07.001 11.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
ClinicalEndocrinol 2013; 78:9-16; http://dx.doi.org/10.1111/ cen.12055 12.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Pediatr Res 2007; 61:5R-10R; PMID:17413851; http://dx.doi.org/10.1203/pdr.0b013e318045bedb 14.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Diabetes 2011; 60:1528-34; PMID:21471513; http://dx.doi.org/10.2337/db10-0979 16.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
PloS one 2012; 7:e47193; PMID:23091611; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Cancer Res 2012; 72:2304-13; PMID:22374981; http://dx.doi.org/10.1158/0008-5472.CAN-11-3157 20.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
BMC Bioinformatics 2012; 13:86; PMID:22568884; http://dx.doi.org/10.1186/ 1471-2105-13-86 22.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
"PLoS Computational Biol 2008 4(5):e1000071; http://dx.doi.org/10.1371/journal.pcbi.1000071 23 Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al.",OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Nature Genetics 2009;41:178-86; PMID:19151715; http://dx.doi.org/ 10.1038/ng.298 24.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
PLoS Genetics 2013; 9: e1003572; PMID:23825961; http://dx.doi.org/ 10.1371/journal.pgen.1003572 25.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Epigenetics 2013;8:34-43; http://dx.doi.org/10.4161/epi.23062 26.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Am J Human Genetics 2013; 93:876-90; http://dx.doi.org/10.1016/j.ajhg.2013.10.004 27.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Mol Cell 2012; 45:447-58; PMID:22264824; http://dx.doi.org/10.1016/j.molcel.2011.12.021 28.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
"Roessler J, Ammerpohl O, Gutwein J, Hasemeier B, Lukman S, Kreipe H, Lehmann U. Quantitative cross-validation and content analysis of the 450k DNA meth- ylation array from Illumina, Inc. BMC Res Notes 2012; 5:210; PMID:22546179; http://dx.doi.org/10.1186/1756-0500-5-210 29.",OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Genome Biol 2015; 16:8;PMID:25651499; http://dx.doi.org/10.1186/s13059- 014-0569-x 30.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
PloS One 2012; 7:e40924; PMID:22808284; http://dx.doi.org/10.1371/ journal.pone.0040924 31.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
FASEB J 2010; 24:3135-44; PMID:20385621; http://dx.doi.org/10.1096/fj.09-150490 32.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
JExp Med 1999; 190:1189-96; http://dx.doi.org/ 10.1084/jem.190.8.1189 33.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Mol Cell Biol 2013; 33:1797-808; PMID:23438599; http://dx.doi.org/10.1128/ MCB.01410-12 35.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Cell Metabolism 2010; 11:113-24;PMID:20142099; http://dx.doi.org/10.1016/j.cmet.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Diabe-tes 2013; 62:1537-46; PMID:23321073; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Future Med Chem 2010; 2:1785-96; PMID:21428801; http://dx.doi.org/ 10.4155/fmc.10.264 40.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Biochemical Biophysical Research Com- munications 2007; 359:497-502; PMID:17544373; http://dx.doi.org/10.1016/j.bbrc.2007.05.136 41.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Plos One 2012; 7:e50594; PMID:23227189; http://dx.doi.org/10.1371/journal.pone.0050594 43.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Mol Cell Biol 2010; 30:106-15;PMID:19841069; http://dx.doi.org/10.1128/ MCB.01162-09 1004 Volume 10 Issue 11 Epigenetics,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
J Biol Chem 2007; 282:15439-50; PMID:17416903; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Science 2013; 339:218-22; PMID:23223452; http://dx.doi.org/10.1126/ science.1227568 4 6 .,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Hypertension 2008; 51:1156-62;PMID:18259002; http://dx.doi.org/10.1161/ HYPERTENSIONAHA.107.105247 47.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
J Nutr Metab 2012;2012:476380; http://dx.doi.org/10.1155/2012/476380 49.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Nat Rev Mol Cell Biol 2003; 4:373-84;PMID:12728271; http://dx.doi.org/10.1038/nrm1105 50.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Faseb J 2011; 25:1378-89;PMID:21209057; http://dx.doi.org/10.1096/fj.10- 170365 51.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Epigenetics Chromatin 2009; 2:3; PMID:19284538; http://dx.doi.org/10.1186/1756- 8935-2-3 55.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
"Methods 2010; 52, 255-8; PMID:20599507; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Transl Psychiatry 2014; 4:e433; PMID:25180572; http://dx.doi.org/10.1038/ tp.2014.70 57.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
PLoS Genet 2010; 6:e1000952; PMID:20485568; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Pediatr 2002; 109:45-60; PMID:11773541; http://dx.doi.org/10.1542/peds.109.1.45 59.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
J Pediatr 2010; 157:552-8; PMID:20542285; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
"Epigenomics 2011; 3,:771-84; PMID:22126295; http://dx.doi.org/10.2217/epi.",OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
Epigenetics 2012; 7:1173-87; http://dx.doi.org/ 10.4161/epi.22102 62.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
PLoS One 2012; 7:e41361;PMID:22848472; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d8/08/kepi-10-11-1080411.PMC4844195.pdf
"Gene ontology analysis of affectedgenes revealed biological processes signiﬁcantly targeted in the © Lukas Vrba, James C Garbe, Martha R Stampfer, and Bernard W Futscher *Correspondence to: Bernard W Futscher; Email: bfutscher@uacc.arizona.eduSubmitted: 09/04/2015; Revised: 09/28/2015; Accepted: 10/05/2015 http://dx.doi.org/10.1080/15592294.2015.1106673 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
The results shown here are in part based upon data gener-ated by the TCGA Research Network: http://cancergenome.nih.gov/.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cell Cycle 2014; 13:3423-35;PMID:25485586; http://dx.doi.org/10.4161/ 15384101.2014.954456 2.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Nat Genet 2015; 47:199-208; PMID:25599403; http://dx.doi.org/10.1038/ng.3192 4.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cell 2013; 154:26-46; PMID:23827673; http://dx.doi.org/10.1016/j.cell.2013.06.020 5.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Nat Cell Biol 2012; 14:659-65; PMID:22684254; http://dx.doi.org/10.1038/ncb2521 6.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cell 2014; 157:77-94; PMID:24679528; http://dx.doi.org/ 10.1016/j.cell.2014.03.008 7.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
The product of the H19 gene may function as an RNA.Mol Cell Biol 1990; 10:28-36; PMID:1688465; http://dx.doi.org/10.1128/MCB.10.1.28 8.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Annu Rev Biochem 2012; 81:145-66; PMID:22663078; http://dx.doi.org/10.1146/annurev- biochem-051410-092902 9.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Nature 1996; 379:131-7; PMID:8538762; http://dx.doi.org/10.1038/379131a0 10.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Annu Rev Cell Dev Biol 2014; 30:561-80; PMID:25000994; http://dx.doi.org/10.1146/annurev- cellbio-101512-122415 11.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cold Spring Harbor Symposia Quantitative Biol 2004; 69:89-102; PMID:16117637; http://dx.doi.org/10.1101/sqb.2004.69.89 12.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cell 2013; 152:1308-23; PMID:23498939; http://dx.doi.org/10.1016/j.cell.2013.02.016 13.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cancer Res 2007; 67:5134-40;PMID:17545591; http://dx.doi.org/10.1158/0008- 5472.CAN-07-0465 14.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Sci 2013; 341:1237973; PMID:23828888; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cell 2007; 129:1311-23; PMID:17604720; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Front Genet 2012; 3:17; PMID:22363342; http://dx.doi.org/10.3389/ fgene.2012.00017 19.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Nature 2010;464:1071-6; PMID:20393566; http://dx.doi.org/ 10.1038/nature08975 20.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Oncogene 2003; 22:8031-41; PMID:12970751; http://dx.doi.org/10.1038/sj.onc.1206928 21.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
J Cell Sci 2009; 122:207-14; PMID:19118213; http://dx.doi.org/10.1242/jcs.040394 22.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Proc Soc Exp Biol Med 1999; 222:124-38; PMID:10564536; http://dx.doi.org/10.1046/j.1525-1373.1999.d01-122.x 23.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cell 2002; 110:673-87;PMID:12297042; http://dx.doi.org/10.1016/S0092- 8674(02)00971-6 24.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Nucleic Acids Res 2013; 41:e74; PMID:23335781; http://dx.doi.org/ 10.1093/nar/gkt006 25.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Genome Res 2012; 22:1775- 89; PMID:22955988; http://dx.doi.org/10.1101/gr.132159.11126.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Nature 2012; 483:603-7; PMID:22460905; http://dx.doi.org/10.1038/nature11003 27.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cell Rep 2015; 11:1110-22; PMID:25959816; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Can- cer Res 2009; 69:7557-68; PMID:19773443; http://dx.doi.org/10.1158/0008-5472.CAN-09-0270 33.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Oncogene 2003;22:3624-34; PMID:12789271; http://dx.doi.org/ 10.1038/sj.onc.1206545 34.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Oncogene 1998; 17:1807-12;PMID:9778046; http://dx.doi.org/10.1038/sj.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Biostatistics2007; 8:485-99; PMID:17189563; http://dx.doi.org/ 10.1093/biostatistics/kxl042 37.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Bioinformatics 2007; 23:257-8; PMID:17098774; http://dx.doi.org/10.1093/ bioinformatics/btl567 39.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
PLoS Comput Biol 2008; 4:e1000176; PMID:19043537; http://dx.doi.org/ 10.1371/journal.pcbi.100017640.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Cancer Res 2009;69:5251-8; PMID:19509227; http://dx.doi.org/ 10.1158/0008-5472.CAN-08-4977 41.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
BMC Genomics 2008; 9:486; PMID:18922183;http://dx.doi.org/10.1186/1471-2164-9-486 42.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Bioinformatics2009; 25:1105-11; PMID:19289445; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Bio- informatics 2009; 25:2078-9; PMID:19505943; http://dx.doi.org/10.1093/bioinformatics/btp352 44.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
Genome Biol 2014; 15:R29; PMID:24485249; http://dx.doi.org/10.1186/gb-2014- 15-2-r29 www.tandfonline.com 1083 Epigenetics,Non-OADS,/arxiv_data1/oa_pdf/2c/52/kepi-10-11-1106673.PMC4844203.pdf
"5,12,13The majority of FSHD2 individuals carry heterozygous mutations in the structural maintenance of © Judit Balog, Peter E. Thijssen, Sean Shadle, Kirsten R. Straasheijm, Patrick J. van der Vliet, Yvonne D. Krom, Marlinde L. van den Boogaard, Annika de Jong, Richard J. L. F Lemmers, Rabi Tawil, Stephen J. Tapscott, and Silv /C18ere M. van der Maarel *Correspondence to: Silv /C18ere M van der Maarel and Stephen J Tapscott; Email: Maarel@lumc.nl and stapscot@fhcrc.org Submitted: 07/15/2015; Revised: 09/20/2015; Accepted: 10/22/2015 http://dx.doi.org/10.1080/15592294.2015.1113798 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Materials and Methods Culturing of human primary myoblast cell linesHuman primary myoblast cell lines were originating from the University of Rochester bio r epository (http://www.urmc.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Neurol- ogy 2014; 83:1056–9; PMID:25122204; http://dx.doi.org/10.1212/WNL.0000000000000797 3.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Lancet1990; 336:651–3; PMID:1975852; http://dx.doi.org/ 10.1016/0140-6736(90)92148-B 5.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
"Nat Genet 1992; 2:26–30; PMID:1363881; http://dx.doi.org/10.1038/ng0992- 26 6. van der Maarel SM, Tawil R, Tapscott SJ.",OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Trends Mol Med 2011; 17:252–8;PMID:21288772; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
PLoS Genet 2010; 6:e1001181; PMID:21060811; http://dx.doi.org/10.1371/journal.pgen.1001181 9.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Dev Cell 2012; 22:38–51; PMID:22209328; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Ann Neurol 2011; 69:540–52; PMID:21446026;http://dx.doi.org/10.1002/ana.22275 12.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
"Hum Mol Genet 1993;2:2037–42; PMID:8111371; http://dx.doi.org/ 10.1093/hmg/2.12.2037 1 4 .L e m m e r sR J ,T a w i lR ,P e t e kL M ,B a l o gJ ,B l o c k G J ,S a n t e nG W ,A m e l lA M ,v a nd e rV l i e tP J , Almomani R, Straasheijm KR, et al.",OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Nat Genet 2012; 44:1370–4; PMID:23143600; http://dx.doi.org/10.1038/ng.2454 15.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Am J Hum Genet 2013; 93:744–51; PMID:24075187; http://dx.doi.org/ 10.1016/j.ajhg.2013.08.004 16.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
"Hum Mutat 2015; 36:679–83; PMID:25820463; http://dx.doi.org/10.1002/ humu.22792 1 7 .B o d e g aB ,R a m i r e zG D ,G r a s s e rF ,C h e l iS ,B r u - nelli S, Mora M, Meneveri R, Marozzi A, Mueller S, Battaglioli E, et al.",OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
BMC Biol 2009; 7:41; PMID:19607661; http://dx.doi.org/10.1186/1741-7007-7-41 18.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
PLoS Genet 2009; 5:e1000559; PMID:19593370; http://dx.doi.org/ 10.1371/journal.pgen.1000559 19.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Epige- netics 2012; 7:579–84; PMID:22522912; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Hum Mutat 2009; 30:1449–59; PMID:19728363; http://dx.doi.org/10.1002/humu.21091 21.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
"Neurology 2013; 80:392–9; PMID:23284062; http://dx.doi.org/ 10.1212/WNL.0b013e31827f075c 22. van Overveld PG, Lemmers RJ, Sandkuijl LA, Ent- hoven L, Winokur ST, Bakels F, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM.",Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Nat Genet2003; 35:315–7; PMID:14634647; http://dx.doi.org/ 10.1038/ng1262 23.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Cell 2012; 149:819–31; PMID:22541069; http://dx.doi.org/ 10.1016/j.cell.2012.03.035 24.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
RNA Biol 2012; 9:1211–7; PMID:23047063; http://dx.doi.org/10.4161/rna.21922 25.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Hum Mol Genet 2009; 18:2414–30; PMID:19359275; http://dx.doi.org/10.1093/hmg/ddp180 26.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Hum Mol Genet 2015; 24(17):4817–28; PMID:26041815; http://dx.doi.org/ 10.1093/hmg/ddv206 27.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Hum Mol Genet 2012; 21:4419–30; PMID:22798623; http://dx.doi.org/10.1093/hmg/ dds284 28.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
J Cell Mol Med 2013; 17:76–89; PMID:23206257; http://dx.doi.org/10.1111/j.1582- 4934.2012.01647.x 30.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Nature 2012; 492:108–12; PMID:23051747; http://dx.doi.org/10.1038/nature11606 33.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Genome Biol 2013; 14:R25; PMID:23531360; http://dx.doi.org/10.1186/gb-2013-14-3-r25 34.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Mol Cell 2009; 36:61–74; PMID:19818710; http://dx.doi.org/10.1016/j.molcel.2009.08.008 35.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Hum Mutat 2014; 35:998–1010; PMID:24838473; http://dx.doi.org/ 10.1002/humu.22593 36.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Nat Rev Mol Cell Biol 2009; 10:697–708; PMID:19738629; http://dx.doi.org/10.1038/nrn2731 37.,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Nat Chem Biol 2013; 9:136–7; PMID:23416387; http://dx.doi.org/10.1038/nchembio.1187 38.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Nat Struct Mol Biol 2013; 20:671–8; PMID:23644600; http://dx.doi.org/10.1038/ nsmb.2571 39.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Nat Commun 2013; 4:2848; PMID:24270157; http://dx.doi.org/10.1038/ ncomms3848 40.,OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
Skelet Muscle 2013; 3:8; PMID:23566431; http://dx.doi.org/10.1186/2044-5040-3-8 1142 Volume 10 Issue 12 Epigenetics,Non-OADS,/arxiv_data1/oa_pdf/4d/bc/kepi-10-12-1113798.PMC4844215.pdf
"Expression of TRPM3 The trpm3 gene is localized on chromosome 9q21.12 in human and on chromosome 19qb in mouse.19,20The complete © KU Leuven *Correspondence to: Joris Vriens; Email:Joris.Vriens@med.kuleuven.beSubmitted: 10/05/2014; Revised: 11/06/2014; Accepted: 11/12/2014 http://dx.doi.org/10.4161/23328940.2014.988524 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nat Rev Neurosci 2014; 15:573- 89; PMID:25053448; http://dx.doi.org/10.1038/ nrn3784 2.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2000; 405:183-7; PMID:10821274; http://dx.doi.org/ 10.1038/35012076 5.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Neurosci 2004; 24:6410-5; PMID:15254097; http://dx.doi.org/ 10.1523/JNEUROSCI.1421-04.2004 7.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Neuroscience 2005; 135:1277-84; PMID:16165301; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 1999; 398:436-41; PMID:10201375; http://dx.doi.org/10.1038/18906 9.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Science 2002; 296:2046-9; PMID:12016205; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
TRPV3 is a temperature-sensitive vanilloid receptor-lik ep r o t e i n .N a t u r e2 0 0 2 ; 418:186-90; PMID:12077606; http://dx.doi.org/10.1038/nature00894 12.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2002;418:181-6; PMID:12077604; http://dx.doi.org/ 10.1038/nature00882 14.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Neurosci 2011; 31:11425-36; PMID:21832173; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Biol Chem 2007; 282:15894-902; PMID:17395593; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Mol Pain 2011;7:37; PMID:21586160; http://dx.doi.org/10.1186/ 1744-8069-7-37 17.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nat commun 2011;2:369; PMID:21712817; http://dx.doi.org/10.1038/ ncomms1371 18.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Neuron2011; 70:482-94; PMID:21555074; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Biol Chem 2005; 280:22540-8; PMID:15824111; http://dx.doi.org/ 10.1074/jbc.M503092200 21.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Biol Chem 2003; 278:21493-501; PMID:12672799;http://dx.doi.org/10.1074/jbc.M300945200 23.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Recept Signal Transduct Res 2006; 26:159-78; PMID:16777713; http://dx.doi.org/10.1080/10799890600637506 26.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Eur J Neurosci 2012; 35:34-43; PMID:22211741; http://dx.doi.org/10.1111/j.1460- 9568.2011.07944.x 27.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Arch Pharm Res 2012; 35:1823-30;PMID:23139135; http://dx.doi.org/10.1007/s12272- 012-1016-828.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Dev Dyn 2013; 242:1236-49;PMID:23908157; http://dx.doi.org/10.1002/ dvdy.24020 29.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
PLoS Genet 2013; 9:e1003357; PMID:23516376; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Invest Ophthalmol Vis Sci 2007; 48:509- 15; PMID:17251443; http://dx.doi.org/10.1167/ iovs.06-0866 31.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Circ Res 2010; 106:1507- 15; PMID:20360246; http://dx.doi.org/10.1161/ CIRCRESAHA.110.219329 33.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Cell 2009; 139:267-84; PMID:19837031; http://dx.doi.org/10.1016/j.cell.2009.09.028 35.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Chem Senses 2005; 30 Suppl 1:i193-4;PMID:15738110; http://dx.doi.org/10.1093/chemse/ bjh180 36.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
BMC Neurosci 2013; 14:21; PMID:23410158; http://dx.doi.org/10.1186/1471- 2202-14-21 37.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Pﬂugers Arch 2010; 460:755-65; PMID:20401728; http://dx.doi.org/10.1007/s00424- 010-0838-9 38.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2013; 504:113-8; PMID:24305161; http://dx.doi.org/10.1038/nature12823 39.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2013; 504:107-12; PMID:24305160; http://dx.doi.org/10.1038/ nature12822 40.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
EMBO J 2003; 22:776-85;PMID:12574114; http://dx.doi.org/10.1093/emboj/ cdg080 41.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Physiol 2011; 589:4827-35; PMID:21878524; http://dx.doi.org/10.1113/jphysiol.2011.216523 42.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
"J Biol Chem 2011; 286:12221-33; PMID:21278253; http://dx.doi.org/ 10.1074/jbc.M110.202945 4 3 .W uL J ,S w e e tT B ,C l a p h a mD E .I n t e r n a t i o n a l Union of Basic and Clinical Pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Pharmacol Rev 2010; 62:381- 404; PMID:20716668; http://dx.doi.org/10.1124/ pr.110.002725 44.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nat Chem Biol 2014; 10:188-95; PMID:24390427; http://dx.doi.org/ 10.1038/nchembio.1428 45.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Br J Pharmacol 2014;171:1019-32; PMID:24251620; http://dx.doi.org/ 10.1111/bph.12521 46.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Cell Calcium 2012; 51:1-11; PMID:22000496; http://dx.doi.org/10.1016/j.ceca.2011.09.005 47.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nat Cell Biol 2008; 10:1421-30; PMID:18978782; http://dx.doi.org/10.1038/ncb1801 48.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Neuron 2005; 45:379- 88; PMID:15694325; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Front Pharmacol 2014;5:53; PMID:24772081; http://dx.doi.org/10.3389/ fphar.2014.00053 51.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2007; 446:76-8; PMID:17330043; http://dx.doi.org/ 10.1038/nature05598 5 2 .,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2007; 445:546-9; PMID:17187057; http://dx.doi.org/10.1038/ nature05396 53.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Neurology 2007; 69:2045-53; PMID:17872363; http://dx.doi.org/10.1212/01.wnl.0000275523.95103.36 54.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Br J Pharmacol 2011; 162:1757-69; PMID:21198543; http://dx.doi.org/10.1111/j.1476- 5381.2010.01186.x 56.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Mol Pharmacol 2013; 84:736- 50; PMID:24006495; http://dx.doi.org/10.1124/ mol.113.086843 57.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Clin Endocrinol Metab 2002; 87:2225-31; PMID:11994368; http://dx.doi.org/10.1210/jcem.87.5.8499 58.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
"Molecules 2013;18:12012-28; PMID:24084011; http://dx.doi.org/ 10.3390/molecules181012012 5 9 .M a j e e dY ,A g a r w a lA K ,N a y l o rJ ,S e y m o u rV A , Jiang S, Muraki K, Fishwick CW, Beech DJ.",OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Br J Pharmacol 2010; 161:430- 41; PMID:20735426; http://dx.doi.org/10.1111/j.1476-5381.2010.00892.x 60.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Mol Pharmacol 2011; 79:1023- 30; PMID:21406603; http://dx.doi.org/10.1124/ mol.110.069922 61.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Br J Pharmacol 2013; 168:1835- 50; PMID:23190005; http://dx.doi.org/10.1111/ bph.12076 62.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Curr Pharm Biotechnol 2011; 12:35-41; PMID:20932261; http://dx.doi.org/10.2174/ 138920111793937943 63.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Neurosci 2005; 25:8924-37; PMID:16192383; http://dx.doi.org/10.1523/JNEUROSCI.2574-05.2005 64.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Biophys J 2003; 85:2988-3006; PMID: 14581201; http://dx.doi.org/10.1016/S0006-3495 (03)74719-5 68.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Proc Natl Acad Sci U S A 2000; 97:13889-94; PMID:11095706; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2004; 430:748-54;PMID:15306801; http://dx.doi.org/10.1038/ nature02732 72.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
JNeurosci 2007; 27:9874-84; PMID:17855602; http://dx.doi.org/10.1523/JNEUROSCI.2221- 07.2007 73.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nature 2005; 438:1022- 5; PMID:16355226; http://dx.doi.org/10.1038/nature04248 74.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Gen Physiol 2011; 137:173- 95; PMID:21282398; http://dx.doi.org/10.1085/jgp.201010498 75.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Proc Natl Acad Sci U S A 2004;101:15494-9; PMID:15492228; http://dx.doi.org/ 10.1073/pnas.0406773101 76.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Biophys J 2013; 104:2160-9; PMID:23708356; http://dx.doi.org/10.1016/j.bpj.2013.03.055 77.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Cell Calcium 2007; 42:427-38; PMID:17499848; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Neurosci 2006; 26:4835-40; PMID:16672657; http://dx.doi.org/10.1523/ JNEUROSCI.5080-05.2006 80.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nat Neurosci 2010; 13:708-14; PMID:20414199; http://dx.doi.org/ 10.1038/nn.2552 82.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Biotechniques 2009; 47:iii-ix; PMID:19852757; http://dx.doi.org/10.2144/ 000113198 83.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
"Voets T, Owsianik G, Janssens A, Talavera K, Nilius B. TRPM8 voltage sensor mutants reveal a mecha- nism for integrating thermal and chemical stimuli.Nat Chem Biol 2007; 3:174-82; PMID:17293875; http://dx.doi.org/10.1038/nchembio862 84.",OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Curr Biol 2007; 17:1363- 72; PMID:17702581; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Cardiovasc Res 2014; 104:326-36; PMID:25190043; http://dx.doi.org/ 10.1093/cvr/cvu199 87.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Nat Rev Drug Discov 2011; 10:601- 20; PMID:21804597; http://dx.doi.org/10.1038/ nrd3456 88.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Mol Cell Endocrinol 2008; 283:49-57; PMID:18177995; http://dx.doi.org/10.1016/j.mce.2007.11.020 90.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Bioorg Med Chem 2008; 16:8466-70; PMID:18778944; http://dx.doi.org/10.1016/j.bmc.2008.08.034 91.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Am J Physiol Regul Integr Comp Physiol 2007; 292:R37-46; PMID:17008453; http://dx.doi.org/10.1152/ajpregu.00668.2006 92.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Neuron 2004; 41:849-57;PMID:15046718; http://dx.doi.org/10.1016/S0896- 6273(04)00150-3 93.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Neurosci 2008; 28:7863-75;PMID:18667618; http://dx.doi.org/10.1523/ JNEUROSCI.1696-08.2008 94.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Brain Res 2007; 1160:39-46;PMID:17588549; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
"Cell 2003; 112:819-29; PMID:12654248; http://dx.doi.org/10.1016/S0092-8674(03)00158-2 96. de Oliveira C, Garami A, Lehto SG, Pakai E, Tekus V, Pohoczky K, Youngblood BD, Wang W, KortME, Kym PR, et al.",OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
J Neurosci 2014; 34:4445-52; PMID:24671991; http://dx.doi.org/ 10.1523/JNEUROSCI.5387-13.2014 97.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
"J Neurosci 2012; 32:2086-99; PMID:22323721; http://dx.doi.org/10.1523/ JNEUROSCI.5606-11.2012 9 8 .K n o w l t o nW M ,D a n i e l sR L ,P a l k a rR ,M c C o y DD, McKemy DD.",Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
PloS One 2011; 6:e25894; PMID:21984952; http://dx.doi.org/10.1371/ journal.pone.0025894 99.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Pharmacol Rev 2009; 61:228-61; PMID:19749171; http://dx.doi.org/10.1124/pr.109.001263 101.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
"Bennett TM, Mackay DS, Siegfried CJ, Shiels A. Mutation of the Melastati n-Related Cation Chan- nel, TRPM3, Underlies Inherited Cataract and G l a u c o m a .P l o So n e2 0 1 4 ;9 : e 1 0 4 0 0 0 ;PMID:25090642; http://dx.doi.org/10.1371/ journal.pone.0104000 102.",Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Exp Eye Res 2004;78:625-31; PMID:15106942; http://dx.doi.org/ 10.1016/j.exer.2003.09.021 103.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Exp Eye Res 2009; 88:226-34; PMID:19061888; http://dx.doi.org/10.1016/j.exer.2008.10.025 104.,OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
Prog Retinal Eye Res 2007; 26:263-301;PMID:17258931; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/4b/c0/ktmp-02-02-988524.PMC4844244.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/d8/tcrm-12-631.PMC4844252.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 631–642Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  631ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10161 9The Psoriatic arthritis impact of Disease 12-item  questionnaire: equivalence, reliability, validity, and  feasibility of the touch-screen administration  versus the paper-and-pencil version Fausto salaffi1 Marco Di Carlo1 Marina Carotti2 sonia Farah3 Marwin gutierrez1,4 1Rheumatology Department,   Polytechnic University of  Marche, 2Radiology Department,   Polytechnic University of Marche,   3Dii, Department of information  engineering, Polytechnic University of  Marche, ancona, italy; 4Musculoskeletal  Department, national Rehabilitation  institute, Mexico City, MexicoBackground:  Over the last few years, there has been a shift toward a more patient-centered  perspective of the disease by adopting patient-reported outcomes.",Non-OADS,/arxiv_data1/oa_pdf/3c/d8/tcrm-12-631.PMC4844252.pdf
"The prevalence  of psoriasis is ~0.5% in the general population,1,2 and the prevalence of PsA among Correspondence: Fausto Salaffi Rheumatology Department, Polytechnic  University of Marche, c/o Ospedale  “Carlo Urbani”, Via aldo Moro 25,  Jesi, 60035 ancona, italy Tel +39 731 53 4128 Fax +39 731 53 4124 email fausto.salaffi@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Salaffi et al Running head recto: Validity, reliability, and feasibility of the touch-screen PsAID-12 DOI: http://dx.doi.org/10.2147/TCRM.S101619",Non-OADS,/arxiv_data1/oa_pdf/3c/d8/tcrm-12-631.PMC4844252.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3c/d8/tcrm-12-631.PMC4844252.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/d8/tcrm-12-631.PMC4844252.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/17/tcrm-12-623.PMC4844253.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 623–630Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  623ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10277 2Cardiac, renal, and neurological benefits of  preoperative levosimendan administration in patients  with right ventricular dysfunction and pulmonary  hypertension undergoing cardiac surgery: evaluation  with two biomarkers neutrophil gelatinase- associated lipocalin and neuronal enolase José luis guerrero-Orriach,1  Daniel ariza-Villanueva,1 ana  Florez-Vela,1 lourdes garrido- sánchez,2,3 María isabel  Moreno-Cortés,1 Manuel  galán-Ortega,1 alicia Ramírez- Fernández,1 Juan alcaide  T orres,3 Concepción santiago  Fernandez,3 isabel navarro  arce,1 José María Melero- T ejedor,4 Manuel Rubio- navarro,1 José Cruz-Mañas1 1Department of Cardio-Anaesthesiology,   University hospital Virgen de la Victoria,   Málaga, spain; 2CiBeR Fisiología de la  Obesidad y nutrición (CiBeROBn ),   instituto de salud Carlos iii, Málaga,   spain; 3Department of Nutrition and  endocrinology, instituto de investigaciones  Biomédicas de Málaga (iBiM a), University  hospital Virgen de la Victoria, Málaga, spain;   4Department of Cardiovascular Surgery,   University hospital Virgen de la Victoria,   Málaga, spainPurpose:  To evaluate if the preoperative administration of levosimendan in patients with  right ventricular (RV) dysfunction, pulmonary hypertension, and high perioperative risk would  improve cardiac function and would also have a protective effect on renal and neurological  functions, assessed using two biomarkers neutrophil gelatinase-associated lipocalin (N-GAL)  and neuronal enolase.",Non-OADS,/arxiv_data1/oa_pdf/28/17/tcrm-12-623.PMC4844253.pdf
"29010,  Málaga, spain Tel +34 951 032 051; +34 951 032 000 email guerreroorriach@terra.co m;   lourgarrido@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Guerrero-Orriach et al Running head recto: Preoperative levosimendan improves organic functions DOI: http://dx.doi.org/10.2147/TCRM.S102772",Non-OADS,/arxiv_data1/oa_pdf/28/17/tcrm-12-623.PMC4844253.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/28/17/tcrm-12-623.PMC4844253.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/17/tcrm-12-623.PMC4844253.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Vascular Health and Risk Management Vascular Health and Risk Management 2016:12 163–169Dove press submit your manuscript | www.dovepress.co m Dove press  ReViewopen access to scientific and medical research Open Access Full T ext Article 163 http: //dx.doi.org/10.2147/VHRM.S8238 7Clinical efficacy and safety of evolocumab for low- density lipoprotein cholesterol reduction Courtney A Henry Ronald A Lyon Hua Ling Department of Pharmacy Practice,   School of Pharmacy, Hampton  University, Hampton, VA, USA Correspondence: Hua Ling   Department of Pharmacy Practice,   School of Pharmacy, Hampton University,  100 E Queen Street, Hampton, VA   23668, USA   email hua.ling@hamptonu.ed uAbstract:  Multiple categories of medications have been developed to manage lipid profiles  and reduce the risk of cardiovascular events in patients with heart disease.",Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT01764633?term =FOURIER&r ank=6.,Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT01879319?term =20120356&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
Available from:  https://clinicaltrials.gov/show/NCT0184949 7.,Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
"Avail - able from: http://cepac.icer-review.org/wp-content/uploads/2015/04/ PCSK9_Draft_Report_0908151.pd f. Accessed October 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6f/83/vhrm-12-163.PMC4844254.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/82/jmdh-9-173.PMC4844255.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Interdisciplinary collaboration experiences in  creating an everyday rehabilitation model: a pilot  study Aud Moe1,2 Hildfrid V Brataas1,2 1Faculty of Health Science, Nord  University, Steinkjer, Nord-Trøndelag,   2Center of Care Research,    Mid-Norway, Steinkjer,    Nord-Trøndelag, Norway Correspondence: Aud Moe   Faculty of Health Science, Nord  University, Serviceboks 2501, N-7729  Steinkjer, Nord-Trøndelag, Norway   T el +47 911 31 163   Fax +47 7402 2501   Email aud.moe@nord.n oBackground:  When functional impairment occurs, assistance to achieve self-help can lead to  qualitatively more active everyday life for recipients and better use of community resources.",Non-OADS,/arxiv_data1/oa_pdf/9d/82/jmdh-9-173.PMC4844255.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/9d/82/jmdh-9-173.PMC4844255.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/82/jmdh-9-173.PMC4844255.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/3c/jaa-9-083.PMC4844256.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/5f/3c/jaa-9-083.PMC4844256.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Sleep-disordered breathing in children with  asthma: a systematic review on the impact of  treatment Trinidad Sánchez1 José A Castro-Rodríguez2 Pablo E Brockmann2,3 1Division of Pediatrics, School of  Medicine, 2Department of Pediatric  Cardiology and Pulmonology, Division  of Pediatrics, School of Medicine,   3Sleep Medicine Center, Department  of Neurology, School of Medicine,   Pontificia Universidad Católica de  Chile, Santiago, Chile Correspondence: Pablo E Brockmann   Department of Pediatric Cardiology  and Pulmonology, Division of Pediatrics,  School of Medicine, Pontificia Universidad  Católica de Chile, Lira 85 5to piso,  8330074 Santiago, Chile   T el +56 2 2354 3767   Fax +56 2 2638 4307   Email pbrockmann@med.puc.c lBackground:  The objective was to perform a systematic review in order to describe the relation­ ship between asthma and sleep­disordered breathing (SDB) in children, especially regarding  the impact of treatment and management.",Non-OADS,/arxiv_data1/oa_pdf/5f/3c/jaa-9-083.PMC4844256.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer ­reviewed  open ­access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi ­ ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/5f/3c/jaa-9-083.PMC4844256.pdf
Visit http://www.dovepress.com/testimonials.php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/3c/jaa-9-083.PMC4844256.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4e/40/jmdh-9-183.PMC4844257.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/4e/40/jmdh-9-183.PMC4844257.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Multidisciplinary Healthcare 2016:9 183–190Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  183Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S9605 5Systematic, early identification of dementia and  dementia care management are highly appreciated by  general physicians in primary care – results within a  cluster-randomized-controlled trial (DelpHi) Jochen rené Thyrian1,* Tilly eichler1,* andrea Pooch1 Kerstin albuerne1 adina Dreier2 Bernhard Michalowsky1 Diana Wucherer1 Wolfgang Hoffmann1,2 1german center for neurode- generative Diseases (DZ ne), site  greifswald, W g interventional  Health care research, greifswald,   2Department of epidemiology of  Health care and community Health,   institute for community Medicine,   University of greifswald, greifswald,   germany *These authors contributed equally to  this work correspondence: Jochen rené Thyrian   german center for neurodegenerative  Diseases (DZne), site rostock/ greifswald, ellernholzstraße 1-2, 17489  greifswald, germany   Tel +49 3834 86 7592   Fax +49 3834 86 19551   email rene.thyrian@dzne.d eBackground:  There is evidence about the benefits of early detection of dementia and subsequent  provision of adequate treatment and care.",Non-OADS,/arxiv_data1/oa_pdf/4e/40/jmdh-9-183.PMC4844257.pdf
Available from: http://www.dgppn.de/fileadmin/user_upload/_medien/ download/pdf/kurzversion-leitlinien/s3-leitlinie-demenz-lf.pdf ; 2009.,Non-OADS,/arxiv_data1/oa_pdf/4e/40/jmdh-9-183.PMC4844257.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/4e/40/jmdh-9-183.PMC4844257.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/40/jmdh-9-183.PMC4844257.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/29/dddt-10-1525.PMC4844258.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1525–1531Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1525Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9469 4The influence of dietary sodium content on the  pharmacokinetics and pharmacodynamics of  fimasartan namyi gu1,2 Joo-Y oun cho3 Kwang-hee shin4 in-Jin Jang3 Moo-Y ong rhee2,5 1Department of Clinical Pharmacology  and Therapeutics, 2clinical Trial  center, Dongguk University college  of Medicine and Ilsan Hospital,   goyang, 3Department of Clinical  Pharmacology and Therapeutics,   seoul national University college  of Medicine and Hospital, Seoul,   4Pharmacotherapy & Translational  Research Lab., College of Pharmacy,   Research Institute of Pharmaceutical  sciences, Kyungpook national  University, Daegu, 5cardiovascular  center, Dongguk University college  of Medicine and Ilsan Hospital,   Goyang, Republic of KoreaAbstract:  A low sodium diet enhances the hemodynamic effect of renin–angiotensin system  blockers.",Non-OADS,/arxiv_data1/oa_pdf/61/29/dddt-10-1525.PMC4844258.pdf
"High dietary sodium intake  had been reported to be related to 20%–60% reduction of the oral bioavailability in some  cardiovascular drugs, such as verapamil, atenolol, and quinidine, which are substrates of correspondence: Moo-Yong rhee cardiovascular center, Dongguk  University College of Medicine and Ilsan  hospital, 27 Dongguk-ro, siksa-dong,  ilsandong-gu, goyang, gyeonggi, 410-773,  Republic of Korea Tel +82 31 961 7125 (Office) Fax +82 31 961 8449 email mooyong_rhee@dumc.or.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gu et al Running head recto: Pharmacokinetics and pharmacodynamics of fimasartan and sodium intake DOI: http://dx.doi.org/10.2147/DDDT.S94694",Non-OADS,/arxiv_data1/oa_pdf/61/29/dddt-10-1525.PMC4844258.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/61/29/dddt-10-1525.PMC4844258.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/61/29/dddt-10-1525.PMC4844258.pdf
"Available from: http://www.wma.net/ en/30publications/10policies/b3/17c.pd f. Accessed April 4, 2015.",Non-OADS,/arxiv_data1/oa_pdf/61/29/dddt-10-1525.PMC4844258.pdf
Available from: http://www.ich.org/ fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/ E6_R1_Guideline.pd f. Accessed April 2015.,Non-OADS,/arxiv_data1/oa_pdf/61/29/dddt-10-1525.PMC4844258.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/77/ijn-11-1629.PMC4844271.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1629–1641International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1629OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10416 2c(rgDyK)-decorated Pluronic micelles for  enhanced doxorubicin and paclitaxel delivery  to brain glioma YuKun huang1 Wenchao liu1 Feng gao1 Xiaoling Fang2 Yanzuo chen1 1Department of Pharmaceutics, school  of Pharmacy, east china University  of science and T echnology, 2Key  laboratory of smart Drug Delivery,   Ministry of education & P la, school  of Pharmacy, Fudan University,   shanghai, People’s republic of chinaAbstract:  Brain glioma therapy is an important challenge in oncology.",Non-OADS,/arxiv_data1/oa_pdf/b8/77/ijn-11-1629.PMC4844271.pdf
"Pluronic polymeric micelles,  such as paclitaxel (PTX)-loaded vitamin E succinate-modified Pluronic micelles,9 gold  nanoparticle crosslinked PF-PTX-micelles,10 17-AAG-loaded Pluronic P-123, F-127 correspondence: Yanzuo chen Department of Pharmaceutics, school  of Pharmacy, east china University of  science and Technology, 130 Meilong  road, Xuhui, shanghai 200237,  People’s republic of china Tel +86 21 6425 2449 Fax +86 21 6425 2449 email chenyz@ecust.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Huang et al Running head recto: Pluronic micelles for enhanced DOX and PTX delivery to brain glioma DOI: http://dx.doi.org/10.2147/IJN.S104162",Non-OADS,/arxiv_data1/oa_pdf/b8/77/ijn-11-1629.PMC4844271.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b8/77/ijn-11-1629.PMC4844271.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/77/ijn-11-1629.PMC4844271.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/f1/vhrm-12-143.PMC4844294.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Vascular health and risk Management 2016:12 143–151submit your manuscript | www.dovepress.co m Dove press  143 http: //dx.doi.org/10.2147/VHRM.S9539 1Mortality in primary angioplasty patients starting  antiplatelet therapy with prehospital prasugrel or  clopidogrel: a 1-year follow-up from the european  MUlTiPrac registry Patrick goldstein1 niccolò grieco2 hüseyin ince3,4 nicolas Danchin5 Yvonne ramos6 Jochen goedicke7 Peter clemmensen8,9 On behalf of the MU lTiPrac study  investigators 1emergency Department, lille  regional University hospital, lille,   France; 2Department of cardiology,   hospital niguarda cà granda Milano,   Milan, italy; 3internal Medicine centre,   cardiology Department, rostock  University clinic, rostock, germany;   4Department of cardiology, Vivantes  Klinikum im Friedrichshain and am  Urban, Berlin, germany; 5Department  of cardiology, european hospital  georges-Pompidou, Paris, France;   6Medical Department, Daiichi sankyo  europe, Munich, 7Medical Department,   lilly Deutschland gmbh, Bad  homburg, germany; 8Department  of Medicine, Division of cardiology,   rigshospitalet copenhagen University  hospital, 9Department of Medicine,   Division of cardiology, nykoebing F  hospital, copenhagen, Denmark correspondence: Patrick goldstein   emergency Department, lille regional  University hospital, centre hospitalier  régional Universitaire de lille,   2 avenue Oscar lambret,   59037 lille, France   T el +33 3 2044 4638   Fax +33 3 2044 4915   email patrick.goldstein@chru-lille.f rAim:  MULTIPRAC was designed to provide insights into the use and outcomes associated  with prehospital initiation of antiplatelet therapy with either prasugrel or clopidogrel in the  context of primary percutaneous coronary intervention.",Non-OADS,/arxiv_data1/oa_pdf/51/f1/vhrm-12-143.PMC4844294.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/51/f1/vhrm-12-143.PMC4844294.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/f1/vhrm-12-143.PMC4844294.pdf
Available  from: http://www.tctmd.com/show.aspx?id=12640 3.,Non-OADS,/arxiv_data1/oa_pdf/51/f1/vhrm-12-143.PMC4844294.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/da/tcrm-12-617.PMC4844302.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 617–622Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  617ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S10055 7are the blood groups of women with preeclampsia  a risk factor for the development of hypertension  postpartum?",Non-OADS,/arxiv_data1/oa_pdf/5a/da/tcrm-12-617.PMC4844302.pdf
"Kat, Kocasinan, Kayseri,  38010, Turkey Tel +90 532 7803805 email drsameterden@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Avci et al Running head recto: Blood groups in preeclampsia and hypertension postpartum DOI: http://dx.doi.org/10.2147/TCRM.S100557",Non-OADS,/arxiv_data1/oa_pdf/5a/da/tcrm-12-617.PMC4844302.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5a/da/tcrm-12-617.PMC4844302.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/da/tcrm-12-617.PMC4844302.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/bc/dddt-10-1515.PMC4844303.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1515–1523Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1515Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10602 5Long-term efficacy and safety of oxycodone– naloxone prolonged release in geriatric patients  with moderate-to-severe chronic noncancer pain:  a 52-week open-label extension phase study Fabio guerriero1,2 anna roberto3 Maria T eresa greco4 carmelo sgarlata1 Marco rollone2 Oscar corli3 1Department of internal Medicine and  Medical Therapy, section of geriatrics,   University of Pavia, 2Department of  geriatrics, agency for elderly People  of Pavia, santa Margherita institute,   Pavia, 3Department of Oncology,   Pain and Palliative care research  Unit, irccs-Mario negri institute  for Pharmacological research, 4Unit  of Medical statistics, Biometry  and epidemiology ga Maccacaro,   Department of clinical sciences and  community health, University of  Milan, Milan, italyBackground:  Two-thirds of older people suffer from chronic pain and finding valid treatment  options is essential.",Non-OADS,/arxiv_data1/oa_pdf/18/bc/dddt-10-1515.PMC4844303.pdf
"The ladder consists of the  use of nonopioid analgesics for mild pain (step 1), “weak” opioids, like codeine  and tramadol, associated generally with nonopioids for moderate pain (step 2), and  “strong” opioids with or without nonopioids for strong pain (step 3).1 On one hand, correspondence: Fabio guerriero Department of internal Medicine and  Medical Therapy, section of geriatrics,  University of Pavia, via emilia 12, 27100  Pavia, italy Tel +39 382 381 772 Fax +39 382 381 217 email fabio_guerriero@yahoo.i t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Guerriero et al Running head recto: Oxycodone/naloxone long term in older patients DOI: http://dx.doi.org/10.2147/DDDT.S106025",Non-OADS,/arxiv_data1/oa_pdf/18/bc/dddt-10-1515.PMC4844303.pdf
Available from: http://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/18/bc/dddt-10-1515.PMC4844303.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/18/bc/dddt-10-1515.PMC4844303.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/bc/dddt-10-1515.PMC4844303.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/7e/dddt-10-1533.PMC4844316.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1533–1542Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1533Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7776 1effects of a novel ace inhibitor, 3-(3-thienyl)- l- alanyl-ornithyl-proline, on endothelial vasodilation  and hepatotoxicity in l-naMe-induced  hypertensive rats Mahesh Kumar seth1–3 M ejaz hussain2 santosh Pasha1 Mohammad Fahim3 1Peptide synthesis laboratory, csir,   institute of genomics and integrative  Biology, Delhi, india; 2centre for  Physiotherapy and  rehabilitation  sciences, Jamia Millia islamia,   new Delhi, india; 3Department of  Physiology, Jamia hamdard Deemed  University, new Delhi, indiaAbstract:  Nitric oxide (NO) is a widespread biological mediator involved in many physiological  and pathological processes, eg, in the regulation of vascular tone and hypertension.",Non-OADS,/arxiv_data1/oa_pdf/b9/7e/dddt-10-1533.PMC4844316.pdf
"In addition to the inhibition of ACE, it prevents the break - down of bradykinin, a potent endothelium-dependent vasodilator,4 further decreasing correspondence: santosh Pasha Peptide synthesis laboratory, csir, institute of genomics and integrative  Biology, Mall road, Delhi 110007, india  email spasha@igib.res.in Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Seth et al Running head recto: Effects of TOP on l-NAME hypertension DOI: http://dx.doi.org/10.2147/DDDT.S77761",Non-OADS,/arxiv_data1/oa_pdf/b9/7e/dddt-10-1533.PMC4844316.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b9/7e/dddt-10-1533.PMC4844316.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/7e/dddt-10-1533.PMC4844316.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:317 –327; http://dx.doi.org/10.1016/j.jcmgh.2015.12.010 ) Keywords: CFTR; Constipation; High-Throughput Screening; Loperamide.,OADS,/arxiv_data1/oa_pdf/d5/37/main.PMC4844355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/37/main.PMC4844355.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.12.010,OADS,/arxiv_data1/oa_pdf/d5/37/main.PMC4844355.pdf
19.https://www.amitizahcp.com/ef ﬁcacy-indication-1/ .,Non-OADS,/arxiv_data1/oa_pdf/d5/37/main.PMC4844355.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/c5/opth-10-713.PMC4844427.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 713–720submit your manuscript | www.dovepress.co m Dove press  713 http: //dx.doi.org/10.2147/OPTH.S5131 3Dove press Reviewopen access to scientific and medical research Open Access Full T ext Article ectasia risk factors in refractive surgery Marcony R Santhiago1 Natalia T Giacomin1 David Smadja2 Samir J Bechara1 1Department of Ophthalmology,   Federal University of São Paulo,   São Paulo, Brazil, 2Ophthalmology  Department, Tel Aviv Sourasky  Medical Center, T el Aviv, israelAbstract:  This review outlines risk factors of post-laser in situ keratomileusis (LASIK) ectasia  that can be detected preoperatively and presents a new metric to be considered in the detection  of ectasia risk.",Non-OADS,/arxiv_data1/oa_pdf/ce/c5/opth-10-713.PMC4844427.pdf
"Analysis of prevalence is not sufficient to Correspondence: Marcony R Santhiago Department of Ophthalmology, instituto  Central, Federal University of São Paulo,  Av Dr enéas de Carvalho Aguiar, 255,  São Paulo, Brazil email marconysanthiago@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Santhiago et al Running head recto: Ectasia risk factors in refractive surgery DOI: http://dx.doi.org/10.2147/OPTH.S51313",Non-OADS,/arxiv_data1/oa_pdf/ce/c5/opth-10-713.PMC4844427.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ce/c5/opth-10-713.PMC4844427.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/c5/opth-10-713.PMC4844427.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/43/ott-9-2421.PMC4844428.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2421–2428OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2421Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9615 6risk of adverse events with bevacizumab addition  to therapy in advanced non-small-cell lung cancer:  a meta-analysis of randomized controlled trials Xi-Xi lai ren-ai Xu Yu-Ping li han Yang Department of respiratory Medicine,   The First affiliated hospital of  Wenzhou Medical University,   Wenzhou, Zhejiang, People’s republic  of chinaBackground:  Bevacizumab, a monoclonal antibody against vascular endothelial growth factor  ligand, has shown survival benefits in the treatment of many types of malignant tumors, including  non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/63/43/ott-9-2421.PMC4844428.pdf
"However, beva - cizumab presents an anti-VEGF toxicity profile with the most common AEs being correspondence: Xi-Xi lai; han Yang Department of respiratory Medicine,  The First Affiliated Hospital of  Wenzhou Medical University, no 2  Fuyi street, Wenzhou, Zhejiang 32500,  People’s republic of china Tel +86 577 5557 8166 email chenlingyan1020@163.co m;   yanghan20150909@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lai et al Running head recto: AEs related to bevacizumab in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S96156",Non-OADS,/arxiv_data1/oa_pdf/63/43/ott-9-2421.PMC4844428.pdf
We also searched abstracts and virtual  meeting presentations from the American Society of Clinical  Oncology ( http://www.asco.org/ASC O) conferences that  took place between January 2004 and January 2014.,Non-OADS,/arxiv_data1/oa_pdf/63/43/ott-9-2421.PMC4844428.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/63/43/ott-9-2421.PMC4844428.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/43/ott-9-2421.PMC4844428.pdf
"Available from: http://ctep.cancer.gov/protocolDevelopment/ electronic_applications/ctc.ht m. Accessed January 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/63/43/ott-9-2421.PMC4844428.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/23/8c/ott-9-2255.PMC4844429.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2255–2263OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2255Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10355 4DUSP4 /MKP2 overexpression is associated with  BraFV600e mutation and aggressive behavior  of papillary thyroid cancer Ben Ma1,2,* rongliang shi1–3,* shuwen Yang1,2 li Zhou1,2 ning Qu1,2 Tian liao1,2 Yu Wang1,2 Yulong Wang1,2 Qinghai Ji1,2 1Department of head and neck  surgery, Fudan University shanghai  cancer center, 2Department of  Oncology, shanghai Medical college,   3Department of general surgery,   Fudan University, Minhang hospital,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  The study was performed to retrospectively analyze the correlation of dual specificity  phosphatase 4 ( DUSP4 ) expression with clinicopathological variables and BRAFV600E muta - tion to better characterize the potential role of DUSP4  as a biomarker in papillary thyroid  cancer (PTC).",Non-OADS,/arxiv_data1/oa_pdf/23/8c/ott-9-2255.PMC4844429.pdf
"Identification of specific molecular  markers for the prediction of these aggressive behaviors of PTC may assist us in  evaluating disease status and prognosis for patients.correspondence: Yu Wang Department of head and neck surgery,  Fudan University shanghai cancer  center, no 270, Dong’an road, shanghai  200032, People’s republic of china Fax +86 21 6404 0207 email neck130@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ma et al Running head recto: DUSP4 /MKP2 in papillary thyroid cancer DOI: http://dx.doi.org/10.2147/OTT.S103554",Non-OADS,/arxiv_data1/oa_pdf/23/8c/ott-9-2255.PMC4844429.pdf
"A total of 499 primary  PTC patients with detailed DUSP4  expression, BRAFV600E  mutation, and clinical data were collected from the updated  TCGA database according to parameters in a previous  study.20 The TCGA cohort data were available on the web - site of Cancer Genomics Brower of California Santa Cruz  (UCSC) ( https://genome-cancer.ucsc.edu /), and the gene  expression dataset and clinical data were obtained from the  file named TCGA_THCA_exp_HiSeqV2_PANCAN.21 The  process of analysis of DUSP4  in the TCGA cohort in detail  is shown in Figure S1.",OADS,/arxiv_data1/oa_pdf/23/8c/ott-9-2255.PMC4844429.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/23/8c/ott-9-2255.PMC4844429.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/8c/ott-9-2255.PMC4844429.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/7c/opth-10-721.PMC4844430.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 721–729Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  721Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10509 6relationship between magnetic resonance imaging  signal intensity and volume of extraocular muscles  in thyroid-associated ophthalmopathy with  methylprednisolone pulse therapy T omoaki higashiyama1 Yasuhiro nishida2 Masahito Ohji1 1Department of Ophthalmology,   2Clinical Medical education Center,   shiga University of Medical science,   shiga, JapanPurpose:  To characterize the relationship between inflammation and swelling of extraocular  muscles in thyroid-associated ophthalmopathy before and after methylprednisolone pulse  therapy.",Non-OADS,/arxiv_data1/oa_pdf/ae/7c/opth-10-721.PMC4844430.pdf
"Previous studies reported immunosuppressive therapy, such as corticosteroids and  orbital radiotherapy, for patients with TAO in the acute active inflammatory phase.2,5–9  The European Group on Graves’ Orbitopathy recommends methylprednisolone  pulse therapy for moderate-to-severe active TAO.10 Previous studies reported the Correspondence: Tomoaki higashiyama Department of Ophthalmology,  shiga University of Medical science,  seta, Tsukinowa-cho, Otsu, shiga   520-2192, Japan Tel +81 77 548 2276 Fax +81 77 548 2279 email higashi@belle.shiga-med.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Higashiyama et al Running head recto: MRI signal intensity and volume in TAO DOI: http://dx.doi.org/10.2147/OPTH.S105096",Non-OADS,/arxiv_data1/oa_pdf/ae/7c/opth-10-721.PMC4844430.pdf
"Volume measurements The cross-sectional areas of the five extraocular muscles  (ie, SR, IR, LR, MR, and SO muscles) were measured by  tracing outlines of each tissue on T2-weighted images with  Image J software (National Institutes of Health, http://rsbweb.nih.gov/ij/index.htm l) (Figure 2).24 The cross-sectional  areas for the SR and IR muscles were measured on sagittal  images, and for MR, LR, and SO muscles on axial images.",OADS,/arxiv_data1/oa_pdf/ae/7c/opth-10-721.PMC4844430.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ae/7c/opth-10-721.PMC4844430.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/7c/opth-10-721.PMC4844430.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 969–981Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  969OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10445 0White matter alterations related to attention- deficit hyperactivity disorder and COMT  val158met  polymorphism: children with valine homozygote  attention-deficit hyperactivity disorder have  altered white matter connectivity in the right  cingulum (cingulate gyrus) Burge Kabukcu Basay1 ahmet Buber1 Omer Basay1 huseyin alacam2 Onder Ozturk1 serkan suren3 Ozlem izci ay4 cengizhan acikel5 Kadir Agladıoglu6 Mehmet emin erdal4 eyup sabri ercan7 hasan herken2 1child and adolescent Psychiatry  Department, Pamukkale University  Medical Faculty, Denizli, 2Psychiatry  Department, Pamukkale University  Medical Faculty, Denizli, 3Medical Park  samsun hospital, samsun, 4Medical  Biology and genetics Department,  Mersin University Medical Faculty,  Mersin, 5Biostatistics Department,  gaTa (gMM a), ankara, 6radiology  Department, Pamukkale University  Medical Faculty, Denizli, 7child and  adolescent Psychiatry Department, ege  University Medical Faculty, izmir, T urkeyIntroduction:  In this article, the COMT  gene val158met polymorphism and attention-deficit  hyperactivity disorder (ADHD)-related differences in diffusion-tensor-imaging-measured white  matter (WM) structure in children with ADHD and controls were investigated.",Non-OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
"It has  a worldwide pooled prevalence of 5.2%.1 ADHD has been reported to be associated  with alterations in the dopaminergic system2,3 and in the structural architecture of the correspondence: hasan herken Pamukkale University Medical Faculty,  habib Kiziltas Psychiatry hospital,  University street, 20070, Kinikli, Denizli,  Turkey email hherken@pau.edu.t r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Kabukcu Basay et al Running head recto: WM alterations related to ADHD and COMT  val158met polymorphism DOI: http://dx.doi.org/10.2147/NDT.S104450",Non-OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
"image processing The Oxford Center for Functional Magnetic Resonance  Imaging of the Brain Statistical Library (FMRIB Software  Library [FSL 4.1.4], http://www.fmrib.ox.ac.uk/fs l) was used  in the image analyses and tensor calculations.28 The imaging  data were processed in the following manner.",OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
Available from: http://www.fmrib.,Non-OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
Available from: http://www.fmrib.ox.ac.uk/analysis/ techrep /.,Non-OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/03/ndt-12-969.PMC4844431.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/bb/ndt-12-897.PMC4844432.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 897–907Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  897OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10040 5Patterns of psychotropic medication use in inpatient  and outpatient psychiatric settings in saudi arabia Fahad D alosaimi1 abdulhadi alhabbad2 Mohammed F abalhassan3 ebtihaj O Fallata4 Nasser M alzain5 Mohammad Zayed alassiry6 Bander abdullah haddad7 1Department of Psychiatry, King  saud University, riyadh, 2Department  of Psychiatry, Prince Mohammed  Medical city, aljouf, 3Department of  Medicine, Prince sattam Bin abdulaziz  University, al-Kharj, 4Department of  Psychiatry, Mental health hospital,   Jeddah, 5Department of Psychiatry,   al-amal complex for Mental  health, Dammam, 6Medical services  Department, abha Psychiatric  hospital, abha, 7Department  of Medicine, King abdulaziz  Medical city, Ministry of National  guard, riyadh,  saudi arabiaObjective:  To study the pattern of psychotropic medication use and compare this pattern  between inpatient and outpatient psychiatric settings in Saudi Arabia.",Non-OADS,/arxiv_data1/oa_pdf/1e/bb/ndt-12-897.PMC4844432.pdf
"Keywords:  psychotropic, inpatient, outpatient, antipsychotics, antidepressants, mood stabiliz - ers, Saudi Arabiacorrespondence: abdulhadi alhabbad Prince Mohammed Medical city, aljouf,  King Khalid street, PO Box 88893,  riyadh 12372, saudi arabia email abdulhadi.alhabbad@pmmc.med.s a Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Alosaimi et al Running head recto: Patterns of psychotropic use in Saudi Arabia DOI: http://dx.doi.org/10.2147/NDT.S100405",Non-OADS,/arxiv_data1/oa_pdf/1e/bb/ndt-12-897.PMC4844432.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1e/bb/ndt-12-897.PMC4844432.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/bb/ndt-12-897.PMC4844432.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/14/ppa-10-571.PMC4844433.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 571–577Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  571OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10327 6characteristics and prognostic factors for pain  management in 152 patients with lung cancer lei shi1,* Yumei liu2,* hua he1 cong Wang1 hongwei li1 nanya Wang1 1cancer center, The First hospital  of Jilin University, changchun,   2Department of hematology, Tianjin  Medical University general hospital,   Tianjin, People’s republic of china *These authors contributed equally  to this workObjective:  The objective of this study was to analyze the pain characteristics and factors  influencing the outcome of pain control in patients with lung cancer having pain.",Non-OADS,/arxiv_data1/oa_pdf/df/14/ppa-10-571.PMC4844433.pdf
"The incidence of  pain is 47% in all patients with lung cancer, and 76% in those in palliative care.4 Although most patients achieve adequate pain control, those with more complex  pain syndromes require intense and complex analgesic schedules.5 Pain intensity  is a key element of prognostication and management of cancer pain,6–8 and greater correspondence: nanya Wang cancer center, The First hospital of  Jilin University, no 71 Xinmin street,  changchun 130021, People’s republic  of china Tel +86 158 0430 2611 email nanyawang@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Shi et al Running head recto: Characteristics and prognostic factors for pain management DOI: http://dx.doi.org/10.2147/PPA.S103276",Non-OADS,/arxiv_data1/oa_pdf/df/14/ppa-10-571.PMC4844433.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/df/14/ppa-10-571.PMC4844433.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/10/ott-9-2111.PMC4844434.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2111–2119submit your manuscript | www.dovepress.co m Dove press  2111 http: //dx.doi.org/10.2147/OTT .S9673 8Dove press ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article Association of the miR-196a2 C .T and miR-499  A.G polymorphisms with hepatitis B virus- related hepatocellular carcinoma risk: an updated  meta-analysis Shao-Liang Zhu1,* Jian-Hong Zhong1,* Wen-Feng Gong1,* Hang Li2 Le-Qun Li1 1Department of Hepatobiliary Surgery,   2Department of Ultrasound, Affiliated  T umor Hospital of Guangxi Medical  University, Nanning, People’s Republic  of China *These authors contributed equally  to this workBackground:  This study meta-analyzed data on the possible association of the miR-196a2  C.T (rs11614913) and miR-499 A .G (rs3746444) polymorphisms with risk of hepatitis B  virus (HBV)-related hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/a5/10/ott-9-2111.PMC4844434.pdf
"miRNAs posttranscrip - tionally suppress target gene expression, usually by binding to the 3 ′-untranslated Correspondence: Le-Qun Li Department of Hepatobiliary Surgery,  Affiliated Tumor Hospital of Guangxi  Medical University, He Di Rd #71,  Nanning 530021, People’s Republic of  China Tel +86 771 533 0855 Fax +86 771 531 2000 Email xitongpingjia@163.co mJournal name: OncoTargets and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 9 Running head verso: Zhu et al Running head recto: miR-196a2 and miR-499 polymorphisms and HBV -related HCC risk DOI: http://dx.doi.org/10.2147/OTT.S96738",Non-OADS,/arxiv_data1/oa_pdf/a5/10/ott-9-2111.PMC4844434.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a5/10/ott-9-2111.PMC4844434.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/10/ott-9-2111.PMC4844434.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f6/02/ott-9-2403.PMC4844435.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2403–2408OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2403Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10418 1genetic association between interluekin-4   rs2243250 polymorphism and gastric cancer  susceptibility: evidence based on a meta-analysis chi Zhang1,* Jing-Yu huang1,* Zi-Qi he2,* hong Weng3 1Department of Oncology, Zhongnan  hospital of Wuhan University,   Wuhan, hubei, People’s republic  of china; 2Department of Urology,   First affiliated hospital of guangxi  Medical University, nanning, guangxi,   People’s republic of china; 3center  for evidence-Based and Translational  Medicine, Zhongnan hospital of  Wuhan University, Wuhan, hubei,   People’s republic of china *These authors contributed equally to  this workPurpose:  Numerous studies have suggested that the interleukin-4  (IL-4) rs2243250  polymorphism is associated with gastric cancer susceptibility.",Non-OADS,/arxiv_data1/oa_pdf/f6/02/ott-9-2403.PMC4844435.pdf
"The IL-4  gene rs2243250 polymorphism, C to T base substitution at -590 of the IL-4 promoter, correspondence: hong Weng center for evidence-Based and  Translational Medicine, Zhongnan  hospital of Wuhan University, 169  Donghu road, Wuchang, Wuhan 430071,  hubei, People’s republic of china Tel +86 27 6781 2817 Fax +86 27 6781 2817 email wengh92@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: IL-4 polymorphism and gastric cancer risk DOI: http://dx.doi.org/10.2147/OTT.S104181",Non-OADS,/arxiv_data1/oa_pdf/f6/02/ott-9-2403.PMC4844435.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f6/02/ott-9-2403.PMC4844435.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/02/ott-9-2403.PMC4844435.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/eb/ott-9-2337.PMC4844436.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2337–2348OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2337Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10096 5The predictive and prognostic values of factors  associated with visceral pleural involvement in  resected lung adenocarcinomas huibiao Zhang1 chen lu2 Yingjie lu1 Bo Yu2 Fanzhen lv1 Zhenghong Zhu1 1Department of Thoracic surgery,   2Department of Pathology, huadong  hospital, Fudan University, shanghai,   People’s republic of chinaBackground:  The predictive and prognostic impact of factors associated with visceral pleural  invasion (VPI) on survival and recurrence in patients with resected lung adenocarcinomas is  not clearly defined.",Non-OADS,/arxiv_data1/oa_pdf/e5/eb/ott-9-2337.PMC4844436.pdf
"Keywords:  lung cancer, visceral pleural invasion, histologic subtype, TNM stage, follow-up Introduction Lung cancer is the leading cause of cancer-related deaths worldwide.1 Visceral pleural  invasion (VPI) has been shown as an independent prognostic factor in patients with  non-small-cell lung cancers (NSCLCs).2–4 Consequently, VPI status was included in  the seventh TNM staging system, alongside tumor size.5 However, results of some  studies have challenged the role of VPI as a prognostic parameter in NSCLCs.6–8 Since  the existence of VPI upgrades T stage of primary tumor from T1 to T2 in TNM staging  system and may determine whether adjuvant chemotherapy is required, it is necessary correspondence: Zhenghong Zhu Department of Thoracic surgery,  huadong hospital, Fudan University,  221 West Yan’an road, shanghai 200040,  People’s republic of china Tel +86 21 6248 3180; ext 70703 Fax +86 21 6248 3180 email drzhuzhenghong@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Visceral pleural involvement in resected lung adenocarcinomas DOI: http://dx.doi.org/10.2147/OTT.S100965",Non-OADS,/arxiv_data1/oa_pdf/e5/eb/ott-9-2337.PMC4844436.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/eb/ott-9-2337.PMC4844436.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/eb/ott-9-2337.PMC4844436.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 523–530Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  523OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9563 4Adherence to alendronic or risedronic acid  treatment, combined or not to calcium and  vitamin D, and related determinants in italian  patients with osteoporosis s calabria1 e cinconze2 M rossini3 e rossi2 AP Maggioni1,4 A Pedrini1 M De rosa2 1cOre, collaborative Outcome  research, Bologna, italy; 2health  care systems Department, cinec A,   interuniversity consortium, Bologna,   italy; 3rheumatology Unit, University  of Verona, Verona, italy; 4AnMcO  research center, Firenze, italyPurpose:  Osteoporosis is a chronic disease and an important health and social burden due to  its worldwide prevalence.",Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
"The World Health Organization estimated that more  than 75 million people in the United States, European Union, and Japan suffer from  this disease.1 In Italy, 23% of women over 40 years and 14% of men over the age correspondence: s calabria health care systems Department,  cinecA, Via Magnanelli 6/3, 40033  casalecchio di reno, Bologna, italy Tel +39 051 716 1348 Fax +39 051 613 2198 email calabria@coreteam.i t Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Calabria et al Running head recto: Adherence and determinants to antiosteoporosis treatment in Italy DOI: http://dx.doi.org/10.2147/PPA.S95634",Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
"Available  from:  https://www.ars.toscana.it/it/aree-dintervento/cure-e-assistenza/ farmacoepidemiologia.htm l. Accessed January 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
Available  from: http://www.biomedcentral.com/1472-6874/10/2 6.,Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
"Available from: http://www.agenziafarmaco.gov.it/ it/content/note-aif a. Accessed February 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
Available from: http://www.iofbonehealth.org/ osteoporosis-men-report-200 4.,Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
Available from: http://www.biomedcentral.com/1471-2474/14/27 6.,Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/82/37/ppa-10-523.PMC4844437.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/68/ott-9-2429.PMC4844438.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2429–2436OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2429Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10455 6Metadherin regulates epithelial–mesenchymal  transition in carcinoma Zhao wang1,2 Zheng-yan Tang2 Zhuo Yin1 Y ong-bao wei1,3 Long-fei Liu2 Bin Yan1 Ke-qin Zhou1 Ye-qi Nian1 Yun-liang Gao1 Jin-rui Yang1 1Department of Urology, The Second  Xiangya Hospital, Central South  University, Fu Rong District, Changsha,   2Department of Urology, Xiangya  Hospital, Central South University,   Kai Fu District, 3Department of  Urology, Fujian Provincial Hospital,   The Teaching Hospital of Fujian  Medical University, Fuzhou, People’s  Republic of ChinaAbstract:  Metadherin ( MTDH ) was first identified in primary human fetal astrocytes exposed to  HIV -1 in 2002 and then recognized as an important oncogene mediating tumorigenesis, progres - sion, invasiveness, and metastasis of carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/a0/68/ott-9-2429.PMC4844438.pdf
"Keywords:  signal pathway, chemoprevention, oncogene, biomarker, progression, therapeutic  target Introduction Metadherin (MTDH) is also known as lysine-rich carcinoembryonic antigen-related cell  adhesion molecule (CEACAM)-1-coisolated (LYRIC) protein and astrocyte elevated  gene-1 (AEG-1) protein.1,2 MTDH was first identified in primary human fetal astro - cytes exposed to HIV -1 in 2002,3 and then some researchers found that MTDH was  overexpressed in many cancer tissues and cell lines.4,5 MTDH  has been considered a  vital oncogene located in 8q22.6,7 Further investigations and studies reveal that MTDH  also mediates tumor progression, angiogenesis, invasiveness, metastasis, and chemo - therapy resistance.4–9 MTDH overexpression may serve as an important biomarker to  predict prognosis in clinical retrospective analyses.1,10 Signal pathways and drugs or  molecular targets of MTDH have also been studied, which have indicated potential  therapeutic effects of MTDH in malignancies.1,5,11,12 Epithelial–mesenchymal transition (EMT) refers to a morphogenetic process in  which cells lose epithelial polarization and gain mesenchymal characteristics, such as  motility and invasiveness.13 During EMT, epithelial biomarkers (such as E-cadherin  and cytokeratin) are downregulated, while mesenchymal biomarkers (such as vimentin)  are upregulated, accompanied by changes of transcriptional factors in the process.14,15  EMT originates from embryonic development, and then in cancers, it extends to pro - gression and metastasis.13,14 The relationship between MTDH expression and EMT has been established in  some cancers.2,10,12,15 This review highlights the overexpression of MTDH and EMT Correspondence: Jin-rui Yang Department of Urology, The Second  Xiangya Hospital, Central South  University, 139 Ren Min Road, Fu Rong  District, Changsha 410011, People’s  Republic of China Tel +86 136 0744 3048 Fax +86 731 8529 5134 email xy2yangjinrui@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: MTDH regulates epithelial–mesenchymal transition in carcinoma DOI: http://dx.doi.org/10.2147/OTT.S104556",Non-OADS,/arxiv_data1/oa_pdf/a0/68/ott-9-2429.PMC4844438.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/68/ott-9-2429.PMC4844438.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/68/ott-9-2429.PMC4844438.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/ppa-10-601.PMC4844439.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 601–612Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  601OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10445 3Determinants and influencing mechanism of  outpatient satisfaction: a survey on tertiary  hospitals in the People’s republic of china Wenya Yu1,* Meina li1,* chen Xue1,* Jingrui Wang1 Jiazhen liu2 Haiping Chen1 Lulu Zhang1 1institute of Military health  Management, Second Military Medical  University, 2Shanghai Sixth People’s  Hospital, Shanghai, People’s Republic  of china *These authors contributed equally  to this workObjective:  Most patients in the People’s Republic of China prefer tertiary hospitals when  seeking medical services.",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/ppa-10-601.PMC4844439.pdf
"Keywords:  outpatient satisfaction, tertiary hospitals, sociodemographic characteristics, influ - encing factor Introduction Patient satisfaction refers to the degree of conformity between patients’ expectations  and the reality regarding their experience of medical services, the quality of received  health care, feelings related to diagnosis and treatment, and consensus about the treat - ment program.1,2 In other words, it is a reflection of patients’ perceptions of medical  care processes, and it is considered an important index of medical quality.3,4 Outpatient  services – which represent an entry point for medical services – can directly influence  patients’ satisfaction.5 In 2010, The Lancet  reported on the extremely poor-quality Correspondence: Lulu Zhang Institute of Military Health Management,  second Military Medical University,  Shanghai 200433, People’s Republic  of china Tel +86 21 8187 1421 Fax +86 21 8187 1436 email zllrmit@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Yu et al Running head recto: Determinants of outpatient satisfaction DOI: http://dx.doi.org/10.2147/PPA.S104453",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/ppa-10-601.PMC4844439.pdf
Available from: http://srghealth.fudan.edu.cn/a/news/2015/0527/244.,Non-OADS,/arxiv_data1/oa_pdf/7b/7c/ppa-10-601.PMC4844439.pdf
Available from: http://www.shyb.,Non-OADS,/arxiv_data1/oa_pdf/7b/7c/ppa-10-601.PMC4844439.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/7b/7c/ppa-10-601.PMC4844439.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/80/ndt-12-1005.PMC4844440.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1005–1011Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1005OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10401 1Protective effects of l-glutamine against toxicity  of deltamethrin in the cerebral tissue sefer Varol hasan hüseyin Özdemir Mehmet Ug ˘ur Çevik Yaşar Altun Ibrahim Ibilog ˘lu Aysun Ekinci Aslıhan Okan Ibilog ˘lu Metin Balduz Demet arslan Recep T ekin Fesih Aktar Mehmet Ufuk Aluçlu Department of Neurology,   Faculty of Medicine, Dicle University,   Diyarbakır, T urkeyBackground:  Deltamethrin (DLM) is a broad-spectrum synthetic dibromo-pyrethroid pesticide  that is widely used for agricultural and veterinary purposes.",Non-OADS,/arxiv_data1/oa_pdf/34/80/ndt-12-1005.PMC4844440.pdf
"It represents an environmental and industrial pollutant that is toxic to animals,  birds, fish, and human beings living in the same ecosystem, as well as those directly  or indirectly at risk of exposure, leading to substantial hazards.2 It is used in various Correspondence: Mehmet Ug ˘ur Çevik Dicle University, Faculty of Medicine,  Department of Neurology, sur,  Diyarbakır, Turkey, 21280 Tel +90 412 248 8016 Fax +90 412 248 8523 email mehmetugur.cevik@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Varol et al Running head recto: Protective effects of l-glutamine in cerebral tissue DOI: http://dx.doi.org/10.2147/NDT.S104011",Non-OADS,/arxiv_data1/oa_pdf/34/80/ndt-12-1005.PMC4844440.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/34/80/ndt-12-1005.PMC4844440.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/80/ndt-12-1005.PMC4844440.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/19/a0/ott-9-2227.PMC4844442.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2227–2236OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2227Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9651 0Overexpression of sT3gal-i promotes migration  and invasion of hcclM3 in vitro and poor  prognosis in human hepatocellular carcinoma han Wu1,* Xue-liang shi1,* hai-Jian Zhang2 Qing-Jie song1 Xiao-Bing Yang1 Wei-Dong hu1 guang-lin Mei1 Xi chen1 Qin-sheng Mao1 Zhong chen1 1Department of general surgery,   The affiliated hospital of nantong  University, 2research center of  clinical Medicine, The affiliated  hospital of nantong University,   nantong, People’s republic of china *These authors contributed equally  to this workPurpose:  Excessive ST3Gal-I levels predict a poor outcome for patients with several types  of tumors.",Non-OADS,/arxiv_data1/oa_pdf/19/a0/ott-9-2227.PMC4844442.pdf
"Aberrations in this process affect various correspondence: Zhong chen Department of general surgery,  The Affiliated Hospital of Nantong  University, 20 Xisi road, nantong,  226001, People’s republic of china Tel +86 513 8116 1001 Fax +86 513 8116 1001 email chenz9806@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wu et al Running head recto: ST3Gal-I promotes HCC poor prognosis DOI: http://dx.doi.org/10.2147/OTT.S96510",Non-OADS,/arxiv_data1/oa_pdf/19/a0/ott-9-2227.PMC4844442.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/19/a0/ott-9-2227.PMC4844442.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/a0/ott-9-2227.PMC4844442.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e2/b3/ndt-12-917.PMC4844443.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 917–929Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  917Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S8863 2Second-generation long-acting injectable  antipsychotics in schizophrenia: patient  functioning and quality of life Cristiana Montemagni1,2 Tiziana Frieri1,2 Paola Rocca1,2 1Department of Neuroscience, Unit  of Psychiatry, University of T urin,   2Department of Mental Health,   Azienda Sanitaria Locale (ASL) T orino  1 (TO1), Azienda Ospedaliero- Universitaria (AOU) Città della Salute  e della Scienza di T orino, T urin, italyAbstract:  Long-acting injectable antipsychotics (LAIs) were developed to make treatment  easier, improve adherence, and/or signal the clinician when nonadherence occurs.",Non-OADS,/arxiv_data1/oa_pdf/e2/b3/ndt-12-917.PMC4844443.pdf
"A review of eight controlled trials has highlighted the fact that rates  of unemployment for patients with schizophrenia, although they have good support,  ranged from only 30% to 80%, with a median of 60% across these studies,3 even in  the context that the majority of them frequently expressed their keenness to work.4,5  Otherwise, rates of marriage for patients with schizophrenia were reported to range  from about 5% to 30%, with the majority ranging between 15% and 30%.6–12Correspondence: Paola Rocca Department of Neuroscience,   Unit of Psychiatry, University of Turin,  via Cherasco 11, 10126 Turin, italy Tel +39 011 633 6780 Fax +39 011 673 473 email paola.rocca@unito.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Montemagni et al Running head recto: Second-generation antipsychotics in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S88632",Non-OADS,/arxiv_data1/oa_pdf/e2/b3/ndt-12-917.PMC4844443.pdf
"Avail - able from: http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pd f. Accessed November 1, 2012.",Non-OADS,/arxiv_data1/oa_pdf/e2/b3/ndt-12-917.PMC4844443.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e2/b3/ndt-12-917.PMC4844443.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/b3/ndt-12-917.PMC4844443.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8e/5c/ndt-12-931.PMC4844444.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 931–939Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  931PersPecTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10090 8Medication management during electroconvulsant  therapy Monica Zolezzi clinical Pharmacy and Practice,   college of Pharmacy, Qatar University,   Doha, QatarAbstract:  Electroconvulsive therapy (ECT) has demonstrated to be highly effective and safe,  even life saving for many psychiatric disorders such as major depression, bipolar disorder  and schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/8e/5c/ndt-12-931.PMC4844444.pdf
"As such, all patients  must be assessed prior to ECT for the presence of conditions such as cardiovascular  disease, space-occupying intracranial lesion with the evidence of elevated intracra - nial pressure, recent cerebral hemorrhage or stroke, bleeding or otherwise unstable  vascular aneurysm, and severe pulmonary disease, as all of these can be associated  with increased risk of complications from the general anesthesia and induction of  seizure activity.1 ECT is considered safe with a mortality of ~1/10,000 patients or  1/80,000 treatments.6 Most patients report some adverse cognitive effects during and  after a course of ECT, such as postictal confusion state (the result of both anesthesia  and the seizure), anterograde amnesia (decreased ability to retain newly acquired correspondence: Monica Zolezzi clinical Pharmacy and Practice,  college of Pharmacy, Qatar University,  PO Box 2713, Doha, Qatar Tel +974 44 035 623 Fax +974 44 035 551 email mzolezzi@qu.edu.q aJournal name: Neuropsychiatric Disease and Treatment Article Designation: Perspectives Y ear: 2016 Volume: 12 Running head verso: Zolezzi Running head recto: Medication management during ECT DOI: http://dx.doi.org/10.2147/NDT.S100908",Non-OADS,/arxiv_data1/oa_pdf/8e/5c/ndt-12-931.PMC4844444.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8e/5c/ndt-12-931.PMC4844444.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/5c/ndt-12-931.PMC4844444.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/03/ppa-10-591.PMC4844445.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 591–599Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  591OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9785 2higher diversity in fungal species discriminates  children with type 1 diabetes mellitus from  healthy control Beata Kowalewska1 Katarzyna Zorena2 Małgorzata Szmigiero- Kawko3 Piotr Wąż4 Małgorzata My śliwiec3 1Department of Tropical Medicine and  epidemiology, institute of Maritime  and Tropical Medicine, 2Department  of immunology and environmental  Microbiology, 3clinic of Paediatrics,   Diabetology and endocrinology,   4Department of n uclear Medicine,   Medical University of gdańsk,   gdańsk, PolandObjective:  To conduct qualitative and quantitative assessment of yeast-like fungi in the feces  of children and adolescents with type 1 diabetes mellitus (T1DM) with respect to their metabolic  control and duration of the disease.",Non-OADS,/arxiv_data1/oa_pdf/75/03/ppa-10-591.PMC4844445.pdf
"The human correspondence: Katarzyna Zorena Department of immunology and  environmental Microbiology, Medical  University of gda ńsk, Dębinki 7, 80-211  gdańsk, Poland Tel +48 58 349 1766 Fax +48 58 349 1766 email kzorena@gumed.edu.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kowalewska et al Running head recto: Higher fungal species diversity in children with T1DM DOI: http://dx.doi.org/10.2147/PPA.S97852",Non-OADS,/arxiv_data1/oa_pdf/75/03/ppa-10-591.PMC4844445.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/75/03/ppa-10-591.PMC4844445.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/c9/opth-10-697.PMC4844446.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 697–703Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  697Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S9974 1 Advances in femtosecond laser technology Thais Pinheiro Callou Renato Garcia Adriana Mukai Natalia T Giacomin Rodrigo Guimarães de  Souza Samir J Bechara Department of Ophthalmology,   University of Sao Paulo, Sao Paulo,   BrazilAbstract:  Femtosecond laser technology has become widely adopted by ophthalmic surgeons.",Non-OADS,/arxiv_data1/oa_pdf/cf/c9/opth-10-697.PMC4844446.pdf
"FS laser  has also been used for the removal of corneal lenticules for the correction of myopia,  presbyopia, natural astigmatism, and post-corneal implant astigmatism.1 Lately, FS  laser has also been used in phacoemulsification surgery for incisions, fragmentation  of the nucleus and capsulorhexis.5–15 Commercially available FS laser types include IntraLase (Abbott Medical Optics  Inc., Santa Ana, CA, USA), Femtec (20/10 Perfect Vision AG, Heidelberg, Germany)  Femto LDV (Ziemer Ophthalmic Systems, Port, Switzerland), VisuMax (Carl Zeiss  Meditec AG, Jena, Germany), WaveLight FS200 (Alcon Laboratories, Inc., Fort Worth,  TX, USA), LenSx (Alcon Laboratories, Inc.),16 Victus (Bausch & Lomb Incorporated, Correspondence: Thais Pinheiro Callou Department of Ophthalmology,  University of Sao Paulo, instituto Central,  255 eneas de Carvalho Aguiar Av, Sao  Paulo, Brazil email thaiscallou@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Callou et al Running head recto: Advances in femtosecond laser technology DOI: http://dx.doi.org/10.2147/OPTH.S99741",Non-OADS,/arxiv_data1/oa_pdf/cf/c9/opth-10-697.PMC4844446.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cf/c9/opth-10-697.PMC4844446.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/c9/opth-10-697.PMC4844446.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/72/ndt-12-951.PMC4844447.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 951–959Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  951OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10405 0The efficacy and safety of multiple doses of  vortioxetine for generalized anxiety disorder:  a meta-analysis Jie Fu1 lilei Peng2 Xiaogang li1 1Department of Neurology,   2Department of Neurosurgery,   The affiliated hospital of luzhou  Medical college, luzhou, People’s  republic of chinaObjective:  Vortioxetine is a novel antidepressant approved for the treatment of major depressive  disorder by the US Food and Drug Administration in September 2013.",Non-OADS,/arxiv_data1/oa_pdf/7e/72/ndt-12-951.PMC4844447.pdf
"Keywords:  vortioxetine, placebo, generalized anxiety disorder, meta-analysis Introduction Generalized anxiety disorder (GAD) is a common mental disorder marked by persistent  anxiety and worries as well as multiple psychological and physical symptoms.1 GAD is a  burden on the society because it is costly and has a significant adverse effect on the qual - ity of life.2 The serotonin (5-hydroxytryptamine [5-HT]) transporter, 5-HT receptors, are  promising therapeutic targets for treating GAD, and currently most psychiatrists prefer  the use of selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine  reuptake inhibitors (SNRIs).3 In addition, the recent guidelines suggest SSRI/SNRI correspondence: Xiaogang li Department of Neurology, The Affiliated  hospital of luzhou Medical college,  Jiangyang region, Taiping street, luzhou  646000, People’s republic of china Tel +86 13 8082 85453 email xiao_gangli@sina.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original research Y ear: 2016 Volume: 12 Running head verso: Fu et al Running head recto: Efficacy and safety of vortioxetine for GAD DOI: http://dx.doi.org/10.2147/NDT.S104050",Non-OADS,/arxiv_data1/oa_pdf/7e/72/ndt-12-951.PMC4844447.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7e/72/ndt-12-951.PMC4844447.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/72/ndt-12-951.PMC4844447.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/ff/ott-9-2211.PMC4844448.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2211–2220OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2211Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10199 4Overexpression of BUB1B contributes to  progression of prostate cancer and predicts poor  outcome in patients with prostate cancer Xin Fu,1 guo chen,1 Zhi- duan cai,1,2 cong Wang,3  Ze-zhen liu,1 Zhuo-yuan  lin,1,2 Y ong-ding Wu,1,4  Yu-xiang liang,1 Zhao-dong  han,1 Jun-chen liu,5 Wei-De  Zhong,1,2,6 1Department of Urology, guangdong  Key laboratory of clinical Molecular  Medicine and Diagnostics, guangzhou  First People’s hospital, guangzhou  Medical University, 2guangdong  Provincial institute of nephrology,   nanfang hospital, southern Medical  University, 3school of Pharmacy,   Wenzhou Medical University,   Wenzhou, 4school of Public health,   guangzhou Medical University,   guangzhou, People's republic of  china; 5center for Translational  cancer research, institute of  Biosciences and Technology and  college of Medicine, Texas a&M  health science center, houston,   TX, Usa; 6Urology Key laboratory  of guangdong Province, The First  affiliated hospital of guangzhou  Medical University, guangzhou  Medical University, guangzhou,   People's republic of chinaAbstract:  BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) is a member of the  spindle assembly checkpoint protein family, which has been proven to be associated with many  kinds of cancers.",Non-OADS,/arxiv_data1/oa_pdf/1e/ff/ott-9-2211.PMC4844448.pdf
"The  main function of SAC is to maintain genome stability by delaying cell division until  accurate chromosome segregation is guaranteed during mitosis and meiosis.7 Muta - tions or abnormal expression of SAC proteins can contribute to cancer progression.8 correspondence: Wei-De Zhong Department of Urology, guangdong Key  laboratory of clinical Molecular Medicine  and Diagnostics, guangzhou First  People’s hospital, guangzhou Medical  University, 1 Panfu road, Yuexiu District,  guangzhou 510180, People’s republic  of china Tel +86 20 8104 8312 Fax +86 20 8337 3322 email zhongwd2009@live.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Fu et al Running head recto: Overexpression of BUB1B contributes to progression of prostate cancer  DOI: http://dx.doi.org/10.2147/OTT.S101994",Non-OADS,/arxiv_data1/oa_pdf/1e/ff/ott-9-2211.PMC4844448.pdf
"The Taylor dataset (NCBI GEO accession no: GSE21032),  an online PCa dataset with microarray for messenger RNAs  (mRNAs) and miRNAs that included 150 primary PCa  tissues and 29 adjacent noncancerous prostate tissues was  downloaded from http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc =GSE2103 2.19 For the analysis of survival and  follow-up, the date of prostatectomy was defined as the  beginning of the follow-up period.",OADS,/arxiv_data1/oa_pdf/1e/ff/ott-9-2211.PMC4844448.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1e/ff/ott-9-2211.PMC4844448.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/ff/ott-9-2211.PMC4844448.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 941–949Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  941OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9740 7Medication use patterns, health care resource  utilization, and economic burden for patients with  major depressive disorder in Beijing, People’s  republic of china ling Zhang1–4 Yun chen5 li Yue5 Qingjing liu6 William Montgomery7 lihua Zhi5 Wanqi Wang5 1Mood Disorders center, Beijing  anding hospital, capital Medical  University, 2china clinical research  center for Mental Disorders,   3china center of Depression,   Beijing institute for Brain Disorders,   4Department of Psychiatry,   capital Medical University,  Beijing,   5Medical Department, lilly suzhou  Pharmaceutical company, ltd,   shanghai, 6Pharmacoeconomics  and Outcomes research, Beijing  Brainpower Pharma consulting  co, ltd, Beijing, People’s republic  of china; 7Medical Department,   eli lilly australia Pty, ltd, sydney,   NsW, australiaObjective:  The objective of the study was to investigate medication usage patterns, health care  resource utilization, and direct medical costs of patients with major depressive disorder (MDD)  in Beijing, People’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
"Keywords:  depression, People’s Republic of China, antidepressants, health care resource,  persistence Introduction Major depressive disorder (MDD) is a mental disorder characterized by a persistently low  mood, accompanied by feelings of inferiority and loss of interest or pleasure in normally  enjoyable activities.1 With a relatively high prevalence, MDD can afflict anyone at any correspondence: Yun chen lilly suzhou Pharmaceutical company,  ltd, 16F, 1 corporate avenue, No 222,  hubin road, shanghai 200021, People’s  republic of china Tel +86 21 2302 1007 Fax +86 21 3331 2891 email chen_yun_kathy@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Zhang et al Running head recto: Medication, health care resource use, and costs for patients with MDD DOI: http://dx.doi.org/10.2147/NDT.S97407",Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
"The poster’s  abstract was published in “Poster Abstracts” in V alue in  Health  (November 2014, Volume 17, Issue 7, Page A457:  http://www.valueinhealthjournal.com /).",Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
Available  from: http://www.whocc.no/ddd/definition_and_general_considera /.,Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
"Available from: https://en.wikipedia.org/wiki/ List_of_renminbi_exchange_rate s. Accessed February 1, 2016.",OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
Available from: http://www.myeducs.,Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
"Available from:  http://www.gov.cn/gzdt/2013-01/21/content_2316558.ht m. Accessed  February 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/f5/4b/ndt-12-941.PMC4844449.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/2a/ott-9-2409.PMC4844452.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2409–2414OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2409Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10223 6comparison of erlotinib and pemetrexed as second-/ third-line treatment for lung adenocarcinoma  patients with asymptomatic brain metastases Yayi he1,* Wenwen sun2,* Yan Wang3,* shengxiang ren1 Xuefei li3 Jiayu li3 christopher J rivard4 caicun Zhou1 Fred r hirsch4 1Department of Oncology, shanghai  Pulmonary hospital, 2clinic and  research center of T uberculosis,   shanghai Key laboratory of  Tuberculosis, shanghai Pulmonary  hospital, 3Department of lung  cancer and immunology, shanghai  Pulmonary hospital, T ongji University  Medical school cancer institute,   T ongji University school of Medicine,   shanghai, People’s republic of china;   4Division of Medical Oncology,   Department of Medicine, University  of colorado, aurora, cO, Usa *These authors contributed equally  to this workObjective:  Brain metastases occur in one-third of all non-small-cell lung cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6d/2a/ott-9-2409.PMC4844452.pdf
"Epidermal growth factor receptor tyrosine kinase inhibitors ( EGFR -TKIs) have  been widely used in the treatment of advanced non-small-cell lung cancer (NSCLC).8–10 correspondence: caicun Zhou Department of Oncology, shanghai  Pulmonary hospital, Tongji University  school of Medicine, 507 Zhengmin road,  shanghai, People’s republic of china Tel +86 133 0182 5532 email caicunzhoudr@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: He et al Running head recto: Erlotinib and pemetrexed as second-/third-line treatment for lung cancer DOI: http://dx.doi.org/10.2147/OTT.S102236",Non-OADS,/arxiv_data1/oa_pdf/6d/2a/ott-9-2409.PMC4844452.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6d/2a/ott-9-2409.PMC4844452.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/2a/ott-9-2409.PMC4844452.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/mder-9-061.PMC4844453.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/mder-9-061.PMC4844453.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Cardiac resynchronization therapy pacemaker: critical appraisal of the  adaptive CRT -P device [Corrigendum] Daoud GE, Houmsse M. Cardiac resynchronization therapy  pacemaker: critical appraisal of the adaptive CRT -P device.",Non-OADS,/arxiv_data1/oa_pdf/5e/ba/mder-9-061.PMC4844453.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research Medical Devices: Evidence and Research 2016:9 61Dove press submit your manuscript | www.dovepress.co m Dove press  Dove pres sCoRRig EnDuMopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S10898 261,Non-OADS,/arxiv_data1/oa_pdf/5e/ba/mder-9-061.PMC4844453.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/ott-9-2273.PMC4844455.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2273–2286OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2273Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8386 8Therapeutic approaches in myelofibrosis and  myelodysplastic/myeloproliferative overlap  syndromes Andrew L Sochacki1 Melissa A Fischer1 Michael R Savona1,2 1Department of internal Medicine,   Vanderbilt University Medical Center,   2Vanderbilt-Ingram Cancer Center,   Nashville, TN, USAAbstract:  The discovery of JAK2V617F a decade ago led to optimism for a rapidly developing  treatment revolution in Ph− myeloproliferative neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/ott-9-2273.PMC4844455.pdf
"MDS/ MPNs include chronic myelomonocytic leukemia (CMML), juvenile MML, atypical Correspondence: Michael R Savona Division of Hematology/Oncology,  Department of internal Medicine,  Vanderbilt University Medical Center,  2220 Pierce Avenue – 777 PRB, Nashville,  TN 37232-6307, USA Tel +1 615 936 3321 email michael.savona@vanderbilt.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Sochacki et al Running head recto: Therapy for myelofibrosis and MDS/MPN DOI: http://dx.doi.org/10.2147/OTT.S83868",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/ott-9-2273.PMC4844455.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0e/c6/ott-9-2273.PMC4844455.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0e/c6/ott-9-2273.PMC4844455.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/9d/ndt-12-983.PMC4844458.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 983–993Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  983Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S9852 5The correlation between stress and economic  crisis: a systematic review Nicola Mucci1 Gabriele Giorgi2 Mattia Roncaioli3 Javier Fiz Perez2 Giulio Arcangeli1 1Department of experimental and  Clinical Medicine, University of  Florence, Florence, 2Department  of Psychology, european University  of Rome, Rome, 3Department of  Biomedical Sciences for Health,   University of Milan, Milan, italyAbstract:  In 2008 a deep economic crisis started in the US and rapidly spread around the world.",Non-OADS,/arxiv_data1/oa_pdf/5d/9d/ndt-12-983.PMC4844458.pdf
"The crisis increased job insecurity, in  particular, for those who remained employed in industries where many layoffs had  already occurred.5 In addition, the reduction in staff also led to stressful workplace  conditions such as an increased workload with longer shifts and less rest, reduction Correspondence: Gabriele Giorgi european University of Rome, 190, via  degli Aldobrandeschi, i-00163 Rome, italy Tel +39 06 6654 3111 Fax +39 06 6654 3840 email gabriele.giorgi@unier.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Mucci et al Running head recto: Stress and economic crisis DOI: http://dx.doi.org/10.2147/NDT.S98525",Non-OADS,/arxiv_data1/oa_pdf/5d/9d/ndt-12-983.PMC4844458.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5d/9d/ndt-12-983.PMC4844458.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/9d/ndt-12-983.PMC4844458.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/06/19/ppa-10-579.PMC4844459.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 579–589Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  579OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10304 3clinical factors affecting quality of life of patients  with asthma Bartosz Uchmanowicz1 Bernard Panaszek2 izabella Uchmanowicz1 Joanna Rosińczuk3 1Division of nursing in internal  Medicine Procedures, Department  of clinical nursing, Wroclaw  Medical University, Wroclaw, Poland;   2Department and clinic of internal  Diseases, geriatrics and Allergology,   Wroclaw Medical University, Wroclaw,   Poland; 3Department of nervous  system Diseases, Department of  clinical nursing, Wroclaw Medical  University, Wroclaw, PolandBackground:  In recent years, there has been increased interest in the subjective quality of life  (QoL) of patients with bronchial asthma.",Non-OADS,/arxiv_data1/oa_pdf/06/19/ppa-10-579.PMC4844459.pdf
"Many clinical studies on chronic illness outcomes depart from correspondence: izabella Uchmanowicz Division of nursing in internal Medicine  Procedures, Department of clinical  nursing, Wroclaw Medical University,  5 Bartla street, Wroclaw 51-618, Poland Tel +48 71 784 1824 Fax +48 71 345 9324 email izabella.uchmanowicz@umed.wroc.p lJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Uchmanowicz et al Running head recto: Quality of life in asthma patients DOI: http://dx.doi.org/10.2147/PPA.S103043",Non-OADS,/arxiv_data1/oa_pdf/06/19/ppa-10-579.PMC4844459.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/06/19/ppa-10-579.PMC4844459.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/1b/ndt-12-995.PMC4844460.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 995–1004Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  995OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S9460 0sense of alexithymia in patients with anxiety  disorders comorbid with recurrent urticaria Ewa A Ogłodek1 anna M szota1 Marek J Just2 Aleksander Araszkiewicz1 Adam R Szromek3 1Department of Psychiatry, collegium  Medicum in Bydgoszcz, Nicolaus  Copernicus University in T oruń,   T oruń, 2Department of general  and endocrine surgery, Municipal  Hospital, Piekary Śląskie, 3Department  of Organization and Management,   silesian University of T echnology,   gliwice, PolandAim:  Alexithymia is associated with limited cognitive processing of emotions by an individual  suffering from recurrent urticaria and alexithymia and makes them focus on somatic manifesta - tions of emotional arousal and on poorly controlled compulsive reactions to negative stimulation.",Non-OADS,/arxiv_data1/oa_pdf/7a/1b/ndt-12-995.PMC4844460.pdf
"This is followed by inclination of affected individuals to react to external Correspondence: Ewa A Ogłodek Department of Psychiatry, collegium  Medicum in Bydgoszcz, Nicolaus  Copernicus University in Toruń, 9 Curie- Sklodowska Street, 85-094 Bydgoszcz,  Poland Tel +48 52 585 4260 Fax +48 52 585 4266 email ewa.oglodek@wp.p l Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Ogłodek et al Running head recto: Sense of alexithymia in patients with anxiety disorders DOI: http://dx.doi.org/10.2147/NDT.S94600",Non-OADS,/arxiv_data1/oa_pdf/7a/1b/ndt-12-995.PMC4844460.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7a/1b/ndt-12-995.PMC4844460.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/1b/ndt-12-995.PMC4844460.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2057-2065,DOI:http://dx.doi.org/ 10.19082/2057 Corresponding author: Associate Professor Dr.Roya Sadeghi ,Department of Health Promotion, Tehran University of Medical Sciences, Tehran,Iran.E-mail:sadeghi_roya@yahoo.co.uk Received: November 23, 2015 , Accepted: January 14, 2016 , Published: March2016 iThenticate screening: January 13, 2016 , English editing: January 27, 2016 , Quality control: February 03, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
"http://www.ephysician.ir Page2058heart disease (11, 12), as well as cancer an d chronic pains (10).",Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
http://www.ephysician.ir Page2060Table 1.,Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
http://www.ephysician.ir Page20623.3.2.,Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
http://www.ephysician.ir Page2064suggested that women identify some health centers with free or reasonable prices in order to consult psychologists or psychiatrists for their services.,Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
Available from: http://www.comm.umn.edu/~akoerner/My%20pubs/Koerner&Fitzpatrick_2006(Conflict_HB).pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
"Available from: http://ohioline.osu.edu/hyg -fact/5000/pdf/5191.pdf 8)Fincham FD, Beach SRH.",Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
"Available from: http://pauldavidphd.com/wp -content/uploads/Pair - Bonding-Repair.pdf 14)Dildar S, Sitwat A, Yasin S. Intimate Enemies: Marital Conflicts and Conflict Resolution Styles in Dissatisfied Married Couples.",Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
Available from: http://www.kilmanndiagnostics.com/overview -thomas-kilmann-conflict-mode-instrument -tki,Non-OADS,/arxiv_data1/oa_pdf/56/53/epj-08-2057.PMC4844469.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir February2016, Volume: 8, Issue:2, Pages:2066-2072,DOI:http://dx.doi.org/ 10.19082/ 2066 Corresponding author: Safiyeh Rakhsh ani, Department of Medical library and information Sciences, Faculty of Management and Medical Information, Kerman University of Medical Sciences, Kerman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/69/b2/epj-08-2066.PMC4844470.pdf
"http://www.ephysician.ir Page2068determine the effects of ea ch variable, and determine the relationships between them in the form of an integrated pattern.",OADS,/arxiv_data1/oa_pdf/69/b2/epj-08-2066.PMC4844470.pdf
"http://www.ephysician.ir Page2070The coefficients of the t -values in the structural equations represented confirmation or rejection of the hypotheses; if the coefficient were greater than 2, the hypothesis was confirmed, otherwise it was rejected.",Non-OADS,/arxiv_data1/oa_pdf/69/b2/epj-08-2066.PMC4844470.pdf
"http://www.ephysician.ir Page207210)Wixom BH, Todd PA. A theoretical integration of user satisfaction and technology acceptance.",Non-OADS,/arxiv_data1/oa_pdf/69/b2/epj-08-2066.PMC4844470.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2073-2080,DOI:http://dx.doi.org/ 10.19082/ 2073 Corresponding author: Mehran Alijanzadeh, Social Det erminants of Health Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.",Non-OADS,/arxiv_data1/oa_pdf/07/cd/epj-08-2073.PMC4844471.pdf
http://www.ephysician.ir Page2074realization of health and medical organizations (6).,Non-OADS,/arxiv_data1/oa_pdf/07/cd/epj-08-2073.PMC4844471.pdf
http://www.ephysician.ir Page2076Table 1.,Non-OADS,/arxiv_data1/oa_pdf/07/cd/epj-08-2073.PMC4844471.pdf
http://www.ephysician.ir Page2078Conflict of Interest: There is no conflict of interest to be declared.,Non-OADS,/arxiv_data1/oa_pdf/07/cd/epj-08-2073.PMC4844471.pdf
"http://www.ephysician.ir Page208040)RohiniR, Mahadevappa B.",Non-OADS,/arxiv_data1/oa_pdf/07/cd/epj-08-2073.PMC4844471.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2081-2087,DOI:http://dx.doi.org/ 10.19082/ 2081 Corresponding author: Babak Soltani, Department of Pediatrics, Kashan University of Medical Sciences, Kashan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/36/c5/epj-08-2081.PMC4844472.pdf
"http://www.ephysician.ir Page2082creation of carb apenemase among gram negative bacteria (6).The prevalence of ESBL producing strains varies in different parts of the world ,with lower rates (3 -8%) in Singapore, Japan ,and Sweden despite thehigher rates in Italy (37%), Turkey (58%) ,andIran (59.2%)(7,8).",Non-OADS,/arxiv_data1/oa_pdf/36/c5/epj-08-2081.PMC4844472.pdf
http://www.ephysician.ir Page2084Table 3.,Non-OADS,/arxiv_data1/oa_pdf/36/c5/epj-08-2081.PMC4844472.pdf
http://www.ephysician.ir Page2086et al.’ssurvey(17).,Non-OADS,/arxiv_data1/oa_pdf/36/c5/epj-08-2081.PMC4844472.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2088-2093,DOI:http://dx.doi.org/ 10.19082/ 2088 Corresponding author: Associate Professor Dr. Zahra Zamanian, Department of Ergonomics, School of Health, Shiraz University of Medical Sciences, S hiraz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/b6/55/epj-08-2088.PMC4844473.pdf
http://www.ephysician.ir Page20902.3.,Non-OADS,/arxiv_data1/oa_pdf/b6/55/epj-08-2088.PMC4844473.pdf
http://www.ephysician.ir Page2092Authors' contributions: All authors contributed to this project and article equally.,Non-OADS,/arxiv_data1/oa_pdf/b6/55/epj-08-2088.PMC4844473.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2094-2100,DOI:http://dx.doi.org/ 10.19082/ 2094 Corresponding author: Dr.Mohammad Bagher Owlia, Department of Rheumatology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/epj-08-2094.PMC4844474.pdf
"http://www.ephysician.ir Page2096joint of hand and foot arthritis, 13 (9.6%) had muscle pain, 3 (2.2%) had chronic diarrhea, and 3 (2.2%) had psoriatic skin lesions.",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/epj-08-2094.PMC4844474.pdf
http://www.ephysician.ir Page20984.2.,Non-OADS,/arxiv_data1/oa_pdf/ad/3e/epj-08-2094.PMC4844474.pdf
"http://www.ephysician.ir Page210025)Priest JR, Low D, Wang C, Bush T. Brucellosis and sacroiliitis: a common presentation of an uncommon pathogen.",Non-OADS,/arxiv_data1/oa_pdf/ad/3e/epj-08-2094.PMC4844474.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2101-2106,DOI:http://dx.doi.org/ 10.19082/ 2101 Corresponding author: Khalil Moradi, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6d/65/epj-08-2101.PMC4844475.pdf
"http://www.ephysician.ir Page2102of patients (4, 5).",Non-OADS,/arxiv_data1/oa_pdf/6d/65/epj-08-2101.PMC4844475.pdf
"http://www.ephysician.ir Page2104very important, i.e., responsiveness (91%), tangibility (75%), reliability (86%), assurance (79%), and empathy (83%) (Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/6d/65/epj-08-2101.PMC4844475.pdf
"http://www.ephysician.ir Page21069)Caruana A, Ewing MT, Ramaseshan B.",Non-OADS,/arxiv_data1/oa_pdf/6d/65/epj-08-2101.PMC4844475.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2107-2114,DOI:http://dx.doi.org/ 10.19082/ 2107 Corresponding author: Assistant Professor Dr. Mahrokh Dolatian, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Science s, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/3e/26/epj-08-2107.PMC4844476.pdf
http://www.ephysician.ir Page2108elimination of this problem (1).,Non-OADS,/arxiv_data1/oa_pdf/3e/26/epj-08-2107.PMC4844476.pdf
http://www.ephysician.ir Page2110experiencing dysmenorrhea were reduced by 0.05.,OADS,/arxiv_data1/oa_pdf/3e/26/epj-08-2107.PMC4844476.pdf
http://www.ephysician.ir Page2112Conflict of Interest: There is no conflict of interest to be declared.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/epj-08-2107.PMC4844476.pdf
http://www.ephysician.ir Page211446)Hudson T. Natural progesterone: Clinical indications in women's health.,Non-OADS,/arxiv_data1/oa_pdf/3e/26/epj-08-2107.PMC4844476.pdf
"ephysician.ir March2016, Volume: 8, Issue:3, Pages:2115-2122,DOI:http://dx.doi.org/ 10.19082/ 2115 Corresponding author: Hamid Reza Dehghan.",Non-OADS,/arxiv_data1/oa_pdf/e7/00/epj-08-2115.PMC4844477.pdf
http://www.ephysician.ir Page2116it increases with age (6).,Non-OADS,/arxiv_data1/oa_pdf/e7/00/epj-08-2115.PMC4844477.pdf
http://www.ephysician.ir Page21183.2.,Non-OADS,/arxiv_data1/oa_pdf/e7/00/epj-08-2115.PMC4844477.pdf
http://www.ephysician.ir Page2120 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/e7/00/epj-08-2115.PMC4844477.pdf
"http://www.ephysician.ir Page212218)Sánchez M, Anitua E, Azofra J, Aguirre JJ, Andia I. Intra -articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retro spective cohort study.",Non-OADS,/arxiv_data1/oa_pdf/e7/00/epj-08-2115.PMC4844477.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2123-2128,DOI:http://dx.doi.org/ 10.19082/ 2123 Corresponding author: Mahboobeh Rajabi, Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.",Non-OADS,/arxiv_data1/oa_pdf/d5/7d/epj-08-2123.PMC4844478.pdf
"http://www.ephysician.ir Page2124person is saying, listening carefully while showing interest and not interrupting (4).",Non-OADS,/arxiv_data1/oa_pdf/d5/7d/epj-08-2123.PMC4844478.pdf
http://www.ephysician.ir Page21263.3.,Non-OADS,/arxiv_data1/oa_pdf/d5/7d/epj-08-2123.PMC4844478.pdf
http://www.ephysician.ir Page21283)Gonzalez TD.,Non-OADS,/arxiv_data1/oa_pdf/d5/7d/epj-08-2123.PMC4844478.pdf
Available from: http://www.mheducation.ca/college/mcshane4/student/olc/4obm_sa_08.html.,Non-OADS,/arxiv_data1/oa_pdf/d5/7d/epj-08-2123.PMC4844478.pdf
Available from: http://www.ccdf.ca/ccdf/NewCoach/english.,Non-OADS,/arxiv_data1/oa_pdf/d5/7d/epj-08-2123.PMC4844478.pdf
Available from: http://www.medscape.com/ partners/niosh/public/niosh.,OADS,/arxiv_data1/oa_pdf/d5/7d/epj-08-2123.PMC4844478.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2129-2135,DOI:http://dx.doi.org/ 10.19082/ 2129 Corresponding author: Rezvan Dashti, School of Rehabilitation, Ahvaz Jundishapur University of medical sciences, Ahvaz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/4e/67/epj-08-2129.PMC4844479.pdf
http://www.ephysician.ir Page2130commitment and the predictors that a ffect it.,Non-OADS,/arxiv_data1/oa_pdf/4e/67/epj-08-2129.PMC4844479.pdf
http://www.ephysician.ir Page2132situation with a mean score of 49.55 ± 4.36.,Non-OADS,/arxiv_data1/oa_pdf/4e/67/epj-08-2129.PMC4844479.pdf
http://www.ephysician.ir Page2134of faculty members should be considered as one of the determinants of their organizational commitment in human resource management practices.,Non-OADS,/arxiv_data1/oa_pdf/4e/67/epj-08-2129.PMC4844479.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2136-2143,DOI:http://dx.doi.org/ 10.19082/ 2136 Corresponding author: Assistant Professor Dr.Mohammad Hossein Ebrahimi, Department of Occupational Health Engineering, Occupational and Environmental Health Research C enter, Shahroud University of Medical Sciences, Shahroud, Iran.Tel: +98.9189928285, E -mail: Ebrahimi_Mh@hotmail.com Received: October 03, 2015 , Accepted: December 25, 2015 , Published: March2016 iThenticate screening: December 18, 2015 , English editing: February 12, 2016 , Quality control: March 08, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c4/09/epj-08-2136.PMC4844480.pdf
"http://www.ephysician.ir Page2138Broadbent's cognitive failures questionnaire consists of 25 questions that address the four aspects of failure in memory, memory for names, perception, and motor function (16).",Non-OADS,/arxiv_data1/oa_pdf/c4/09/epj-08-2136.PMC4844480.pdf
http://www.ephysician.ir Page2140Table 4.Relation between demographic and background variables with work ability index and its subscales WAI Background variables [Pearson and Spearman correlation (p -value)] Age Body mass indexExperience Number of shiftsNumber of patients under supervision Current work ability compared with the lifetime best0.15 (0.0.6)-0.03 (0.7) 0.18* (0.03)0.09 (0.28)-0.1 (0.23) Work ability in relation to the demands of the job0.04 (0.57) -0.004 (0.96)0.04 (0.59) 0.05 (0.53)0.49 (0.56) current diseases diagnosed by a physician-0.19* (0.02)0.22* (0.01)-0.23* (0.001)0.05 (0.53)-0.12 (0.17) Estimated work impairment due to diseases-0.15 (0.07) -0.31* (0.001)-0.14 (0.09)0.1 (0.24) -0.06 (0.47) Sick leave during the past 12 months-0.36* (0.001)0.07 (0.38) -0.34* (0.001)0.1 (0.24) -0.23 (0.001) Personal prognosis of work ability 2 years from now-0.29* (0.001)-0.02 (0.8) -0.28* (0.011)0.1 (0.24) 0.03 (0.69) Mental resources 0.2* (0.01) 0.08 (0.34) -0.19* (0.02)0.1 (0.24) -0.01 (0.86) Total score of WAI -0.33* (0.001)-0.18* (0.03)-0.32* (0.001)0.09(0.29) -0.11 (0.19) * Significant at a confidence level of 95% Table 5.Relation between demographic and background variables with CFsand its subscales CFs Background variables [Pearson and Spearman correlation (p -value)] Age Body mass indexExperience Number o f shiftsNumber of patients under supervision Memory 0.38* (0.001) 0.13 (0.12) 0.37* (0.001) 0.09 (0.28) -0.003 (0.96) Memory for names 0.35* (0.001) 0.19 (0.02) 0.33* (0.001) 0.05 (0.54) -0.17 (0.04) Perception 0.39* (0.001) 0.08 (0.33) 0.38* (0.001) 0.05 (0.53) 0.07 (0.38) Motor function 0.41* (0.001) 0.07 (0.38) 0.39* (0.001) 0.1 (0.24) -0.009 (0.92) Total score of CFs 0.046* (0.001) 0.12 (0.14) 0.47* (0.001) 0.09 (0.29) 0.007 (0.93) * Significant at a confidence level of 95% 4.Discussion 4.1.,Non-OADS,/arxiv_data1/oa_pdf/c4/09/epj-08-2136.PMC4844480.pdf
"http://www.ephysician.ir Page2142References : 1)Aiken LH, Clarke SP, Sloane DM.",Non-OADS,/arxiv_data1/oa_pdf/c4/09/epj-08-2136.PMC4844480.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2144-2149,DOI:http://dx.doi.org/ 10.19082/ 2144 Corresponding author: Elham Davaridolatabadi, Faculty of Nursing and Midwifery, Young Researchers and Elite Club, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ac/23/epj-08-2144.PMC4844481.pdf
http://www.ephysician.ir Page2146Cronbach's alpha (87%) (13).,Non-OADS,/arxiv_data1/oa_pdf/ac/23/epj-08-2144.PMC4844481.pdf
http://www.ephysician.ir Page2148most powerful and most important predictive factor of mental health.,Non-OADS,/arxiv_data1/oa_pdf/ac/23/epj-08-2144.PMC4844481.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2150-2159,DOI:http://dx.doi.org/ 10.19082/ 2150 Corresponding author: Narjes Bahri, Department of Midwifery, faculty of Nursing and Midwifery, Gonabad University of Medic al Sciences, Gonabad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/00/97/epj-08-2150.PMC4844482.pdf
"http://www.ephysician.ir Page21522.2.2.Step 2-Assembling the team: At this stage, 11 specialists became members of the HFMEA team, including a risk assessment manager as the team leader; a PhD holder in healthcare management and two Ph .D.candidates in reproductive health as consultants; an OB/GYN, the head of the maternity ward, an anesthesiologist, an anesthesiologist’s assistant, a midwife, two authorities, one in charge of hospital fa cilities and the other responsible for providing services.",Non-OADS,/arxiv_data1/oa_pdf/00/97/epj-08-2150.PMC4844482.pdf
"http://www.ephysician.ir Page2154Classification of error modes according to the “nursing error management association” model showed that 59.4% of the error modes are related to the care process, 24.6% to communication, 10.14% to administrative errors, and 5.79% to knowledge and skill.",Non-OADS,/arxiv_data1/oa_pdf/00/97/epj-08-2150.PMC4844482.pdf
"http://www.ephysician.ir Page2156to the issue by mi dwives due to the harmlessness of Entonoxtime highlighted in red ,Making obligatory hourly examination of the woman by the midwife Inattention to ceasing the flow of gas 4312YesYes NoControl Controlling the cessation of Entonox by the midwife Entonox emitted in the delivery unit 4312 NoNoYes Weekly control of the cylinders by Technical Services ,Writing a report on  the technical control of the cylinders by the controllerNo monitoring by Technical Services236 NoNoYesControl Delay in identifying the second phase of labor and lack of en ough time to prescribe oxygen428 NoNoYes Making obligatory the use of oxygen for mothers using Entonox during labor,Individual monitoring (one midwife for each mother)Inattentiveness of the staff Control Crowdedness of the ward 339 NoNoYesControl Wrong recording of the time inhalation was ceased428 NoYesNoControl Observation of the written reports by the head of the shift Delay in transferring the woman in labor4312 NoNoYes Individual monitoring (one mi dwife for each mother ,Increasing the number of personnel on the wardStaff shortage 236No NoControl Crowded ward 339 NoNoYesControl 4.Discussion In this study, HFMEA, as a proactive method, was used to detect the important errors in using Entonox, and corrective actions were recommended for each error.",Non-OADS,/arxiv_data1/oa_pdf/00/97/epj-08-2150.PMC4844482.pdf
"November 1999, Available from: http://www.iom.edu/~/media/Files/Report%20Files/1999/To -Err-is Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf",Non-OADS,/arxiv_data1/oa_pdf/00/97/epj-08-2150.PMC4844482.pdf
"http://www.ephysician.ir Page21583)Carolyn M, Clancy M. Ten Years After To Err Is Human.",Non-OADS,/arxiv_data1/oa_pdf/00/97/epj-08-2150.PMC4844482.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2160-2167,DOI:http://dx.doi.org/ 10.19082/ 2160 Corresponding author: Associate Professor Dr. Abbas He ydari, School of Nursing, Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/e6/8e/epj-08-2160.PMC4844483.pdf
http://www.ephysician.ir Page21622.6.,Non-OADS,/arxiv_data1/oa_pdf/e6/8e/epj-08-2160.PMC4844483.pdf
http://www.ephysician.ir Page21643.3.,Non-OADS,/arxiv_data1/oa_pdf/e6/8e/epj-08-2160.PMC4844483.pdf
http://www.ephysician.ir Page2166Authors' contributions: All authors contributed to this project and article equally.,Non-OADS,/arxiv_data1/oa_pdf/e6/8e/epj-08-2160.PMC4844483.pdf
"Available from: http://www.gutenberg.org/ 22)Kim, MA.",Non-OADS,/arxiv_data1/oa_pdf/e6/8e/epj-08-2160.PMC4844483.pdf
"Electronic P hysician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2168-2174,DOI:http://dx.doi.org/ 10.19082/ 2168 Corresponding author: Associate Professor Dr. A mir Afshin Khaki, Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/81/0e/epj-08-2168.PMC4844484.pdf
"http://www.ephysician.ir Page2170follicles, we evaluated degenerative changes in the granulosa of the growing primary follicles, the status of cells around the oocytes, and the structure of ovarian stroma.",Non-OADS,/arxiv_data1/oa_pdf/81/0e/epj-08-2168.PMC4844484.pdf
http://www.ephysician.ir Page2172 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/81/0e/epj-08-2168.PMC4844484.pdf
"http://www.ephysician.ir Page21746)Roshangar L, Hamdi B, Khaki A, Rad JS, Soleimani -Rad S. Effect of low -frequency electromagnetic field exposure on oocyte differentiation and follicular development.",Non-OADS,/arxiv_data1/oa_pdf/81/0e/epj-08-2168.PMC4844484.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2175-2180,DOI:http://dx.doi.org/ 10.19082/ 2175 Corresponding author: Mohammad Hossein Sorbi, Department of Psychology, Faculty of Medicine, Kermanshah University of Me dical Science, Kermanshah, Iran.",Non-OADS,/arxiv_data1/oa_pdf/5f/31/epj-08-2175.PMC4844485.pdf
http://www.ephysician.ir Page21761.,Non-OADS,/arxiv_data1/oa_pdf/5f/31/epj-08-2175.PMC4844485.pdf
http://www.ephysician.ir Page2178concluded that these two groups were the same in demographic variables (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/5f/31/epj-08-2175.PMC4844485.pdf
http://www.ephysician.ir Page2180responsiveness in postmenopa usal breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/5f/31/epj-08-2175.PMC4844485.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2181-2186,DOI:http://dx.doi.org/ 10.19082/ 2181 Corresponding author: Professor Dr. Ramezan Ali Ataee, Department of Virology and Bacteriology, Faculty of Medicine, Baq iyatallah University of Medical S ciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/44/70/epj-08-2181.PMC4844486.pdf
"http://www.ephysician.ir Page2182between EBV and some autoimmune diseases, such as systemic lupus erythematous (SLE) and RA, have been documented (2).",Non-OADS,/arxiv_data1/oa_pdf/44/70/epj-08-2181.PMC4844486.pdf
"http://www.ephysician.ir Page2184Staphylococcal (30 -32) and Mycoplasma superantigens (33, 34), were reported in the synovial fluids of RA patients.",Non-OADS,/arxiv_data1/oa_pdf/44/70/epj-08-2181.PMC4844486.pdf
"http://www.ephysician.ir Page218633)Golmohammadi R, Ataee RA, Alishiri GH, Mirnejad R, Mehrabi TA, Esmaieli D. Design of PCR -based method for detection of a gene -encoding Mycoplasma arthritidis mitogen superantigen in synovial fluid of rheumatoid arthritis patients.",Non-OADS,/arxiv_data1/oa_pdf/44/70/epj-08-2181.PMC4844486.pdf
"Electronic Physician (ISSN: 200 8-5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2187-2193,DOI:http://dx.doi.org/ 10.19082/ 2187 Corresponding author: Dr. Malihe Mohammadzadeh, Department of Pediatrics, Faculty of Medicine, Hormozgan University of Medical Sciences.Tel: +98.9177314740, Email: Pahlavanzadeh@sksco.ir Received: April 12, 2015 , Accepted: September 04, 2015 , Published: March2016 iThenticate screening: September 09, 2015 , English editing: November 01, 2 015, Quality control: February 27, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c8/88/epj-08-2187.PMC4844487.pdf
http://www.ephysician.ir Page21881.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/epj-08-2187.PMC4844487.pdf
http://www.ephysician.ir Page2190Table 1.Baseline characteristics of two groups Baseline characteristics Desmopressin; n (%) Oxybutynin; n (%) Gender Male 30 (76.9%) 21(77.8%) Female 9 (23.1%) 6 (22.2%) Place of residence Urban areas 34 (87.2%) 23 (85.2%) Rural areas 5 (12.8%) 4 (14.8%) Age (year) 6.92 ± 0.83 7.27 ± 1.1 Nocturnal enuresis 39 (100%) 27 (100%) Urinary incontinency 2 (5.1%) 5 (18.5%) Frequency of nocturnal enuresis (per week) 18.28 ± 5 .47 18.85 ± 6.9 Urgency 1 (2.6%) 7 (25.9%) Frequency 38 (97.4%) 25 (92.6%) 3.2.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/epj-08-2187.PMC4844487.pdf
http://www.ephysician.ir Page21924.2.,Non-OADS,/arxiv_data1/oa_pdf/c8/88/epj-08-2187.PMC4844487.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2194-2198,DOI:http://dx.doi.org/ 10.19082/ 2194 Corresponding author: Azizreza Ghasemzadeh.",Non-OADS,/arxiv_data1/oa_pdf/dd/5e/epj-08-2194.PMC4844488.pdf
http://www.ephysician.ir Page2196We used SPSS version 20 (IBM -SPSS) to analyze the data.,OADS,/arxiv_data1/oa_pdf/dd/5e/epj-08-2194.PMC4844488.pdf
"http://www.ephysician.ir Page219811)Seyedian M, Falah M, Nourouzian M, Nejat S, Delavar A, Ghasemzadeh HA.",Non-OADS,/arxiv_data1/oa_pdf/dd/5e/epj-08-2194.PMC4844488.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir March2016, Volume: 8, Issue:3, Pages:2199-2207,DOI:http://dx.doi.org/ 10.19082/ 2199 Corresponding author: Mansour Babaei, Health Management Research Center, Baqiyatallah University o f Medical Science, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/93/ca/epj-08-2199.PMC4844489.pdf
http://www.ephysician.ir Page2200prevent 90% of diabetes type II and 80% of cardiovascular disease (2).,Non-OADS,/arxiv_data1/oa_pdf/93/ca/epj-08-2199.PMC4844489.pdf
http://www.ephysician.ir Page22024)The article being publi shed in Persian or English 2.2.,Non-OADS,/arxiv_data1/oa_pdf/93/ca/epj-08-2199.PMC4844489.pdf
http://www.ephysician.ir Page2204statistically significant relationship between the parents’ cultural and economic capital and their adolescent children’s lifestyle.,Non-OADS,/arxiv_data1/oa_pdf/93/ca/epj-08-2199.PMC4844489.pdf
"http://www.ephysician.ir Page220624)Black JM, Hawks J, Keene A.",Non-OADS,/arxiv_data1/oa_pdf/93/ca/epj-08-2199.PMC4844489.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9b/2a/ott-9-2385.PMC4844502.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2385–2392OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2385Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10264 8aeg-1 as a predictor of sensitivity to neoadjuvant  chemotherapy in advanced epithelial ovarian  cancer Yao Wang1,* Xin Jin2,* hongtao song3 Fanling Meng4 1Department of gynecology and  Obstetrics, 2Department of intensive  care Unit, The general hospital of  Daqing Oil Field, Daqing, 3Department  of Pathology, 4Department of  gynecology, The affiliated Tumor  hospital, harbin Medical University,   harbin, People’s republic of china *These authors contributed equally  to this workObjectives:  Astrocyte elevated gene-1 (AEG-1) plays a critical role in tumor progression  and chemoresistance.",Non-OADS,/arxiv_data1/oa_pdf/9b/2a/ott-9-2385.PMC4844502.pdf
"Therefore, it is necessary to identify reliable predictive biomarkers  for responsiveness to NAC and to address the issue of drug resistance.correspondence: Fanling Meng Department of Gynecology, The Affiliated   Tumor hospital, harbin  Medical University, 150 haping road,   nangang District, harbin 150081,  People’s republic of china Tel +86 451 8629 8395 email dr_mfl1979@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: AEG-1 expression in advanced EOC DOI: http://dx.doi.org/10.2147/OTT.S102648",Non-OADS,/arxiv_data1/oa_pdf/9b/2a/ott-9-2385.PMC4844502.pdf
Available from: http://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/9b/2a/ott-9-2385.PMC4844502.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9b/2a/ott-9-2385.PMC4844502.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/2a/ott-9-2385.PMC4844502.pdf
"Ji-il Kim1, Hye-Y eon Cho2, Jin-Hee Han2 and Bong-Kiun Kaang1* 1Department of Biological Sciences, College of Natural Sciences, Seoul National University, Seoul 08826,  2Department of Biological Sciences, KAIST Institute for the BioCentury (KIB),   Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Koreahttp://dx.doi.org/10.5607/en.2016.25.2.55 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
"TEL: 82-2-880-9024, FAX: 82-2-884-9577 e-mail: kaang@snu.ac.kr Copyright © Experimental Neurobiology 2016. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
"56 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Ji-il Kim, et al.",OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
57 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Which Neurons Will Be the Engram - Activated Neurons and/or More Excitable Neurons?,Non-OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
"58 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Ji-il Kim, et al.",OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
59 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Which Neurons Will Be the Engram - Activated Neurons and/or More Excitable Neurons?,Non-OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
"60 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Ji-il Kim, et al.",OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
61 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Which Neurons Will Be the Engram - Activated Neurons and/or More Excitable Neurons?,Non-OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
"62 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Ji-il Kim, et al.",OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
63 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.55Which Neurons Will Be the Engram - Activated Neurons and/or More Excitable Neurons?,Non-OADS,/arxiv_data1/oa_pdf/44/d7/en-25-55.PMC4844563.pdf
"Moreover, it has also been Induction of Nerve Injury-Induced Protein 1  (Ninjurin 1) in Myeloid Cells in Rat Brain after  Transient Focal Cerebral Ischemia Hye-Kyung Lee1,2, Hahnbie Lee1,2, Lidan Luo1,2 and Ja-Kyeong Lee1,2* 1Department of Anatomy, Inha University School of Medicine,   2Medical Research Center, Inha University School of Medicine, Incheon, Koreahttp://dx.doi.org/10.5607/en.2016.25.2.64 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
"TEL: 82-32-890-0913, FAX: 82-32-884-2105 e-mail: jklee@inha.ac.kr Copyright © Experimental Neurobiology 2016. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
65 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.64Induction of Ninjurin 1 in Rat Brain after MCAO shown that Ninj1 enhanced macrophage motility and consequent  extravasation by modulating protrusive membrane dynamics [6].,Non-OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
All animal studies were carried out in strict accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health and complied with ARRIVE guidelines (http://www.nc3rs.org/ARRIVE).,Non-OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
"66 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.64Hye-Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
67 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.64Induction of Ninjurin 1 in Rat Brain after MCAO and striata prompted us to identify the cell types expressing  Ninj1 in different regions at different times.,Non-OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
"68 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.64Hye-Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
"69 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.64Induction of Ninjurin 1 in Rat Brain after MCAO marker CD45, Ninj1 was expressed in reactive macrophages but  not in resident microglia in cortical penumbras (Fig.",OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
"70 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.64Hye-Kyung Lee, et al.",OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
71 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.64Induction of Ninjurin 1 in Rat Brain after MCAO 6.,Non-OADS,/arxiv_data1/oa_pdf/8f/41/en-25-64.PMC4844564.pdf
"A Fluoride Induces a Volume Reduction in CA1  Hippocampal Slices Via MAP Kinase Pathway  Through Volume Regulated Anion Channels Jaekwang Lee1, Y oung-Eun Han1,2, Oleg Favorov3, Mark Tommerdahl3,   Barry Whitsel3,4 and C. Justin Lee1,2* 1Center for Neuroscience and Functional Connectomics, Korea Institute of Science and Technology (KIST), Seoul 02792,   2Neuroscience Program, University of Science and Technology (UST), Daejeon 34113, Korea 3Departments of Biomedical Engineering, University of North Carolina at Chapel Hill, CB#7575, Chapel Hill, NC, USA  4Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, CB#7575, Chapel Hill, NC, USAhttp://dx.doi.org/10.5607/en.2016.25.2.72 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
"TEL: 82-2-958-6940, FAX: 82-2-958-6937 e-mail: cjl@kist.re.kr Copyright © Experimental Neurobiology 2016. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
73 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.72Fluoride Reduces Hippocampal Volume Via MAPK by Opening VRAC recent report from the National Research Council (NRC 2006) in  US concluded that adverse effects of high fluoride concentrations in drinking water might be of concern.,Non-OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
"74 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.72Jaekwang Lee, et al.",OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
75 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.72Fluoride Reduces Hippocampal Volume Via MAPK by Opening VRAC (70~80 s) in light transmittance through stratum radiatum  of  CA1 hippocampal slices (Fig.,OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
"76 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.72Jaekwang Lee, et al.",OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
77 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.72Fluoride Reduces Hippocampal Volume Via MAPK by Opening VRAC negative influence on brain volume dynamics.,Non-OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
"78 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.72Jaekwang Lee, et al.",OADS,/arxiv_data1/oa_pdf/1e/4d/en-25-72.PMC4844565.pdf
"The dorsal striatum, particularly the Reversal of an Unconditioned Behavioral  Preference for Specific Food Pellets by Intervention  of Whisker Sensory Inputs Hannah Kim1, Yunjin Lee1, Ji-Eun Kim1 and Pyung-Lim Han1,2,3* 1Department of Brain and Cognitive Sciences, 2Brain Disease Research Institute, and   3Department of Chemistry and Nano Science, Ewha Womans University, Seoul 03760, Koreahttp://dx.doi.org/10.5607/en.2016.25.2.79 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
"TEL: 82-2-3277-4130, FAX: 82-2-3277-3419 e-mail: plhan@ewha.ac.kr Copyright © Experimental Neurobiology 2016. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
"80 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.79Hannah Kim, et al.",OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
"81 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.79Reversal of Unconditioned Behaviors by Changing Sensory Inputs mice were termed WT pellets, while those from home cages  carrying AC5 KO mice were termed KO pellets.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
"82 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.79Hannah Kim, et al.",OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
83 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.79Reversal of Unconditioned Behaviors by Changing Sensory Inputs exhibited a behavioral preference for AC5 KO pellets over WT  pellets (Fig.,OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
"84 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.79Hannah Kim, et al.",OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
85 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.79Reversal of Unconditioned Behaviors by Changing Sensory Inputs RefeR eNC es 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/86/en-25-79.PMC4844566.pdf
"[13] showed that pupil dilation and constriction track the cortical membrane potential during “ quiet wakefulness”—the moments between exploratory Pupil Size in Relation to Cortical States during  Isoflurane Anesthesia Jeung Eun Kum1,3, Hio-Been Han1,2 and Jee Hyun Choi1,3* 1Center for Neuroscience, Korea Institute of Science and Technology, Seoul 02792,   2Department of Psychology, Yonsei University, Seoul 03722,   3Department of Neuroscience, University of Science and Technology, Daejon 34113, Koreahttp://dx.doi.org/10.5607/en.2016.25.2.86 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
"TEL: 82-2-958-6952, FAX: 82-2-958-6737 e-mail: jeechoi@kist.re.kr Copyright © Experimental Neurobiology 2016. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
87 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.86Pupil Dilation Predicts Cortical Transition in Emergence of Anesthesia behaviors.,OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
"88 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.86Jeung Eun Kum, et al.",OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
The code is downloadable from http://www.shawnlankton.com/2008/04/active-contour-matlab-code-demo/.,OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
"89 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.86Pupil Dilation Predicts Cortical Transition in Emergence of Anesthesia ResU lTs Mydriasis occurring in the recovery phase of anesthesia  Different doses of anesthesia were tested to mimic the induction  of anesthesia (induction phase, stepwise increase in anesthetic  dose), or emergence of anesthesia (emergence phase, stepwise decrease in anesthetic dose).",OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
"90 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.86Jeung Eun Kum, et al.",OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
91 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.86Pupil Dilation Predicts Cortical Transition in Emergence of Anesthesia animal.,Non-OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
"92 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.86Jeung Eun Kum, et al.",OADS,/arxiv_data1/oa_pdf/44/cc/en-25-86.PMC4844567.pdf
"The current Fractionated Stereotactic Gamma Knife  Radiosurgery for Medial Temporal Lobe Epilepsy:  A Case Report Hye Ran Park1,3, Hyun-Tai Chung1, Sang Kun Lee2, Dong Gyu Kim1 and Sun Ha Paek1* Department of 1Neurosurgery, 2Neurology, Seoul National University Hospital, Seoul 03080,   3Department of Neurosurgery, Soonchunhyang University Seoul Hospital, Seoul 04401, Koreahttp://dx.doi.org/10.5607/en.2016.25.2.93 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
"TEL: 82-2-2072-3993, 82-2-2072-3957, FAX: 82-2-744-8459, 82-2-747-3799 e-mail: paeksh@snu.ac.kr Copyright © Experimental Neurobiology 2016. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/ 4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
"94 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Hye Ran Park, et al.",OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
"95 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Fractionated GKS for MTLE seizure episodes were initiated by a rising sensation in the  epigastrium followed by nausea and vomiting, loss of awareness, turning of his head to the left, and drooling.",Non-OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
"96 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Hye Ran Park, et al.",OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
97 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Fractionated GKS for MTLE Table 1.,OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
"98 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Hye Ran Park, et al.",OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
99 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Fractionated GKS for MTLE underwent radiosurgery with 20 Gy to the 50% isodose [13].,Non-OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
"100 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Hye Ran Park, et al.",OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
101 www.enjournal.org http://dx.doi.org/10.5607/en.2016.25.2.93Fractionated GKS for MTLE surgery.,Non-OADS,/arxiv_data1/oa_pdf/9e/d5/en-25-93.PMC4844568.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Schizophrenia Working memory EEGSomatosensorySteady-state evoked potential (SSEP) 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1016/j.nicl.2016.04.004 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1126/ science.1736359 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/ 10.1017/S135561770410307X .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1093/cercor/bhu050 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1093/ schbul/sbp091 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"http://dx.doi.org/10.1038/nrn3475 .Cannon, T.D., Glahn, D.C., Kim, J., Van Erp, T.G.M., Karlsgodt, K., Cohen, M.S., Nuechterlein, K.H., Bava, S., Shirinyan, D., 2005.",Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1001/ archpsyc.62.10.1071 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"32, 12 –20.http://dx.doi.org/10.1523/JNEUROSCI.3405-11.2012 .",Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.09.048 .,OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"20, 58 –66.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"Psychiatry 47, 34 –42.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1037/0021-843X.115.4.658 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"31, 26 –35.http://dx.doi.org/10.1002/ hbm.20842 .",Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1001/archpsyc.64.11.1229 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1093/schbul/sbp110 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1016/j.neulet.2004.10.,OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"53, 63 –88.http://dx.doi.org/10.1016/j.brainresrev.2006.06.",OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1016/j.clinph.2004.,OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1037/0021-843X.114.4.599 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1176/appi.ajp.2010.09030338 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.06.022 .,OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"8, 204 –210.http://dx.doi.org/10.1016/j.tics.2004.03.008 .",OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"72, 29–39.http://dx.doi.org/10.1016/j.schres.2004.09.007 .",OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1016/0013-4694(66)90088-5 .,OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1038/nrn1058 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/ 10.1038/20939 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1038/npp.2013.168 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5280-11.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1093/cercor/bht084 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"Neuroimaging 212, 73 –78.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"4, 88. http://dx.doi.org/10.3389/fpsyg.2013.00088 .",Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1002/hbm.20306 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
http://dx.doi.org/10.1038/nrn2774 .,Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"Psychiatry 4, 184. http://dx.doi.org/10.3389/ fpsyt.2013.00184 .",Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
"1, 5 –15.http://dx.doi.org/10.1177/ 2167702612464618 .587 S. Ludwig et al.",Non-OADS,/arxiv_data1/oa_pdf/2f/08/main.PMC4844590.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MEGASDGammaM100 Maturation 1.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.021 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.bbr.2008.08.049 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
1 –7http://dx.doi.org/10.3174/ ajnr.A4687.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1038/npp.2014.7 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"6, 1 –10.http://dx.doi.org/10.1002/aur.1260 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1146/annurev-neuro-062111-150444 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1038/nature08002 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.14814/phy2.12077 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"John Wiley & Sons, Inc., Hoboken, NJ, USA http://dx.doi.org/10.1002/0470119055 Danielsson, S., Gillberg, I.C., Billstedt, E., Gillberg, C., Olsson, I., 2005.",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1542/peds.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1002/hbm.21203 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.nicl.2013.11.004 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"8, 417. http://dx.doi.org/10.3389/fnhum.2014.00417 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
Autism 6. http://dx.doi.org/10.1186/s13229-015-0065-5 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1007/s10803-013-1904-x .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1002/dneu.22175 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"Cerebellum 8,64–69.http://dx.doi.org/10.1007/s12311-008-0075-3 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1007/s10803-014-2078-x .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.07.033 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"NeuroImage 86, 1 –9.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/S0165-3806(03)00172-X .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1007/s11689-009-9023-x .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.neuron.2014.06.033 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/ 10.1007/s10803-008-0674-3 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.bbr.2011.01.048 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1038/nature11356 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1007/s10803-010-1065-0 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1007/BF00237543 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/S1053-8119(03)00403-8 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
Elsevier B.V. http://dx.doi.org/10.1016/B978-0-444-62630-1.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"http://dx.doi.org/10.1007/s10803-014-2080-3 .Ke lley, E., Paul, J.J., Fein, D., Naigles, L.R., 2006.",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.03.085 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1111/j.1600-0404.2009.01234.x .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1023/A:1005592401947 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.ics.2006.12.073 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"BMC Psychiatry 12, 213. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"2014, 1 –10.http://dx.doi.org/10.1155/2014/472120 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/ 10.1111/j.1471-4159.2010.06858.x .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"2011, 1 –9.http://dx.doi.org/10.1155/2011/156869 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.ijpsycho.2007.10.015 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1007/s10803-015-2409-6 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/S0167-6393(02)00107-3 .,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.3389/fncel.2014.00414 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1097/WNR.0b013e3283306854 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"3, 8 –18.http://dx.doi.org/ 10.1002/aur.111 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"1537, 79 –85.http://dx.doi.org/10.1016/j.brainres.2013.09.011 .",OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"Rep. 2, 46 –57.http://dx.doi.org/10.1007/s40474-014-0032-4 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.clinph.,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"BMC Psychiatry 8, 66. http://dx.doi.org/10.1186/1471-244X-8-66 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"NeuroImage 86, 28 –34.http://dx.doi.org/10.1016/j.neuroimage.2013.01.045 .",OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"Autism 2, 11. http://dx.doi.org/10.1186/2040-2392-2-11 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"6, 60. http://dx.doi.org/10.1186/1744-9081-6-60 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"6, 69 –77.http://dx.doi.org/10.1002/aur.1264 .",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1038/ nrn2851 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"http://dx.doi.org/10.1016/j.brainresrev.2003.08.004 .Tierney, A.L., Gabard-Durnam, L., Vogel-Farley, V., Tager-Flusberg, H., Nelson, C.A., 2012.",OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1371/journal.pone.0039127 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"Psychiatry 11, 18 –23.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1093/cercor/11.10.946 .,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"7, 609. http://dx.doi.org/10.3389/fnhum.",Non-OADS,/arxiv_data1/oa_pdf/49/f6/main.PMC4844592.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.1 Korean J Spine 13(1):1-8, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  1Quantitative Pfirrmann Disc Degeneration Grading System to Over come  the Limitation of Pfirrmann Disc Degeneration Grade Dae Cheol Rim Department of Neurosurgery, Kim Young Soo Spine & Joint Hospital, Seoul, Korea  Objective:  Pfirrmann disc degeneration grade is one of morphologic disc degeneration grading system and it was reliable on  routine T2-weighted magnetic resonance (MR) images.",Non-OADS,/arxiv_data1/oa_pdf/61/23/kjs-13-1.PMC4844654.pdf
"Key Words : Quantitative ㆍPfirrma disc grade ㆍDisc degeneration ㆍMagnetic resonance ㆍSignal intensity ●Received: June 29, 2015  ●Revised: January 6, 2016 ●Accepted: January 7, 2016 Corresponding Author: Dae Cheol Rim , MD, PhD Department of Neurosurgery, Kim Young Soo Spine & Joint Hospital,  15, Eonju-ro 174-gil, Gangnam-gu, Seoul 06017, Korea Tel: +82-2-1577-5075, Fax: +82-2-3447-0015 E-mail: nsrimok@gmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The intervertebral discs are cylindrical, fibrocartilaginous,  articulating structures connecting the vertebral bodies, and it  can be divided microscopically into an outer annulus fibrosus surrounding a centrally located nucleus pulposus (NP) 13).",Non-OADS,/arxiv_data1/oa_pdf/61/23/kjs-13-1.PMC4844654.pdf
Weighted  kappa test was used to assess the interobserver reproducibility  using Microsoft Excel 2013 and VassarStats (website for stati- stical computation http://vassarstats.net/kappa.html).,OADS,/arxiv_data1/oa_pdf/61/23/kjs-13-1.PMC4844654.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.13 Korean J Spine 13(1):13-19, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  13Stand-Alone Cages for Anterior Cervical Fusion: Are There No Pr oblems?",Non-OADS,/arxiv_data1/oa_pdf/ca/b9/kjs-13-13.PMC4844655.pdf
"Key Words : Stand-alone cervical fusion ㆍSegmental subsidence ㆍCervical kyphosis ㆍPlate-assisted cervical fusion ●Received: December 26, 2015  ●Revised: February 4, 2016 ●Accepted: February 5, 2016 Corresponding Author: Hyun Woo Kim , MD, PhD Department of Neurosurgery, Konyang University Hospital, 158  Gwanjeodong-ro, Seo-gu, Daejeon 35365, KoreaTel: +82-42-600-9130, Fax: +82-42-600-8983 E-mail: naturalspine@gmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Anterior cervical discectomy and fusion (ACDF) is the most  frequently performed surgical treatment for several cervical spinal diseases, including herniated disc, compressive myelop- athy, trauma and degenerative disease 8,15).",Non-OADS,/arxiv_data1/oa_pdf/ca/b9/kjs-13-13.PMC4844655.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.20 Korean J Spine 13(1):20-23, 2016 www.e-kjs.org 20  Copyright © 2016 The Korean Spinal Neurosurgery SocietyIs Surgical Drain Useful for Lumbar Disc Surgery?",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/kjs-13-20.PMC4844656.pdf
"Key Words : Suction ㆍInfectionㆍHematoma ㆍDiscectomy ㆍLumbar disc disease ㆍTreatment outcome ●Received: November 27, 2015  ●Revised: December 31, 2015 ●Accepted: January 4, 2016 Corresponding Author: Sang Gu Lee , MD, PhD Department of Neurosurgery, Gachon University Gil Medical Center, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, KoreaTel: +82-32-460-3304, Fax: +82-32-460-3899 E-mail: samddal@gilhospital.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The spine surgery can lead to epidural hematoma.",Non-OADS,/arxiv_data1/oa_pdf/5e/b0/kjs-13-20.PMC4844656.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.24 Korean J Spine 13(1):24-29, 2016 www.e-kjs.org 24  Copyright © 2016 The Korean Spinal Neurosurgery SocietyThe Use Fibrin Sealant after Spinal Intradural Tumor Surgery:  Is It Necessary?",Non-OADS,/arxiv_data1/oa_pdf/13/0a/kjs-13-24.PMC4844657.pdf
"Key Words : Fibrin tissue adhesive ㆍSpineㆍSurgical wound infection ㆍCerebrospinal fluid ㆍSpinal cord neoplasms ●Received: November 28, 2015  ●Revised: January 3, 2016 ●Accepted: January 11, 2016 Corresponding Author: Chi Heon Kim , MD, PhD Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu,  Seoul 03080, KoreaTel: +82-2-2072-3939, Fax: +82-2-744-8459 E-mail: chiheon1@snu.ac.kr ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The goal of dural repair includes the containment of neural  tissue and restoration of the cerebrospinal fluid (CSF) space  around the spinal cord8,19,21).",Non-OADS,/arxiv_data1/oa_pdf/13/0a/kjs-13-24.PMC4844657.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.30 Korean J Spine  13(1):30-32, 2016 www.e-kjs.org 30  Copyright © 2016 The Korean Spinal Neurosurgery SocietyMultiple Intradural Disc Herniations Masquerading as Intradural   Extramedullary Tumors: A Case Report and Review of the Literatu re Young-Seop Park1, Seung-Jae Hyun2, Ki-Jeong Kim2, Tae-Ahn Jahng2 1Department of Neurosurgery, Spine Center, Gyeongsang National University Changwon Hospital,  Gyeongsang National University Graduate School of Medicine, Jinju, 2Department of Neurosurgery, Spine Center, Seoul National University Bundang Hospital,  Seoul National University College of Medicine, Seongnam, Korea Intradural disc herniation is a very rare condition, and multiple intradural disc herniations have not been reported to date.",Non-OADS,/arxiv_data1/oa_pdf/d3/f0/kjs-13-30.PMC4844658.pdf
"Key Words : Intervertebrtal disc displacement ㆍLumbar vertebrae ㆍNeoplasms ●Received: November 3, 2015  ●Revised: January 17, 2016 ●Accepted: January 18, 2016 Corresponding Author: Ki-Jeong Kim , MD, PhD Department of Neurosurgery, Spine Center, Seoul National UniversityBundang Hospital, Seoul National University College of Medicine,  82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7166, Fax: +82-31-787-4097E-mail: kijeong@snu.ac.kr ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Intradural lumbar disc herniation was first reported in  1942, and more than 100 cases have been reported since6,14,20).",Non-OADS,/arxiv_data1/oa_pdf/d3/f0/kjs-13-30.PMC4844658.pdf
"CASE REPORTpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.33 Korean J Spine  13(1):33-36, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  33Concomitant Double Tumors of Myxopapillary Ependymoma Presented   at Cauda Equina-Filum Terminale in Adult Patient Ulaş Yener1, Mustafa G üdük1, Murat Şakir Ekşi2, Murat Hamit Aytar3, Ayd ın Sav4, Serdar Özgen1 1Department of Neurosurgery, Ac ıbadem University Faculty of Medicine, Istanbul, Turkey,  2Department of Orthopedic Surgery-Spine Center, University of California at San Francisco, CA, USA,  3Department of Neurosurgery, Ac ıbadem University Vocational School of Health Services, Istanbul,  4Department of Pathology, Ac ıbadem University Faculty of Medicine, Istanbul, Turkey A 32-year-old man presented with gradually increasing bilateral buttock pain.",Non-OADS,/arxiv_data1/oa_pdf/aa/68/kjs-13-33.PMC4844659.pdf
"Key Words : Ependymoma ㆍSurgeryㆍRadiotherapy ㆍLow back pain ●Received: December 29, 2015  ●Revised: January 28, 2016 ●Accepted: January 29, 2016 Corresponding Author: Ulas Yener , MD Department of Neurosurgery, Ac ıbadem University Faculty of Medicine, Halkal ı Merkez, Turgut Özal Blv No:16, 34303 Halkal ı-Küçükçekmece, Istanbul, Turkey Tel: +90-536-3488978, Fax: +90-212-4044180E-mail: ulasyener@yahoo.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Glial cells are composed of astrocytes and ependymal cells.",Non-OADS,/arxiv_data1/oa_pdf/aa/68/kjs-13-33.PMC4844659.pdf
"TECHNICAL NOTEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.37 Korean J Spine  13(1):37-39, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  37Enlargement of Neural Foramina and Dynamic Stabilization in  Spondylolisthesis without Restoring the Alignment: Technical No te Ali Fahir Ozer1, Tuncer Suzer1, Mehdi Sasani2, Tunc Oktenoglu2, Emrah Egemen3 1Department of Neurosurgery, Koc University School of Medicine, Istanbul,  2Department of Neurosurgery, American Hospital, Istanbul,  3Department of Neurosurgery, Koc University Hospital, Istanbul, Turkey It is well known that the cause of radiculopathy is the compression of the nerve root within the foramina which is narrowed sec on- dary to sliding of the corpus and reduced disc height.",Non-OADS,/arxiv_data1/oa_pdf/ff/d6/kjs-13-37.PMC4844660.pdf
"Key Words : Spondylolisthesis ㆍDynamic stabilization ㆍLumbar pedicle ㆍNeural foraminal stenosis ●Received: December 2, 2015  ●Revised: January 11, 2016 ●Accepted: January 13, 2016 Corresponding Author: Ali Fahir Ozer , MD Department of Neurosurgery, Koc University School of Medicine, Rumelifeneri Yolu Sar ıyer, Istanbul 34450, Turkey Tel: +90-212-338-1401, Fax: +90-212-338-1559 E-mail: alifahirozer@gmail.com ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION In patients who have degenerative spondylolisthesis and  isthmic spondylolisthesis with low slipping rate, radicular  symptoms occur secondary to narrowed neural foramina.",Non-OADS,/arxiv_data1/oa_pdf/ff/d6/kjs-13-37.PMC4844660.pdf
"CLINICAL ARTICLEpISSN 1738-2262/eISSN 2093-6729 http://dx.doi.org/10.14245/kjs.2016.13.1.9 Korean J Spine 13(1):9-12, 2016 www.e-kjs.org Copyright © 2016 The Korean Spinal Neurosurgery Society  9The Applicability of Intraoperative Neuromonitoring in Patients  with  Preoperative Motor Weakness during Spine Surgery Jae Meen Lee1, Dong Hwan Kim2, Hwan Soo Kim2, Byung Kwan Choi2, In Ho Han2 1Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul,  2Medical Research Institute, Pusan National University Hospital, Pusan National University College of Medicine, Busan, Korea Objective:  The purpose of our study is to evaluate the success rate and feasibility of intraoperative neuromonitoring (IONM) focu-  sing on transcranial motor evoked potential (TcMEP) monitoring for patients with preoperative motor weakness in spine surgery.Methods:  Between November 2011 and December 2013, TcMEP and somatosensory evoked potential (SSEP) monitoring were  attempted in 130 consecutive patients undergoing spine surgeries for cervical or thoracic cord lesions.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/kjs-13-9.PMC4844661.pdf
"Key Words : Spine surgery ㆍIntraoperative neuromonitoring ㆍMotor weakness ●Received: November 12, 2015  ●Revised: February 3, 2016 ●Accepted: February 5, 2016 Corresponding Author: In Ho Han , MD, PhD Department of Neurosurgery, Pusan National University Hospital,  179 Gudeok-ro, Seo-gu, Busan 49241, KoreaTel: +82-51-240-7257, Fax: +82-51-244-0282 E-mail: farlateral@hanmail.net ◯∝This is an open access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) whichpermits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Intraoperative neuromonitoring (IONM) has been widely  performed to prevent permanent neurological injury in high-  risk spine surgeries.",Non-OADS,/arxiv_data1/oa_pdf/1f/41/kjs-13-9.PMC4844661.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/45/main.PMC4844662.pdf
"The  patient is deemed drain  dependent  if  there  is  an  increase  in  ICP  after  24  h, http://dx.doi.org/10.1016/j.ijscr.2016.03.006 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/cf/45/main.PMC4844662.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/11/main.PMC4844663.pdf
Con- trast  enhanced  CT  detected  a  cystic  lesion  65  ×  63  ×  55  mm  in  size with  smooth contoured wall  including  calciﬁcations  and  septa  that hold  contrast  and  also  contained  millimetric  nodules  and  soft  tissue http://dx.doi.org/10.1016/j.ijscr.2016.03.014 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/09/11/main.PMC4844663.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/58/main.PMC4844664.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.03.012 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/94/58/main.PMC4844664.pdf
"(2016),  http://dx.doi.org/10.1016/j.jhsa.2004.01.",OADS,/arxiv_data1/oa_pdf/94/58/main.PMC4844664.pdf
020 http://www.jhandsurg.org/article/S0363-5023(04)00199-6/abstract .,Non-OADS,/arxiv_data1/oa_pdf/94/58/main.PMC4844664.pdf
"[9] J. Joel  Gagnier,  Gunver  Kienle,  G.  Douglas  Altman,  David  Moher,  Harold  Sox, David  Riley,  The  CARE  Group,  The  CARE  guidelines:  consensus-based  clinical case  reporting  guideline  development,  BMJ  Case  Rep.  (2013),  http://dx.doi.org/ 10.1136/bcr-2013-201554 .",Non-OADS,/arxiv_data1/oa_pdf/94/58/main.PMC4844664.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.03.016 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
"Trauma  Shock  5  (2012)  70–71,  http://dx.doi.org/10.4103/ 0974-2700.93120  (PMID:  22416159).",Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
"93  (2015)  e9, http://dx.doi.org/10.1016/j.ciresp.2014.09.013 (PMID:  25458548).",OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
"[8] United Nations Population  Division, Department of  Economics  and  Social Affairs,  World  Population  Aging  2009  New  York  Website: http://www.un.org/ esa/population/publications/WPA2009/WPA2009  WorkingPaper.pdf (accessed  on  02.02.16).",Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
"38  (2014) 1009–1018,  http://dx.doi.org/10.1007/s00268-013-2408-8  (PMID: 24357247).",Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
"Trauma  Shock  4  (2011)  501–503,  http://dx.doi.org/10.4103/0974-2700.86646 (PMID:  22090745).",Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
"13  (2015)  267–271,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/9f/main.PMC4844665.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/97/main.PMC4844666.pdf
The  patient  declined  re-operation  and  died  20  months http://dx.doi.org/10.1016/j.ijscr.2016.03.020 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/97/main.PMC4844666.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/63/75/main.PMC4844667.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.03.034 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/63/75/main.PMC4844667.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/aa/main.PMC4844668.pdf
"Once  bowel  was  untwisted,  ascending http://dx.doi.org/10.1016/j.ijscr.2016.03.018 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/a2/aa/main.PMC4844668.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/e3/main.PMC4844669.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.03.015 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/68/e3/main.PMC4844669.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/be/main.PMC4844670.pdf
A  ﬁlarial  infec- tion  in  a  pulmonary  blood  vessel  of  a  patient  was  reported  by  Faust http://dx.doi.org/10.1016/j.ijscr.2016.03.023 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/fe/be/main.PMC4844670.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/14/main.PMC4844695.pdf
"On  the  second  hospital  day,  he  had  his  cervical  spine http://dx.doi.org/10.1016/j.ijscr.2016.03.040 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/83/14/main.PMC4844695.pdf
"RGC explant cultures are a  mixed culture of different retinal cell types, and studies have  shown that RGCs constitute only 5% of the total retinal cells  in the mixed culture, thus limiting the application of RGCs Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> Received 2 August 2015 | Accepted 22 April 2016 | Published 25 April 2016© 2016 Molecular Vision 387Comparative analysis of three purification protocols for retinal  ganglion cells from rat Fengjuan Gao,1 Tingting Li,1 Jianyan Hu,1 Xujiao Zhou,2 Jihong Wu,2 Qiang Wu1 1Department of Ophthalmology, Shanghai Jiao Tong University Affiliated Sixth People’ s Hospital, Shanghai, China; 2Eye & ENT  Hospital, Fudan University, Shanghai, China Purpose:  To make  comparative  analyses  of the common three purification protocols for retinal ganglion cells (RGCs),  providing a solid practical basis for selecting the method for purifying RGCs for use in subsequent experiments.",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  388in the study of RGC function [ 17].,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  389then the cell suspension was filtered through the mesh filter  (pore size 40 μm, BD Falcon, Franklin Lakes, NJ) to yield  a single cell suspension.",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  390humidified atmosphere containing 5% CO2 and 95% air.,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  391with 3% BSA (Sigma-Aldrich) for 1 h. The cells were incu - bated with anti-rat γ-synuclein (1:400 dilution; Abcam),  anti-rat Thy-1 (1:800 dilution; Abcam), anti-rat microtubule  associated protein-2 (MAP2, 1:800 dilution; Abcam), anti-rat  neuron-specific class III beta tubulin (TUJ-1,1:400 dilution;  Abcam), anti-rat Brn3b (1:400 dilution; Abcam), anti-rat  Islet1 (1:400 dilution; Abcam), astrocyte-specific anti-rat  glial fibrillary acidic protein (GFAP; 1:100 dilution; Abcam),  and amacrine-specific anti-rat syntaxin 1 antibodies (1:50  dilution; Abcam) overnight at 4 °C.",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  392Windows, version 18.0.0 (SPSS, Chicago, IL).",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  393and axons that appear at opposing poles of the cell.,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  394of the RGCs, and little expression was observed in the cyto - plasm (Figure 5E-L).",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  395the TIP- and TIPM-RGCs were obviously higher than in the  FC-RGCs (p<0.01), whereas the syntaxin 1 levels in the TIP- RGCs were significantly higher than in the other two groups  (p<0.05), while there were no significant differences in the  TIPM- and FC-RGCs.",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  396with FACS.,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  397have been established to isolate and purify RGCs in attempts  to study retinal pathophysiology.,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  398be isolated from within mixed-cell populations, even when  the cells are present at frequencies as low as 10−6 within  the population [ 39].",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  39913.,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"Molecular Vision  2016; 22:387-400 <http://www.molvis.org/molvis/v 22/387> © 2016 Molecular Vision  400Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/mv-v22-387.PMC4844924.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/a5/ef/10.1177_2048004016639442.PMC4844931.pdf
"Cells 2016; 39(4): 281-285  http://dx.doi.org/10.14348/molcells.2016.0035                    Alternative Polyadenylation of mRNAs:   3’-Untranslated Region Matters in Gene Expression     Hsin-Sung Yeh, and Jeongsik Yong*      Almost all of euka ryotic mRNAs are subjected to polyad- enylation during mRNA processing.",Non-OADS,/arxiv_data1/oa_pdf/de/f1/molce-39-4-281.PMC4844933.pdf
"For CR-APA, Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/de/f1/molce-39-4-281.PMC4844933.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/de/f1/molce-39-4-281.PMC4844933.pdf
Cells http://molcells.org      A                                             B                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/de/f1/molce-39-4-281.PMC4844933.pdf
Gene Regulation by Alternative Polyadenylation in mRNAs  Hsin-Sung Yeh & Jeongsik Yong      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/de/f1/molce-39-4-281.PMC4844933.pdf
Cells http://molcells.org                                   Fig.,Non-OADS,/arxiv_data1/oa_pdf/de/f1/molce-39-4-281.PMC4844933.pdf
Gene Regulation by Alternative Polyadenylation in mRNAs  Hsin-Sung Yeh & Jeongsik Yong      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/de/f1/molce-39-4-281.PMC4844933.pdf
"Cells 2016; 39(4): 286-291  http://dx.doi.org/10.14348/molcells.2016.0066                    Structural and Mechanistic Insights into the  Tropism of Epstein-Barr Virus     Britta S. Möhl1, Jia Chen1, Karthik Sathiyamoorthy2, Theodore S. Jardetzky2, and Richard Longnecker1,*      Epstein-Barr virus (EBV) is the prototypical γ-herpesvirus  and an obligate human pathogen that infects mainly epi-thelial cells and B cells, which can result in malignancies.",Non-OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
"The multispan membrane protein BMRF2 is  thought to bind integrin α5β1, tethering EBV to polarized epi-   Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
"Cells http://molcells.org     REFERENCES    Adler, B.",Non-OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/53/81/molce-39-4-286.PMC4844934.pdf
"Cells 2016; 39(4): 292-298  http://dx.doi.org/10.14348/molcells.2016.2223                    Endothelial Aquaporin-1 (AQP1) Expression Is  Regulated by Transcription Factor Mef2c     Yong Jiang1,*, He Liu1, Wen-jing Liu1, Hai-bin Tong2, Chang-jun Chen1, Fu-gui Lin1, Yan-hang Zhuo1,   Xiao-zhen Qian1, Zeng-bin Wang1, Yu Wang1, Peng Zhang1, and Hong-liang Jia1      Aquaporin 1 (AQP1) is expressed in most microvascula-ture endothelial cells and forms water channels that play  major roles in a variety of physiologic processes.",Non-OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
"MATERIAL AND METHODS   Cell Culture, transient transfection, and luciferase assays  Human umbilical cord vein endo thelial cells (HUVEC) (ATCC, Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
Cells http://molcells.org     Fig.,Non-OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
"Cells http://molcells.org     REFERENCES    Abreu-Rodriguez, I., Sanchez Silva, R., Martins, A.P., Soveral, G.,  Toledo-Aral, J.J., Lopez-Barneo, J. , and Echevarria, M. (2011).",Non-OADS,/arxiv_data1/oa_pdf/dc/ff/molce-39-4-292.PMC4844935.pdf
"Cells 2016; 39(4): 299-309  http://dx.doi.org/10.14348/molcells.2016.2242                    miR-30a Regulates the Expression of CAGE and p53  and Regulates the Response to Anti-Cancer Drugs     Deokbum Park1,2, Hyuna Kim1,2, Youngmi Kim1,2, and Dooil Jeoung1,*      We have previously reported the role of miR-217 in anti- cancer drug-resistance.",Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
"miRNA array kit was purchased from Signosis, Inc.  miR mim- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
Cells http://molcells.org     ic and miR inhibitor were purchased from Bioneer Company  (Korea).,OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
Cells http://molcells.org      A                                                             C                    B                  D                        E                        F                G                          Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
Cells http://molcells.org      A                          B                          C                                     E                            F   D                   Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
Cells http://molcells.org      A                           B                                   C                               D                            E                                   F                            Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
Cells http://molcells.org        Fig.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3e/3c/molce-39-4-299.PMC4844936.pdf
"Cells 2016; 39(4): 310-315  http://dx.doi.org/10.14348/molcells.2016.2250                    Gustatory Receptors Required for Avoiding the Toxic  Compound Coumarin in Drosophila melanogaster     Seeta Poudel, and Youngseok Lee*      Coumarin is a phenolic compound that mainly affects the  liver due to its metabolization into a toxic compound.",Non-OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
The function of the GR receptor  in detecting bitter compounds Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
Coumarin Receptors in Drosophila melanogaster   Seeta Poudel & Youngseok Lee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
Cells http://molcells.org      A                     C         B                    D  E                  Fig.,Non-OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
Coumarin Receptors in Drosophila melanogaster   Seeta Poudel & Youngseok Lee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
Cells http://molcells.org      A                    B                          Fig.,Non-OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
Coumarin Receptors in Drosophila melanogaster   Seeta Poudel & Youngseok Lee      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/09/2c/molce-39-4-310.PMC4844937.pdf
"Cells 2016; 39(4): 316-321  http://dx.doi.org/10.14348/molcells.2016.2286                    Design of a RANK-Mimetic Peptide Inhibitor of  Osteoclastogenesis with Enhanced RANKL-Binding  Affinity     Jeonghwan Hur1,3, Ambarnil Ghosh1,3, Kabsun Kim2, Hai Minh Ta1, Hyunju Kim1, Nacksung Kim2,  Hye-Yeon Hwang1,*, and Kyeong Kyu Kim1,*     The receptor activator of nuclear factor κB (RANK) and its  ligand RANKL are key regulators of osteoclastogenesis  and well-recognized targets in developing treatments for bone disorders associated with excessive bone resorption,  such as osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
Addi- Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
The peptide-RANKL complexes were supplied as a dock- ing input to the Rosetta FlexPepDock ab initio  docking server  (http://flexpepdock.furmanlab.cs.huji.,OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
"Cells http://molcells.org      ing solution obtained from the FlexPepDock docking protocols  (London et al., 2011).",OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
Cells http://molcells.org      Table 2.,OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
"two scores: a FlexPepDock score, which represented the total  Rosetta energy of the model, and an interface score (I_sc), which indicated the difference between the total energy of the  complex and the total energy of partners when separated  (http://flexpepdock.furmanlab.cs.hu ji.ac.il/usage.php).",OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/43/a0/molce-39-4-316.PMC4844938.pdf
"Cells 2016; 39(4): 322-329  http://dx.doi.org/10.14348/molcells.2016.2292                    Dual Regulation of R-Type Ca V2.3 Channels by M 1  Muscarinic Receptors     Jin-Young Jeong, Hae-Jin Kweon, and Byung-Chang Suh*      Voltage-gated Ca2+ (CaV) channels are dynamically modu- lated by G protein-coupled receptors (GPCR).",OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
Cells http://molcells.org      A                    B               C             Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
"Cells http://molcells.org     regenerated from PI(4)P by phosphatidylinositol 4-phosphate 5- kinase (Balla, 2013; Wuttke et al., 2010).",OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/55/99/molce-39-4-322.PMC4844939.pdf
"Cells 2016; 39(4): 330-336  http://dx.doi.org/10.14348/molcells.2016.2308                    Long Non-Coding RNA CCAT1 Acts as a Competing   Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia     Lianxiang Chen1,*, Wei Wang2, Lixia Cao1, Zhijun Li3, and Xing Wang3      Long non-coding RNAs (lncRNAs) are involved in multiple  cellular events, as well as in tumorigenesis.",OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
Cells http://molcells.org     Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
"Cells http://molcells.org     REFERENCES    Alaiyan, B., Ilyayev, N., Stojadinov ic, A., Izadjoo, M., Roistacher, M.,  Pavlov, V., Tzivin, V., Halle, D., Pan, H., Trink, B., et al.",OADS,/arxiv_data1/oa_pdf/0e/d0/molce-39-4-330.PMC4844940.pdf
"Cells 2016; 39(4): 337-344  http://dx.doi.org/10.14348/molcells.2016.2317                    Attenuation of Postischemic Genomic Alteration  by Mesenchymal Stem Cells: a Microarray Study     Chunggab Choi1,6, Seung-Hun Oh2,6, Jeong-Eun Noh1, Yong-Woo Jeong1, Soonhag Kim3,4, Jung Jae Ko1,  Ok-Joon Kim2,*, and Jihwan Song1,5,*     Intravenous administration of mesenchymal stem cells (IV- MSC) protects the ischemic rat brain in a stroke model, but  the molecular mechanism underlying its therapeutic effect is unclear.",Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
This study was per-formed following the approval of an Institutional Review Board  Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
Cells http://molcells.org     from CHA Bundang Medical Center for the use of human UC  resource (IRB no.,Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
6.7 (http://david.abcc.,Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
Cells http://molcells.org     Y.S.,Non-OADS,/arxiv_data1/oa_pdf/c6/91/molce-39-4-337.PMC4844941.pdf
"Cells 2016; 39(4): 345-351  http://dx.doi.org/10.14348/molcells.2016.2336                    Let-7c miRNA Inhibits the Pr oliferation and Migration   of Heat-Denatured Dermal Fibroblasts Through  Down-Regulating HSP70     Tao Jiang1, Xingang Wang2, Weiwei Wu3, Fan Zhang4, and Shifeng Wu2,*      Wound healing is a complex physiological process neces- sitating the coordinated action of various cell types, sig-nals and microRNAs (miRNAs).",Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
"Moreover, HSP70 is a major stress-inducible HSP, Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
"Cells http://molcells.org     which has been reported to be significantly increased in B- lymphocytes under heat stress (Clayton et al., 2005).",Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
Cells http://molcells.org      A                     B                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/db/3c/molce-39-4-345.PMC4844942.pdf
"Cells 2016; 39(4): 352-357  http://dx.doi.org/10.14348/molcells.2016.0006                    xCyp26c  Induced by Inhibition of BMP Signaling Is  Involved in Anterior-Posterior Neural Patterning of Xenopus laevis     Saet-Byeol Yu1, Zobia Umair1, Shiv Kumar1, Unjoo Lee2, Seung-Hwan Lee1, Jong-Il Kim3, SungChan Kim1,  Jae-Bong Park1, Jae-Yong Lee1, and Jaebong Kim1,*     Vertebrate neurogenesis requires inhibition of endoge- nous bone morphogenetic protein (BMP) signals in the  ectoderm.",OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
"The intracellular level of active RA is determined by the bal- ance between RA synthesis by retinaldehyde dehydrogenases (RALDHs) and its degradation by Cyp26  enzymes, the latter of  which constitute a group of P450 enzymes that metabolize RA Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
"Cells http://molcells.org     signaling molecules, such as FGFs and RA, are also involved  in embryonic A-P specification as modifiers (Doniach, 1995; Gavalas and Krumlauf, 2000; Mason, 1996).",OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/86/25/molce-39-4-352.PMC4844943.pdf
"Cells 2016; 39(4): 358-366  http://dx.doi.org/10.14348/molcells.2016.0014                    A Systematic Analysis of Drosophila  Regulatory   Peptide Expression in Enteroendocrine Cells     Ji Chen, Seol-min Kim, and Jae Young Kwon*      The digestive system is gaining interest as a major regula- tor of various functions including immune defense, nutri-ent accumulation, and regulation of feeding behavior,  aside from its conventional function as a digestive organ.",Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
"Regulatory peptides expressed in the enteroendocrine cells  have been suggested to have roles in digestive enzyme secre-tion in response to intestinal nutrient contents, regulation of gut  motility and food intake, as well as involvement in intestinal  stem cell proliferation and differentiation in a paracrine manner Molecules and Cells http://molcells.org   Established in 1990     eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.",Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
Cells http://molcells.org     hybridization solution) and boiled for 40-45 min just before hy- bridization.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
Cells http://molcells.org      Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
Cells http://molcells.org      A      B                                                                     Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
Cells http://molcells.org     melanogaster .,OADS,/arxiv_data1/oa_pdf/c2/89/molce-39-4-358.PMC4844944.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/0b/main.PMC4845041.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/bc/0b/main.PMC4845041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bc/0b/main.PMC4845041.pdf
http://dx.doi.org/10.1016/j.jgr.2015.07.005J Ginseng Res 40 (2016) 176 e184,OADS,/arxiv_data1/oa_pdf/bc/0b/main.PMC4845041.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/0a/main.PMC4845042.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/ed/0a/main.PMC4845042.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/0a/main.PMC4845042.pdf
http://dx.doi.org/10.1016/j.jgr.2015.12.003J Ginseng Res 40 (2016) 196 e202,Non-OADS,/arxiv_data1/oa_pdf/ed/0a/main.PMC4845042.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/7c/main.PMC4845043.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/1c/7c/main.PMC4845043.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/7c/main.PMC4845043.pdf
http://dx.doi.org/10.1016/j.jgr.2015.05.003J Ginseng Res 40 (2016) 97 e104,OADS,/arxiv_data1/oa_pdf/1c/7c/main.PMC4845043.pdf
The sequences of the isolates were searched in EzBioCloud ( http://www.ezbiocloud.net/ ).,OADS,/arxiv_data1/oa_pdf/1c/7c/main.PMC4845043.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/da/main.PMC4845044.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/d7/da/main.PMC4845044.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/da/main.PMC4845044.pdf
http://dx.doi.org/10.1016/j.jgr.2015.07.003J Ginseng Res 40 (2016) 160 e168,OADS,/arxiv_data1/oa_pdf/d7/da/main.PMC4845044.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/86/main.PMC4845045.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/68/86/main.PMC4845045.pdf
http://dx.doi.org/10.1016/j.jgr.2015.06.001J Ginseng Res 40 (2016) 113 e120,OADS,/arxiv_data1/oa_pdf/68/86/main.PMC4845045.pdf
"For proteins without functional annotations in the da- tabases, homologs of these proteins were searched against the NCBI nonredundant protein database with BLASTP ( http://blast.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/68/86/main.PMC4845045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/c9/main.PMC4845046.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/51/c9/main.PMC4845046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/c9/main.PMC4845046.pdf
http://dx.doi.org/10.1016/j.jgr.2015.07.002J Ginseng Res 40 (2016) 151 e159,OADS,/arxiv_data1/oa_pdf/51/c9/main.PMC4845046.pdf
Densitometry quanti ﬁcation was performed in ImageJ software ( http://rsb.onfo.,OADS,/arxiv_data1/oa_pdf/51/c9/main.PMC4845046.pdf
series record number GSE31959 ( http://www.ncbi.nlm.nih.gov/geo/ info/linking.html ).,Non-OADS,/arxiv_data1/oa_pdf/51/c9/main.PMC4845046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4e/f4/main.PMC4845047.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/4e/f4/main.PMC4845047.pdf
http://dx.doi.org/10.1016/j.jgr.2015.06.003J Ginseng Res 40 (2016) 121 e126,OADS,/arxiv_data1/oa_pdf/4e/f4/main.PMC4845047.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/b2/main.PMC4845048.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/55/b2/main.PMC4845048.pdf
http://dx.doi.org/10.1016/j.jgr.2015.06.004J Ginseng Res 40 (2016) 127 e134,OADS,/arxiv_data1/oa_pdf/55/b2/main.PMC4845048.pdf
"All sequences were aligned using UCLUST v1.1.579 ( http://www.drive5.com/uclust/ downloads1_1_579.html ), and complete linkage clustering was used to de ﬁne operational taxonomic units (OTUs) with 97% iden- tity as a cutoff.",OADS,/arxiv_data1/oa_pdf/55/b2/main.PMC4845048.pdf
"DNA sequences were analyzed with DNASTAR version 5.03 software (DNASTAR, Inc., Madison, WI, USA), and fungal identi ﬁcation was performed using the NCBI database ( http://www.ncbi.nlm.nih.gov ) and BLAST searches.",OADS,/arxiv_data1/oa_pdf/55/b2/main.PMC4845048.pdf
"The phylogenetic analysis was performed with MEGA 5 program ( http://www.me- gasoftware.net/ ); the resulting phylogenetic tree of all sequences obtained in this study, together with selected GenBank sequences of close relatives, is shown in Fig.",OADS,/arxiv_data1/oa_pdf/55/b2/main.PMC4845048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/f6/main.PMC4845049.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/f2/f6/main.PMC4845049.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/f6/main.PMC4845049.pdf
http://dx.doi.org/10.1016/j.jgr.2015.07.001J Ginseng Res 40 (2016) 141 e150,OADS,/arxiv_data1/oa_pdf/f2/f6/main.PMC4845049.pdf
Sci Rep 2014;4:7375. http://dx.doi.org/10.1038/srep07375 .,OADS,/arxiv_data1/oa_pdf/f2/f6/main.PMC4845049.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/70/main.PMC4845050.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org 1226-8453/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/main.PMC4845050.pdf
http://dx.doi.org/10.1016/j.jgr.2015.05.007J Ginseng Res 40 (2016) 105 e112,OADS,/arxiv_data1/oa_pdf/e1/70/main.PMC4845050.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/4a/main.PMC4845051.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/ae/4a/main.PMC4845051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/4a/main.PMC4845051.pdf
http://dx.doi.org/10.1016/j.jgr.2015.07.004J Ginseng Res 40 (2016) 169 e175,OADS,/arxiv_data1/oa_pdf/ae/4a/main.PMC4845051.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4845052.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4845052.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4845052.pdf
http://dx.doi.org/10.1016/j.jgr.2015.08.005J Ginseng Res 40 (2016) 185 e195,OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4845052.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/68/main.PMC4845053.pdf
"Contents lists available at ScienceDirect Journal of Ginseng Research journal homepage: http://www.ginsengres.org p1226-8453 e2093-4947/$ esee front matter Copyright 2015, The Korean Society of Ginseng, Published by Elsevier.",Non-OADS,/arxiv_data1/oa_pdf/d2/68/main.PMC4845053.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/68/main.PMC4845053.pdf
http://dx.doi.org/10.1016/j.jgr.2015.06.006J Ginseng Res 40 (2016) 135 e140,OADS,/arxiv_data1/oa_pdf/d2/68/main.PMC4845053.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.03.001,Non-OADS,/arxiv_data1/oa_pdf/c5/7a/main.PMC4845072.pdf
"http://www.who.int/mediacentre/factsheets/fs382/ en/(accessed May, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c5/7a/main.PMC4845072.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8 2 –83 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c5/7a/main.PMC4845072.pdf
"Keywords: Culturomics, genome, Streptococcus varani , taxonogenomics, Varanus niloticus Original Submission: 5 February 2016; Accepted: 14 March 2016 Article published online: 19 March 2016 Corresponding author: P.-E. Fournier, URMITE UM63, CNRS7278, IRD198, INSERM1095, Faculté de Médecine, Aix Mar-seille Université, 27 boulevard Jean Moulin, 13385 Marseille cedex 5, France E-mail: pierre-edouard.fournier@univ-amu.fr Introduction The genus Streptococcus contains 113 recognized species and 22 subspecies ( http://www.bacterio.net/streptococcus.html )a so f 5 February 2016.",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.03.004,Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
Genome Annotation and Genome Analysis Open reading frames (ORFs) were predicted using P RODIGAL (http://prodigal.ornl.gov/ ) with default parameters.,OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 3–102 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/5c/cb/main.PMC4845074.pdf
"Keywords: Culturomics, taxonomy, Lascolabacillus massiliensis , new species Original Submission: 4 March 2016; Revised Submission: 10 March 2016; Accepted: 14 March 2016 Article published online: 19 March 2016 Corresponding author : P.-E. Fournier, Unité de Recherche en Maladies Infectieuses et Tropicales Emergentes (URMITE), UM63, CNRS7278, IRD198, INSERM U1095, Institut Hospitalo-UniversitaireMéditerranée-Infection, Aix-Marseille Université, Faculté deMédecine, 27 bd Jean Moulin, 13385 Marseille cedex 5, France E-mail: pierre-edouard.fournier@univ-amu.fr In 2015, as part of a culturomics study of the human micro- biome [1], we isolated from the stool of a healthy 28-month- old Senegalese boy a bacterial strain that could not be iden- tiﬁed by our systematic matrix-assisted laser desorption- ionization time-of- ﬂight screening ( http://www.mediterranee- infection.com/article.php?laref=256&titre=urms-database )o n a MicroFlex spectrometer (Bruker Daltonics, Bremen, Ger- many) [2].",Non-OADS,/arxiv_data1/oa_pdf/e9/45/main.PMC4845077.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.03.002,Non-OADS,/arxiv_data1/oa_pdf/e9/45/main.PMC4845077.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,9 1 –92 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/e9/45/main.PMC4845077.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.02.012,Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Statistical analysis Numbers of viral RNA copies in the blood of females at days 7, 14 and 21 were compared using the online Kruskal –Wallis test (Aus Vet Animal Health Service http://epitools.ausvet.com.au/ content.php?page=home ).",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Acknowledgements This work was partially funded by INRA, and by the EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext421 ( http://www.edenext.eu ).",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
Supplementary data Supplementary data related to this article can be found online athttp://dx.doi.org/10.1016/j.nmni.2016.02.012 .,OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,7 1–81 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/c9/32/main.PMC4845080.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.03.003,Non-OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8 4–90 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8 4–90 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"For genome annotation, open reading frames (ORFs) were predicted using P RODIGAL (http://prodigal.ornl.gov ) with default parameters but the predicted ORFs were excluded if theyspanned a sequencing gap.",OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8 4–90 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8 4–90 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8 4–90 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,11,8 4–90 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/3b/ca/main.PMC4845082.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/26/omw028.PMC4845088.pdf
Medicine (Baltimore) 2012; 91:35–48.http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/a8/26/omw028.PMC4845088.pdf
"Br J Rheumatol 1994; 33:115 –7.http://www.ncbi.nlm.nih.gov/ pubmed/8162473 (19 November 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/a8/26/omw028.PMC4845088.pdf
"67):S94 –5.http://www.ncbi.nlm.nih .gov/pubmed/21385550 (10 November 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/a8/26/omw028.PMC4845088.pdf
Ann Rheum Dis 2009; 68:1827 –32.http://www.ncbi.nlm.nih.gov/pubmed/19054820 .,Non-OADS,/arxiv_data1/oa_pdf/a8/26/omw028.PMC4845088.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/ae/omw025.PMC4845089.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/57/omw009.PMC4845090.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/e9/omw026.PMC4845091.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/25/omw024.PMC4845092.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/8a/c7/JAH3-4-e001675.PMC4845107.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajour- nals.org/content/4/10/e002193/suppl/DC1 Correspondence to: Shihab Masrur, MD, Division of Cardiology, Hartford Hospital, 80 Seymour St, Hartford, CT 06102.",Non-OADS,/arxiv_data1/oa_pdf/da/0b/JAH3-4-e002193.PMC4845108.pdf
Available at: http://brandgarage.com/event/ aha-health-tech-forum/.,Non-OADS,/arxiv_data1/oa_pdf/04/36/JAH3-4-e001990.PMC4845110.pdf
Available at: http://www.heart.org/idc/groups/heart-public/@wcm/ @adv/documents/downloadable/ucm_464439.pdf.,Non-OADS,/arxiv_data1/oa_pdf/04/36/JAH3-4-e001990.PMC4845110.pdf
Available at: http://nexus.od.nih.gov/all/2012/02/13/age-distribution-of-nih-principal- investigators-and-medical-school-faculty/.,Non-OADS,/arxiv_data1/oa_pdf/04/36/JAH3-4-e001990.PMC4845110.pdf
Available at: http://www.wsj.com/news/articles/SB1000142405270230 4179704579461284247758424.,Non-OADS,/arxiv_data1/oa_pdf/04/36/JAH3-4-e001990.PMC4845110.pdf
Available at: http://masschallenge.org/.,Non-OADS,/arxiv_data1/oa_pdf/04/36/JAH3-4-e001990.PMC4845110.pdf
"Accompanying Videos S1 and S2 are available at http://jaha.ahajour- nals.org/content/4/10/e002222/suppl/DC1 Correspondence to: Marco J. W. G €otte, MD, PhD, Department of Cardiology, HAGA Teaching Hospital, Leyweg 275, 2545CH The Hague, The Netherlands.E-mail: mjw.gotte@hagaziekenhuis.nl Received June 29, 2015; accepted August 12, 2015.ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f3/e7/JAH3-4-e002222.PMC4845111.pdf
The online version of the article has been updated and is available at http://jaha.ahajo urnals.org/content/4/7/e002140.,Non-OADS,/arxiv_data1/oa_pdf/9f/27/JAH3-4-e001977.PMC4845112.pdf
"Accompanying Data S1 and Figure S1 are available at http://jaha.ahajournals.org/content/4/10/e002203/suppl/DC1*Dr Ellero-Simatos, Dr Beitelshees, Dr Lewis, Dr Hankemeier, and Dr Kaddurah-Daouk contributed equally to the manuscript.Correspondence to: Rima Kaddurah-Daouk, PhD, Duke University Medical Center, Box 3903, Durham, NC 27710.",Non-OADS,/arxiv_data1/oa_pdf/83/fc/JAH3-4-e002203.PMC4845113.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/83/fc/JAH3-4-e002203.PMC4845113.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/1/ e000650.,Non-OADS,/arxiv_data1/oa_pdf/69/48/JAH3-4-e001934.PMC4845114.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/1/5/e002279.,Non-OADS,/arxiv_data1/oa_pdf/18/1d/JAH3-4-e001991.PMC4845115.pdf
Available at: http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/eb/97/JAH3-4-e002122.PMC4845116.pdf
Available at: http://www.heart.org/HEARTORG/CPR AndECC/Corporate Training/Heart- saverCourses/Heartsaver-First-Aid-CPR-AED —Classroom_UCM_303778_Ar- ticle.jsp.,Non-OADS,/arxiv_data1/oa_pdf/03/d1/JAH3-4-e002185.PMC4845117.pdf
Available at: http://www.bibliotecadigital.ufmg.br/dspace/handle/1843/GCPA-8Y9GD3.,Non-OADS,/arxiv_data1/oa_pdf/03/d1/JAH3-4-e002185.PMC4845117.pdf
"Accompanying Figure S1 and Tables S1 through S3 are available at http://jaha.ahajournals.org/content/4/10/e002460/suppl/DC1 Correspondence to: Charles A. Herzog, MD, FAHA, Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8thStreet, Suite S4.100, Minneapolis, MN 55404.",Non-OADS,/arxiv_data1/oa_pdf/81/8a/JAH3-4-e002460.PMC4845120.pdf
The publisher regrets the error.The online version of the article has been updated and is available at http://jaha.ahajou rnals.org/content/2/3/e000212.,Non-OADS,/arxiv_data1/oa_pdf/39/68/JAH3-4-e001981.PMC4845121.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/36/e3/JAH3-4-e002490.PMC4845124.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajournals.org/content/4/10/e002490/suppl/DC1Correspondence to: Pontus Andell, MD, Department of Cardiology, Clinical Sciences, Lund University, Skane University Hospital, Lund; 221 85 Lund, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/36/e3/JAH3-4-e002490.PMC4845124.pdf
Methods The PLATO trial (http://www.clinicaltrials.gov identi ﬁer: NCT00391872) enrolled 18 624 patients between October 2006 and July 2008.,Non-OADS,/arxiv_data1/oa_pdf/36/e3/JAH3-4-e002490.PMC4845124.pdf
Available at: http://www.cdc.gov/nchs/data/databriefs/db133.htm.,OADS,/arxiv_data1/oa_pdf/92/55/JAH3-4-e002276.PMC4845128.pdf
Available at: http://www.nih.gov/news/health/sep2015/nhlbi-11.htm.,Non-OADS,/arxiv_data1/oa_pdf/92/55/JAH3-4-e002276.PMC4845128.pdf
Available at: http://onlinelibrary.wiley.com/doi/10.1113/JP270597/ abstract;jsessionid=17EDA301239588FDF956A9B4CA77AA85.f01t03.,Non-OADS,/arxiv_data1/oa_pdf/82/d4/JAH3-4-e001968.PMC4845130.pdf
Accompanying Tables S1 through S7 and Figures S1 through S3 are available at http://jaha.ahajournals.org/content/4/9/e002258/suppl/DC1 Correspondence to: Barbara A.,Non-OADS,/arxiv_data1/oa_pdf/c7/3f/JAH3-4-e002258.PMC4845132.pdf
Available at: http://www.bhf.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/c7/3f/JAH3-4-e002258.PMC4845132.pdf
"Accompanying Figures S1, S2 and Table S1 are available at http://jaha.aha- journals.org/content/4/10/e001823/suppl/DC1 Part of these data (abstract) were presented at the Quality of Care and Outcome Research (QCOR) in Cardiovascular Disease and Stroke Scienti ﬁc Sessions of the American Heart Association, Washington DC, USA, May 12 to 14, 2011.",Non-OADS,/arxiv_data1/oa_pdf/c7/cd/JAH3-4-e001823.PMC4845133.pdf
"BP was recorded according to the procedures reported in the study opera- tion manuals (http://strongheart.ouhsc.edu/manual/Pha- seIV/Volume3.pdf) and in pilot manuscripts,18,19with the participant sitting with the right arm on table and using a standard manometer.",OADS,/arxiv_data1/oa_pdf/ab/16/JAH3-4-e002309.PMC4845134.pdf
Available at: http://www.heart.org/HEARTORG/Conditions/Diabetes/WhyDiabetesMat ters/%20Cardiovascular-Disease-Diabetes_UCM_313865_Article.jsp.,Non-OADS,/arxiv_data1/oa_pdf/a6/6d/JAH3-4-e002314.PMC4845135.pdf
Available at:https://www.ncdr.com/webncdr/cathpci/.,Non-OADS,/arxiv_data1/oa_pdf/a6/6d/JAH3-4-e002314.PMC4845135.pdf
"Accompanying Table S1 and Figures S1 through S5 are available at http://jaha.ahajournals.org/content/4/10/e002408/suppl/DC1 Correspondence to: Duo Li, PhD, Department of Food Science and Nutrition, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.",Non-OADS,/arxiv_data1/oa_pdf/89/a8/JAH3-4-e002408.PMC4845138.pdf
Available at: http://www.thl.,Non-OADS,/arxiv_data1/oa_pdf/89/a8/JAH3-4-e002408.PMC4845138.pdf
Accompanying Figure S1 and Table S1 are available at http://jaha.ahajournals.org/content/4/10/e002156/suppl/DC1 *Dr Twardowski and Dr Cheng contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/d7/f2/JAH3-4-e002156.PMC4845139.pdf
Raw and preprocessed data of the arrays can be downloaded from the National Center for Biotechnology Informationwebsite (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?,OADS,/arxiv_data1/oa_pdf/d7/f2/JAH3-4-e002156.PMC4845139.pdf
Only the best matching probe sets between the 2 different microarray types (HuGene-1_0-st and HG-U133_Plus_2) as de ﬁned by Affyme- trix (http://www.affymetrix.com/Auth/support/downloads/ comparisons/U133PlusVsHuGene_BestMatch.zip) were con- sidered for further analysis.,OADS,/arxiv_data1/oa_pdf/d7/f2/JAH3-4-e002156.PMC4845139.pdf
Available at: https://clinicaltrials.gov/ct2/show/ NCT02089217.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/JAH3-4-e002353.PMC4845140.pdf
Available at: http://www.fda.gov/medicaldevices/deviceregulationandguid- ance/howtomarketyourdevice/premarketsubmissions/humanitariandeviceex- emption/ucm135747.htm.,Non-OADS,/arxiv_data1/oa_pdf/d8/6f/JAH3-4-e002353.PMC4845140.pdf
Available at: http://www.jointcommission.org/facts_about_primary_stroke_center_certi ﬁcation/.,Non-OADS,/arxiv_data1/oa_pdf/1b/1a/JAH3-4-e001877.PMC4845141.pdf
Available at: http://www.hcup-us.ahrq.- gov/nisoverview.jsp.,Non-OADS,/arxiv_data1/oa_pdf/1b/1a/JAH3-4-e001877.PMC4845141.pdf
Available at: https://www.census.gov/newsroom/releases/archives/popula- tion/cb12-243.html.,OADS,/arxiv_data1/oa_pdf/1b/1a/JAH3-4-e001877.PMC4845141.pdf
Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.,OADS,/arxiv_data1/oa_pdf/1b/1a/JAH3-4-e001877.PMC4845141.pdf
Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-06.pdf.,OADS,/arxiv_data1/oa_pdf/1b/1a/JAH3-4-e001877.PMC4845141.pdf
"The chain of survival includes 5 links: (1) Immediate recognition of cardiac arrest and activation of the emergency response system, (2) Early cardiopulmonary resuscitation (CPR) with an emphasis on chest compressions, (3) Rapid de ﬁbrillation, (4) Effective advanced life support, and (5) Integrated post-cardiac arrest care (http://cpr.heart.org/AHAECC/CPRAndECC/AboutCPR- FirstAid/CPRFactsAndStats /UCM_475731_CPR-Chain-of- Survival.jsp).",Non-OADS,/arxiv_data1/oa_pdf/6b/85/JAH3-4-e002631.PMC4845142.pdf
"Accompanying Data S1, Figures S1 through S5, Tables S1 and S2, and Videos S1 and S2 are available at http://jaha.ahajournals.org/content/4/10/ e002254/suppl/DC1 Correspondence to: Kristyn S. Masters, PhD, Department of Biomedical Engineering, University of Wisconsin-Madison, 1550 Engineering Dr, #2152,Madison, WI 53706.",Non-OADS,/arxiv_data1/oa_pdf/fa/15/JAH3-4-e002254.PMC4845146.pdf
"In compliance with MIAME standards, these data have been deposited in NCBI ’s Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo; accession number GSE53997).",OADS,/arxiv_data1/oa_pdf/fa/15/JAH3-4-e002254.PMC4845146.pdf
Available at: https://www.google.com.au/?gws_rd=ssl#q=The+- burden+of+venous+thromboembolism+in+Australia.+Report+by+Access.,Non-OADS,/arxiv_data1/oa_pdf/69/2d/JAH3-4-e002652.PMC4845147.pdf
Clinical Trial Registration- —URL: https://www.clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/86/44/JAH3-4-e002379.PMC4845148.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/e3/main.PMC4845149.pdf
MRI of the left knee on day þ2 demonstrated large complex joint effusions and bone marrowContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.04.001 2211-7539/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/78/e3/main.PMC4845149.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/e3/main.PMC4845149.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MR spectroscopyCholineCreatineNAASpectroscopic peaks Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC4845155.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.04.002 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC4845155.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC4845155.pdf
"[6] American College of Radiology, American Society of Neuroradiology, Society of Pedi- atric Radiology: ACR-ASNR-SPR practice guideline for the performance and inter- pretation of magnetic resonance spectroscopy of the central nervous system, revised, 2013 Retrieved from http://www.acr.org/~/media/ACR/Documents/PGTS/ guidelines/MR_Spectroscopy.pdf .",Non-OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC4845155.pdf
"Imaging (2016), http://dx.doi.org/ 10.1002/jmri.25221 ([Epub ahead of print] PubMed PMID: 26970248).",OADS,/arxiv_data1/oa_pdf/be/e7/main.PMC4845155.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Phase-encoding polarityDiffusion tensor imagingFractional anisotropyEPI distortionsSusceptibility artifactsData quality Group analysis 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/53/main.PMC4845159.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.022 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/53/main.PMC4845159.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/53/main.PMC4845159.pdf
NeuroImage http://dx.doi.org/10.1016/j.neuroimage.2015.10.019 .,OADS,/arxiv_data1/oa_pdf/fa/53/main.PMC4845159.pdf
"Staining for expression of a-smooth muscle actin—an invasion marker—conﬁrmed that the number ofinvasive glands in the DATF3DPten mice was signiﬁcantly increased compared with © Ziyan Wang and Chunhong Yan *Correspondence to: Chunhong Yan; Email: cyan@gru.edu.Submitted: 01/15/2015; Revised: 01/16/2015; Accepted: 01/17/2015 http://dx.doi.org/10.1080/23723556.2015.1010948 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
Mol Cell 2003; 11:915-26; PMID:12718878; http://dx.doi.org/10.1016/S1097-2765(03)00109-6 2 .,OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
EMBO J 2005; 24:2425-35; PMID:15933712; http://dx.doi.org/10.1038/sj.emboj.7600712 3.,Non-OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
J Biol Chem 2010; 285:26908- 15; PMID:20592017; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
Nature 2006; 441:173- 8; PMID:16688168; http://dx.doi.org/10.1038/ nature04768 5.,OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
Cell Cycle 2006; 5:926-929; PMID:16628010;http://dx.doi.org/10.4161/cc.5.9.2714 6.,OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
J Biol Chem 2014; 289:8947-59; PMID:24554706; http://dx.doi.org/10.1074/jbc.M113.503755 7.,OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
Mol Cell Biol 2012; 32 3190-202; PMID:22665497; http://dx.doi.org/10.1128/MCB.00159-12 9.,Non-OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
Cancer Cell 2011; 19575-86; PMID:21575859; http://dx.doi.org/10.1016/ j.ccr.2011.04.008 www.tandfonline.com e1010948-3 Molecular & Cellular Oncology,Non-OADS,/arxiv_data1/oa_pdf/f4/e9/kmco-03-01-1010948.PMC4845162.pdf
"Although regulation of protein synthesis by mTORC1 might be its major contribution to cancer, it is possible that © Young-Mi Kim, Ji-Man Park, Douglas Grunwald, and Do-Hyung Kim *Correspondence to: Do-Hyung Kim; Email: dhkim@umn.eduSubmitted: 01/10/2015; Revised: 01/18/2015; Accepted: 01/19/2015 http://dx.doi.org/10.1080/23723556.2015.1010958 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
Mol Biol Cell 2009; 20:1981-91; PMID:19211835; http://dx.doi.org/ 10.1091/mbc.E08-12-1248 3.,Non-OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
Mol Biol Cell 2009; 20:1992-2003; PMID:19225151; http://dx.doi.org/10.1091/mbc.E08-12-1249 4.,Non-OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
Nat Cell Biol 2011; 13:132-41; PMID:21258367; http://dx.doi.org/10.1038/ncb21525.,OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
Nat Cell Biol 2013; 15:1206-19; PMID:24056303; http://dx.doi.org/10.1038/ncb2848 Figure 1. mTORC1 suppresses both early and late stages of autophagy.,Non-OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
Nat Cell Biol 2008; 10:776-87; PMID:18552835; http://dx.doi.org/10.1038/ncb1740 8.,OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
Autophagy 2010;6:863-70; PMID:20724836; http://dx.doi.org/ 10.4161/auto.6.7.13033 10.,Non-OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
Human Pathol 2008; 39:1059-63; PMID:18495205; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/61/08/kmco-03-01-1010958.PMC4845164.pdf
"Given thesigniﬁcant inhibition of anoikis observed © Cassandra L Buchheit and Zachary T Schafer *Correspondence to: Zachary T Schafer: Email: zschafe1@nd.eduSubmitted: 01/19/2015; Revised: 01/19/2015; Accepted: 01/21/2015 http://dx.doi.org/10.1080/23723556.2015.1011474 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Oncologist 2007; 12:904-12; PMID:17766649; http://dx.doi.org/10.1634/theoncologist.12-8-9042.,Non-OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Inﬂammatory breast cancer: clinical syndrome and molecular determinants.Breast Cancer Res 2000; 2:423-9; PMID:11250736; http://dx.doi.org/10.1186/bcr89 3.,Non-OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Nat Rev Cancer 2014;14:632-41; PMID:25098270; http://dx.doi.org/ 10.1038/nrc3789 4.,Non-OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Differ 2015 Aug; 22(8):1275-86; PMID:25526094; http://dx.doi.org/10.1038/cdd.2014.209 6.,Non-OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Mol Cell Biol 2005; 25:4591- 601; PMID:15899862; http://dx.doi.org/10.1128/ MCB.25.11.4591-4601.2005 8.,Non-OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Nat Cell Biol 2003; 5:733-40; PMID:12844146; http://dx.doi.org/ 10.1038/ncb10269.,OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Mol Cell 2012; 47:359-70; PMID:22742832; http://dx.doi.org/10.1016/j.molcel.2012.05.040 10.,OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
Mol Biol Cell 2008; 19:797- 806; PMID:18094039; http://dx.doi.org/10.1091/mbc.E07-10-1092 www.tandfonline.com e1011474-3 Molecular & Cellular Oncology,Non-OADS,/arxiv_data1/oa_pdf/77/ab/kmco-03-01-1011474.PMC4845165.pdf
"Given its properties as a detergent and emulsiﬁer, Etn is widely used in cosmetic, lifestyle, and householdproducts such as hair colors, bleaches,washing powders, disinfectants, kitchen © Patrick Rockenfeller, Didac Carmona-Gutierrez, Federico Pietrocola, Guido Kroemer, and Frank Madeo *Correspondence to: Patrick Rockenfeller; Email: patrick.rockenfeller@uni-graz.at, Frank Madeo; Email:frank.madeo@uni-graz.atSubmitted: 02/05/2015; Revised: 02/06/2015; Accepted: 02/09/2015 http://dx.doi.org/10.1080/23723556.2015.1019023 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
Biochim Biophys Acta 2004;1686:161-8; PMID:15522832; http://dx.doi.org/ 10.1016/j.bbalip.2004.09.007 2.,OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
J Lipid Res 2008; 49:1377-87; PMID:18204094; http://dx.doi.org/10.1194/jlr.,OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
Biochim Biophys Acta BBA - Biomembr 2004;1666:275-88; PMID:15519321; http://dx.doi.org/ 10.1016/j.bbamem.2004.06.010 4.,OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
Cell Res 2014; 24:24-41;PMID:24366339; http://dx.doi.org/10.1038/ cr.2013.168 6.,OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
Nat Cell Biol 2010; 12:842-6; PMID:20811357; http://dx.doi.org/10.1038/ncb0910-842 7.,OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
Nature 2000; 408:488-92; PMID:11100732; http://dx.doi.org/ 10.1038/35044114 8.,Non-OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
Cell Death Differ [Internet] 2015; 22:499-508; [cited 2015 Jan 21]; Available from: http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd2014219a.,OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
Nat Cell Biol 2009; 11:1305-14; PMID:19801973; http://dx.doi.org/ 10.1038/ncb1975 Figure 1.,OADS,/arxiv_data1/oa_pdf/8e/2b/kmco-03-01-1019023.PMC4845168.pdf
"1, e1050155 (2 pages)http://dx.doi.org/10.1080/23723556.2015.1050155",Non-OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
Nature 2005; 435:677-681; PMID:15902208; http://dx.doi.org/10.1038/nature03579 2.,Non-OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
Cancer Res 2008;68:3421-3428; PMID:18451170; http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
Cell Death Differ 2007; 14:943-951;PMID:17205078; http://dx.doi.org/10.1038/sj.cdd.4402072 4.,Non-OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
Cell2007; 128:1173-1186; PMID:17382885; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
Nat Med 2013; 19:202-208; PMID:23291630; http://dx.doi.org/10.1038/nm.3048 6.,OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
ACS Med Chem Lett 2014; 5:1088-1093; PMID:25313317; http://dx.doi.org/10.1021/ml5001867 7.,Non-OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
Sci Transl Med 2015; 7:279ra40; PMID:25787766; http://dx.doi.org/10.1126/scitranslmed.,Non-OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
Cell Death Dis 2015; 6:e1590; PMID:25590800; http://dx.doi.org/10.1038/ cddis.2014.561 10.,Non-OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
J Med Chem 58:2180-2194; PMID:25679114; http://dx.doi.org/10.1021/jm501258m Figure 1.,OADS,/arxiv_data1/oa_pdf/29/7f/kmco-03-01-1050155.PMC4845185.pdf
"1, e1038423 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1038423",Non-OADS,/arxiv_data1/oa_pdf/6f/1e/kmco-03-01-1038423.PMC4845195.pdf
Nat Rev Mol Cell Biol 2008; 9:713-24; PMID:18719710;http://dx.doi.org/10.1038/nrm2469 3.,OADS,/arxiv_data1/oa_pdf/6f/1e/kmco-03-01-1038423.PMC4845195.pdf
Cancer Res 2008; 68:6292-9; PMID:18676853;http://dx.doi.org/10.1158/0008-5472 5 .,Non-OADS,/arxiv_data1/oa_pdf/6f/1e/kmco-03-01-1038423.PMC4845195.pdf
Nat Rev Cancer 2009; 9:785-97;PMID:19851314; http://dx.doi.org/10.1038/nrc26967.,Non-OADS,/arxiv_data1/oa_pdf/6f/1e/kmco-03-01-1038423.PMC4845195.pdf
Oncogene 2010; 29: 5579-90; PMID:20676136; http://dx.doi.org/10.1038/ onc.2010.296 8.,Non-OADS,/arxiv_data1/oa_pdf/6f/1e/kmco-03-01-1038423.PMC4845195.pdf
Cell Death Differ 2015; Feb 6; PMID:25656653; http://dx.doi.org/10.1038/cdd.2015.4.,Non-OADS,/arxiv_data1/oa_pdf/6f/1e/kmco-03-01-1038423.PMC4845195.pdf
J Cell Biol 2010; 188: 629-38; PMID:20194642; http://dx.doi.org/10.1083/jcb.200905059MOLECULAR & CELLULAR ONCOLOGY e1038423-3,Non-OADS,/arxiv_data1/oa_pdf/6f/1e/kmco-03-01-1038423.PMC4845195.pdf
"1, e1046583 (2 pages)http://dx.doi.org/10.1080/23723556.2015.1046583",Non-OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Nat Rev Mol Cell Biol 2007; 8: 379-93; PMID:17426725;http://dx.doi.org/10.1038/nrm2163 2.,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
DevCell 2004; 7: 637-51; PMID:15525526; http://dx.doi.org/10.1016/j.devcel.2004.09.002 3.,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Cell Cycle 2010; 9:4035-6; PMID:20935484;http://dx.doi.org/10.4161/cc.9.20.13522 4.,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Curr Opin Cell Biol 2013; 25:780-5; PMID:23890995; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Cancer Cell 2009; 16: 347-58; http://dx.doi.org/10.1016/j.ccr.2009.08.020 6.,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
J Cell Sci 2009; 122: 2579-85; PMID:19625502; http://dx.doi.org/ 10.1242/jcs.039719 7.,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Nat Commun 2012; 3: 894; PMID:22692537; http://dx.doi.org/10.1038/ncomms1886 8.,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Cell Death Differ 2015; 22:1551-1560; PMID:25744022; http://dx.doi.org/10.1038/cdd.2015.13 9.,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Genes Dev 2003;17:2520-5; PMID:14561775; http://dx.doi.org/10.1101/gad.267603 1 0 .,OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
Cancer Biol Ther 2010; 9: 514-22; PMID:20107315; http://dx.doi.org/ 10.4161/cbt.9.7.11115 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/kmco-03-01-1046583.PMC4845201.pdf
"1, e1052180 (12 pages)http://dx.doi.org/10.1080/23723556.2015.1052180",Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Nat Rev Cancer 2012; 12:741-52; PMID:23018234; http://dx.doi.org/10.1038/nrc3340 2.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Endocr Rev 2010; 31:194-223; PMID:20007326; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Front Biosci 2008; 13:6135-54; PMID:18508649; http://dx.doi.org/10.2741/3143 4.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Curr Top Med Chem 2013; 13:2907-17; PMID:24171775; http://dx.doi.org/ 10.2174/15680266113136660206 5.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Biol Chem 2004; 279:50754-63; PMID:15381699; http://dx.doi.org/10.1074/jbc.M408388200 6.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Biol Chem 2005; 280:36334-41; PMID:16118205; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Sci Rep 2014;4:6311; PMID:25201160; http://dx.doi.org/10.1038/srep06311 8.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Immunol2008; 181:4685-95; PMID:18802071; http://dx.doi.org/10.4049/ jimmunol.181.7.4685 9.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cell 2007; 130:1095-107; PMID:17889652; http://dx.doi.org/10.1016/j.cell.2007.07.035 10.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
PLoS One 2014; 9:e113939;PMID:25423279; http://dx.doi.org/10.1371/journal.pone.0113939 11.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cell 2004; 117:495-502; PMID:15137942; http://dx.doi.org/10.1016/S0092-8674(04)00416-7 12.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Biol Chem2007; 282:24574-82; PMID:17604275; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Diabetes Metab Res Rev 2011; 27:515-27; PMID:21484978; http://dx.doi.org/10.1002/dmrr.1201 14.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cell Metab 2007; 6:363-75; PMID:17983582; http://dx.doi.org/10.1016/j.cmet.2007.09.003 15.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
PLoS One 2011; 6:e22781; PMID:21826208; http://dx.doi.org/10.1371/journal.pone.0022781 16.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Genes Dev 2012; 26:417-32; PMID:22391446; http://dx.doi.org/10.1101/gad.183509.111 17.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Biochem J 1999; 342(Pt 2):249-68; PMID:10455009; http://dx.doi.org/10.1042/0264- 6021:3420249 18.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Microbiol Mol Biol Rev 2006; 70:789-829; PMID:16959969; http://dx.doi.org/10.1128/MMBR.00040-05 19.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Molecules 2014; 19:20295- 313; PMID:25486244; http://dx.doi.org/10.3390/ molecules191220295 21.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Trends Cell Biol 2014; 24:464-71; PMID:24786309; http://dx.doi.org/10.1016/ j.tcb.2014.04.002 22.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Physiol Rev 2008; 88:841-86; PMID:18626062; http://dx.doi.org/10.1152/ physrev.00035.2007 23.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
World J Biol Chem 2014; 5:58-67; PMID:24600514; http://dx.doi.org/10.4331/ wjbc.v5.i1.58 24.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Ann Hematol 1992; 64:132-9;PMID:1373957; http://dx.doi.org/10.1007/BF01697400 26.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Biochem Biophys Res Com- mun 2006; 346:188-92; PMID:16750163; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Science 1993; 262:1056-9; PMID:8235624; http://dx.doi.org/10.1126/ science.8235624 28.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Pharmacol Ther 2000; 87:161-73; PMID:11007998; http://dx.doi.org/10.1016/ S0163-7258(00)00053-X 29.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Biochem J 2012; 441:131-41; PMID:21933152; http://dx.doi.org/10.1042/BJ20111263 30.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
JAgric Food Chem 2008; 56:11114-21; PMID:19007232; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Trends Endocrinol Metab 2012; 23:420-8;PMID:22819213; http://dx.doi.org/10.1016/j.tem.2012.06.005MOLECULAR & CELLULAR ONCOLOGY e1052180-9,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
FEBS J 2013; 280:3530-41; PMID:23617329; http://dx.doi.org/10.1111/febs.12304 34.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J BiolChem 2011; 286:21767-78; PMID:21504897; http://dx.doi.org/ 10.1074/jbc.M110.213298 35.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Int J Cancer 2002; 101:118-27; PMID:12209988; http://dx.doi.org/10.1002/ijc.10584 36.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Oncogene 2011; 30:907-21; PMID:20956937; http://dx.doi.org/10.1038/onc.2010.468 38.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cancer Biol Ther 2008;7:663-8; PMID:18728403; http://dx.doi.org/10.4161/cbt.7.5.5663 39.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Pigment Cell Melanoma Res 2013; 26:144-6; PMID:23051650;http://dx.doi.org/10.1111/pcmr.12037 40.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
APMIS 2011; 119:296-303; PMID:21492230; http://dx.doi.org/10.1111/j.1600-0463.2011.02733.x 41.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Gynecol Oncol 2013; 129:505-12; PMID:23438672; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Blood 2013; 122:1243-55; PMID:23823317; http://dx.doi.org/10.1182/ blood-2013-02-483511 45.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Mol Cell Biol 2009; 29:5872-88; PMID:19703994; http://dx.doi.org/10.1128/MCB.00112-09 47.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Clin CancerRes 2014; 20:120-30; PMID:24025713; http://dx.doi.org/10.1158/ 1078-0432.CCR-13-0150 48.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Neopla-sia 2013; 15:1151-60; PMID:24204194; http://dx.doi.org/10.1593/neo.131304 49.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Anticancer Drugs 2009; 20:346-54; PMID:19369827; http://dx.doi.org/10.1097/CAD.0b013e3283287c20 50.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cancer Res 2014;74:5948-54; PMID:25145669; http://dx.doi.org/10.1158/0008-5472.CAN-14-0809 51.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Mol Cancer Ther 2010; 9:1609-17; PMID:20515945; http://dx.doi.org/10.1158/1535-7163.MCT-09-1130 52.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Neoplasia 2013; 15:1314-29; PMID:24403854;http://dx.doi.org/10.1593/neo.131718 53.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
ACS ChemBiol 2014; 9:2247-54; PMID:25058389; http://dx.doi.org/10.1021/cb500347p 54.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Bioorg Med Chem Lett 2005; 15:2491-4; PMID:15863303; http://dx.doi.org/10.1016/j.bmcl.2005.03.064 55.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Med Chem 2013; 56:6413-33; PMID:23859118; http://dx.doi.org/10.1021/jm4008664 56.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Bioorg Med Chem Lett 2013; 23:5488-97; PMID:24021463; http://dx.doi.org/10.1016/j.bmcl.2013.08.074 57.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Med Chem 2013; 56:9071-88; PMID:24164086; http://dx.doi.org/10.1021/jm4009949 58.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Biochem Biophys Res Commun 2008; 367:799-804; PMID:18201551; http://dx.doi.org/10.1016/j.bbrc.2008.01.019 60.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Chembiochem 2014; 15:1121-30; PMID:24797455; http://dx.doi.org/10.1002/cbic.201402023 61.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Biol Chem 2013; 288:3500-11;PMID:23239881; http://dx.doi.org/10.1074/jbc.M112.394510e1052180-10 A. ROULSTON AND G. C. SHORE,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
PLoS One 2014; 9:e114019; PMID:25486521; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Clin Cancer Res 2005; 11:3503-13; PMID:15867253; http://dx.doi.org/10.1158/1078-0432.CCR-04-1399 65.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
J Biol Chem 2010; 285:34106-14; PMID:20724478; http://dx.doi.org/10.1074/jbc.M110.136739 66.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Autophagy 2008; 4:385-7;PMID:18227641; http://dx.doi.org/10.4161/auto.5635 67.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Clin CancerRes 2010; 16:898-911; PMID:20103674; http://dx.doi.org/10.1158/ 1078-0432.CCR-09-1945 68.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cell Death Dis 2015; 6:e1599; PMID:25590809; http://dx.doi.org/10.1038/cddis.2014.564 69.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Clin Oncol 2014; 26:250-6; PMID:24602564; http://dx.doi.org/10.1016/j.clon.2014.02.007 70.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Radiother Oncol 2014;110:348-54; PMID:24412016; http://dx.doi.org/10.1016/j.radonc.2013.10.039 71.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cancer Res 2011; 71:2308-17; PMID:21406402; http://dx.doi.org/10.1158/0008-5472.CAN-10-3213 72.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
ExpHematol 2013; 41:547-57.e2; PMID:23435312; http://dx.doi.org/10.1016/j.exphem.2013.02.008 73.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
DNA Repair (Amst)2014; 23:33-8; PMID:24814981; http://dx.doi.org/10.1016/j.dnarep.2014.04.011 74.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
BiochemPharmacol 2014; 92:164-71; PMID:25199458; http://dx.doi.org/ 10.1016/j.bcp.2014.08.026 76.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
PLoS One 2014; 9:e109366; PMID:25285661; http://dx.doi.org/10.1371/journal.pone.0109366 77.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Targetenzyme mutations are the molecular basis for resistance towards phar- macological inhibition of nicotinamide phosphoribosyltransferase.BMC Cancer 2010; 10:677; PMID:21144000; http://dx.doi.org/10.1186/1471-2407-10-677 78.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Invest New Drugs 2008; 26:45-51; PMID:17924057; http://dx.doi.org/10.1007/s10637-007-9083-2 79.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
"Eur J Cancer 2005; 41:702-7; PMID:15763645; http://dx.doi.org/10.1016/j.ejca.2004.12.023 82. von Heideman A, Berglund A, Larsson R, Nygren P. Safety and ef ﬁ- cacy of NAD depleting cancer drugs: results of a phase I clinical trialof CHS 828 and overview of published data.",OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Cancer Chemother Phar-macol 2010; 65:1165-72; PMID:19789873; http://dx.doi.org/10.1007/ s00280-009-1125-3 83.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Clin Cancer Res 2013; 19:6912-23; PMID:24097869; http://dx.doi.org/10.1158/1078-0432.CCR-13-1186 85.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Science 2015; 347:1260419; PMID:25613900; http://dx.doi.org/10.1126/ science.1260419 86.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Immunol Cell Biol 2014; 92:191-9; PMID:24275857; http://dx.doi.org/10.1038/icb.2013.85 87.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Clin Cancer Res 2014; 20:4861-72; PMID:25172933; http://dx.doi.org/10.1158/1078-0432.CCR-14-0624 89.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
MolCancer Ther 2013; 12:2248-60; PMID:23873851; http://dx.doi.org/ 10.1158/1535-7163.MCT-13-0172 90.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Ann Rev Genet 2004; 38:445-76; PMID:15568983; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Mol Cancer Res 2010; 8:67-79; PMID:20068071; http://dx.doi.org/10.1158/1541-7786.MCR-09-0411 92.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Ann N Y Acad Sci 2008; 1147:233-41; PMID:19076445; http://dx.doi.org/10.1196/annals.1427.014MOLECULAR & CELLULAR ONCOLOGY e1052180-11,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
EMBO Mol Med2012; 4:1087-96; PMID:22933245; http://dx.doi.org/10.1002/ emmm.201201250 94.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
PLoS One 2011; 6:e22739; PMID:21818379; http://dx.doi.org/10.1371/journal.pone.0022739 95.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Exp Hematol 2010; 38:979-88; PMID:20696207; http://dx.doi.org/10.1016/j.exphem.2010.07.013 97.,OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
Leuk Lym-phoma 2014; 55:2141-50; PMID:24283753; http://dx.doi.org/10.3109/10428194.2013.869325 98.,Non-OADS,/arxiv_data1/oa_pdf/0c/78/kmco-03-01-1052180.PMC4845202.pdf
"1, e1056331 (3 pages)http://dx.doi.org/10.1080/23723556.2015.1056331",Non-OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
J Clin Invest 2014; 124:1446-53; PMID: 24691479; http://dx.doi.org/10.1172/JCI72589 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
Cell Adhe Migr 2012; 6:231-5; PMID:22568983; http://dx.doi.org/10.4161/cam.20419 5.,Non-OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
Cell 2005; 121:335-48; PMID:15882617;http://dx.doi.org/10.1016/j.cell.2005.02.034 6.,OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
Cancer Res 2010; 70:471-80; PMID:20068185;http://dx.doi.org/10.1158/0008-5472.CAN-09-2863 7.,Non-OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
Cell Cycle 2009;8:3984-4001; PMID:19923890; http://dx.doi.org/10.4161/cc.8.23.,Non-OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
Cell Rep 2015; 10:1335- 48; PMID:25732824; http://dx.doi.org/10.1016/j.celrep.2015.02.006 9.,OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
Gastroenterology 1998; 115:421-32; PMID:9679048; http://dx.doi.org/10.1016/S0016-5085 (98)70209-4MOLECULAR & CELLULAR ONCOLOGY e1056331-3,Non-OADS,/arxiv_data1/oa_pdf/78/a4/kmco-03-01-1056331.PMC4845206.pdf
Clinical Trial Registration- —URL: https://clinicaltrials.gov/ Unique identi ﬁers: NCT01334554 and NCT02126735.,Non-OADS,/arxiv_data1/oa_pdf/fc/f0/JAH3-4-e002388.PMC4845211.pdf
The online version of the article has been updated and is available at http://jaha.ahajourn als.org/content/4/6/e001962.,Non-OADS,/arxiv_data1/oa_pdf/da/5a/JAH3-4-e001945.PMC4845214.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/4/10/ e002084.,Non-OADS,/arxiv_data1/oa_pdf/0a/31/JAH3-4-e002004.PMC4845215.pdf
"Accompanying Data S1, Tables S1 through S3 and Figures S1 and S2 are available at http://jaha.ahajournals.org/content/4/11/e002155/suppl/ DC1 Correspondence to: Ramachandran S. Vasan, MD, Framingham Heart Study, 73 Mount Wayte Ave, Framingham, MA 01702 –5803.",Non-OADS,/arxiv_data1/oa_pdf/17/6a/JAH3-4-e002155.PMC4845218.pdf
"Accompanying Figures S1 through S6 are available at http://jaha.ahajour- nals.org/content/4/11/e002597suppl/DC1 Correspondence to: Peter A. Noseworthy, MD, Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, 200 First Street SW, Rochester,MN 55905.",Non-OADS,/arxiv_data1/oa_pdf/5a/e3/JAH3-4-e002597.PMC4845220.pdf
Available at: http://www.optum.com/ content/dam/optum/resources/productSheets/5302_Data_Assets_Chart_ Sheet_ISPOR.pdf.,OADS,/arxiv_data1/oa_pdf/5a/e3/JAH3-4-e002597.PMC4845220.pdf
"Accompanying Figures S1 through S8 are available at http://jaha.ahajournals.org/content/4/11/e002553/suppl/DC1 Correspondence to: Carlos Fernandez-Patron, PhD, 3-19 Medical Sciences Building, 114 St & 85 Ave, Edmonton, Alberta, Canada T6G 2H7.",Non-OADS,/arxiv_data1/oa_pdf/85/75/JAH3-4-e002553.PMC4845223.pdf
Available at: http://www.nobelprize.org/nobel_prizes/medicine/laureates/1936/loewi- lecture.html.,Non-OADS,/arxiv_data1/oa_pdf/85/75/JAH3-4-e002553.PMC4845223.pdf
"Accompanying Figures S1 through S5 are available at http://jaha.ahajour- nals.org/content/4/11/e002125/suppl/DC1 Correspondence to: Eizo Marutani, MD, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, 149 13th St, 4309, Charlestown, MA 02129.",Non-OADS,/arxiv_data1/oa_pdf/ba/6a/JAH3-4-e002125.PMC4845224.pdf
Available at: https://www.Ndr.Nu/pdf/annual_report_ndr_2013.Pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/JAH3-4-e002411.PMC4845229.pdf
Available at: http://www.Scb.Se/en_/ services/guidance-for-researchers-and-universities/scb-data/longitudinal-in- tegration-database-for-health-insurance-and-labour-market-studies-lisa-by- swedish-acronym.,Non-OADS,/arxiv_data1/oa_pdf/e9/ea/JAH3-4-e002411.PMC4845229.pdf
"Accompanying Figure S1 and Tables S1 through S3 are available at http://jaha.ahajournals.org/content/4/11/e002645/suppl/DC1 Correspondence to: Matthew Taylor, MD, PhD, Division of Cardiology, University of Colorado Health Sciences Center, 12700 East 19th Ave, F442,Room 8022, Aurora, CO 80045.",Non-OADS,/arxiv_data1/oa_pdf/eb/96/JAH3-4-e002645.PMC4845231.pdf
"Mapping the TTN Variants to Protein Domains Severe variants in “likely ”and “possibly ”disease-causing categories were mapped to their respective protein domains starting from their exon location by using the Ensembl database (http://uswest.ensembl.org) with the identi ﬁer Q8WZ42-12 to locate the variants within the cDNA sequence, followed by mapping to amino acid position by referencing the Uniprot database (http://www.uniprot.org) to identify titin domains.",OADS,/arxiv_data1/oa_pdf/eb/96/JAH3-4-e002645.PMC4845231.pdf
Clinical Trial Registration- —URL: http://ClinicalTrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/84/d0/JAH3-4-e002239.PMC4845232.pdf
"Accompanying Figures S1, S2 and Tables S1 through S3 are available at http://jaha.ahajournals.org/content/4/11/e002239/suppl/DC1Presented as an abstract at the Epidemiology and Prevention and Lifestyle and Cardiometabolic Health Scienti ﬁc Sessions, March 3 –6, 2015, in Baltimore, MD, and at the American Heart Association Scienti ﬁc Sessions, November 7 –11, 2015, in Orlando, FL.",Non-OADS,/arxiv_data1/oa_pdf/84/d0/JAH3-4-e002239.PMC4845232.pdf
Available at: http://clinicaltrials.gov/show/ nct01569243.,Non-OADS,/arxiv_data1/oa_pdf/84/d0/JAH3-4-e002239.PMC4845232.pdf
A c opy of the document is available at http://my.americanheart.org/statements by selecting either the “By Topic ”link or the “By Publication Date ”link.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
"The Data Supplement is available with this article at http://jaha.ahajournals.org/content/4/11/e002810/suppl/DC1.The American Heart Association requests that this document be cited as follows: Antman EM, Benjamin EJ, Harrington RA, Houser SR, Peterson ED, Bauman MA, Brown N, Bufalino V, Califf RM, Creager MA, Daugherty A, Demets DL, Dennis BP, Ebadollahi S, Jessup M, Lauer MS, Lo B, MacRae CA, McConnell MV, McCray AT,Mello MM, Mueller E, Newburger JW, Okun S, Packer M, Philippakis A, Ping P, Prasoon P, Roger VL, Singer S, Temple R, Turner MB, Vigilante K, Warner J, Wayt eP ; on behalf of the American Heart Association Data Sharing Summit Attendees.",Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
"For more on AHA statements and guidelines development, visit http://my.americanheart.org/statements and select the “Policies and Development ”link.",Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.rwjf.org/content/dam/farm/reports/reports/2015/ rwjf418628.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://nam.edu/wp-content/uploads/2015/06//Shar- ingHealthData.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.nytimes.com/2013/02/19/opinion/ brooks-what-data-cant-do.html.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://healthaffairs.org/healthpolicybriefs/ brief_pdfs/healthpolicybrief_123.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.ibm.com/smarterplanet/ us/en/ibmwatson/health/.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://csrc.nist.gov/publications/nistpubs/800-145/SP800-145.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.cms.gov/Regulations-and-Guidance/Legis- lation/EHRIncentivePrograms/DataAndReports.html.,OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://acd.od.nih.gov/reports/Report-NLM- 06112015-ACD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.alltrials.net//wp-content/uploads/2013/ 09/What-does-all-trials-registered-and-reported-mean.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://grants.nih.gov/grants/ policy/data_sharing/.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: https://biolincc.nhlbi.nih.gov/home/.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.ukbiobank.ac.uk/physical-activity- monitor/.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://en.wikipedia.org/wiki/ Baseline_Study.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.nih.gov/precisionmedicine/.,OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.openmhealth.org/.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://my.americanheart.org/profess ional/Research/FundingOpportunities/Open-Science-Policy-Statements-for-AHA-Funded-Research_UCM_461225_Article.jsp.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.nih.gov/about/reporting- preclinical-research.htm.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.healthitsafety.org/uploads/4/3/6/4/43647387/road- map.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.hhs.gov/ocr/privacy/hipaa/ understanding/coveredentities/hitechact.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: https://www.whitehouse.gov/sites/ default/ ﬁles/docs/pmi_privacy_and_trust_principles_July_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.accme.org/sites/de- fault/ ﬁles/2014_Annual_Report_20150707_1.pdf.,OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: https://www.politicopro.com/go/?wbid=56665.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
"Available at: https://www.openphacts.org/ Accessed July 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://www.fda.gov/downloads/MedicalDevices/ NewsEvents/WorkshopsConferences/UCM427869.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/JAH3-4-e002810.PMC4845234.pdf
Available at: http://meps.ahrq.- gov/data_stats/quick_tables_results.jsp?component=1&subcomponent= 0&tableSeries=2&year=-1&SearchMethod=1&Action=Search.,OADS,/arxiv_data1/oa_pdf/47/47/JAH3-4-e001470.PMC4845235.pdf
Available at: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm.,OADS,/arxiv_data1/oa_pdf/47/47/JAH3-4-e001470.PMC4845235.pdf
Available at: http://www.cdc.gov/nchs/data_access/data_linkage/mortal- ity.htm.,OADS,/arxiv_data1/oa_pdf/47/47/JAH3-4-e001470.PMC4845235.pdf
Available at: http://www.cdc.gov/nchs/data/ndi/ndi_bibliography_performance.pdf.,OADS,/arxiv_data1/oa_pdf/47/47/JAH3-4-e001470.PMC4845235.pdf
"An accompanying Data S1 is available at http://jaha.ahajournals.org/con- tent/4/11/e002270/suppl/DC1 Correspondence to: Amir Lerman, MD, Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.",Non-OADS,/arxiv_data1/oa_pdf/98/15/JAH3-4-e002270.PMC4845238.pdf
Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/98/15/JAH3-4-e002270.PMC4845238.pdf
Clinical Trial Registration- —URL: https://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/6f/dc/JAH3-4-e002224.PMC4845239.pdf
"Accompanying Tables S1, S2 and Figures S1 through S4 are available at http://jaha.ahajournals.org/content/4/11/e002539/suppl/DC1 Correspondence to: S/C19ergio Barra, MD, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge CB23 3RE, UK.",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/JAH3-4-e002539.PMC4845241.pdf
"the latter had a 50.3% higher relative risk compared with individuals aged 60 to 64 (source: Centers for Disease Control and Prevention, http://www.cdc.gov).",Non-OADS,/arxiv_data1/oa_pdf/ae/8f/JAH3-4-e002539.PMC4845241.pdf
Ottawa Hospital Research Institute [Internet]; Available at: http://www.oh- ri.ca/programs/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/ae/8f/JAH3-4-e002539.PMC4845241.pdf
Available at: http://www.spc.pt/spc/cpc34/infores.aspx?id=2449.,Non-OADS,/arxiv_data1/oa_pdf/ae/8f/JAH3-4-e002539.PMC4845241.pdf
A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org .,Non-OADS,/arxiv_data1/oa_pdf/5c/4c/JAH3-4-e002533.PMC4845242.pdf
Available at: http://www.mesa-nhlbi.org/.,Non-OADS,/arxiv_data1/oa_pdf/5c/4c/JAH3-4-e002533.PMC4845242.pdf
"1, e1062591 (2 pages)http://dx.doi.org/10.1080/23723556.2015.1062591",Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
J Biol Chem 2014; 289:35182 –92; PMID:25355314; http://dx.doi.org/ 10.1074/jbc.M114.580159 2.,OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
J Immunol2008; 181:4685 –95; PMID:18802071; http://dx.doi.org/10.4049/ jimmunol.181.7.4685 3.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
Nature 2011; 471:363 –7; PMID:21368763; http://dx.doi.org/10.1038/nature09852 4.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
Cell Death Differ 2015; PMID:26001219; http://dx.doi.org/10.1038/cdd.2015.60 5.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
Nat Rev Cancer 2012; 12:860 –75; PMID:23151605; http://dx.doi.org/ 10.1038/nrc3380 6.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
Cancer Res 2011; 71:2308 –17; PMID:21406402; http://dx.doi.org/10.1158/0008-5472.CAN-10-3213 7.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
BMC Cancer 2013; 13:580; PMID:24314238; http://dx.doi.org/10.1186/1471-2407-13-580 8.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
Cancer Immunol Res 2015; 3:902-14; PMID:25898986; http://dx.doi.org/10.1158/2326-6066.CIR-14-0219 9.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
Cell Death Dis 2015; 6:e1761; PMID:25973681; http://dx.doi.org/10.1038/ cddis.2015.129 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/33/a0/kmco-03-01-1062591.PMC4845243.pdf
"In our recent report, we showed that levels of both intracellular iron and hemeKeywords: heme, p53, iron deprivation, nuclear export, hemochromatosis,tumorigenesis © Jia Shen, Xiangpeng Sheng, ZeNan Chang, Qian Wu, Dong Xie, Fudi Wang, and Ronggui Hu *Correspondence to: Ronggui Hu; Email: coryhu@sibs.ac.cn Submitted: 08/11/2014Revised: 08/13/2014Accepted: 08/13/2014 http://dx.doi.org/10.4161/23723548.2014.965642 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
Nat Rev Cancer 2013; 13:342-55;PMID:23594855; http://dx.doi.org/10.1038/nrc3495 3.,Non-OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/350426756.,Non-OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
Proc Natl Acad Sci U S A 2008; 105:76-81; PMID:18162538; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
"J Biol Chem 2011; 286, 16716-25; PMID:21454614; http://dx.doi.org/10.1074/jbc.M110.180844 8.",OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
Science 2007; 318:1786-9; PMID:18006707; http://dx.doi.org/ 10.1126/science.1150179 9.,OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
J Inorg Biochem 2005; 99:1-22; PMID:15598487; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
"Cell Rep 2014; 7, 180-93; PMID:24685134; http://dx.doi.org/10.1016/j.celrep.2014.02.042 www.tandfonline.com e965642-3 Molecular & Cellular Oncology",OADS,/arxiv_data1/oa_pdf/cf/f0/kmco-03-01-965642.PMC4845248.pdf
"Importantly, tumor vessel © Hannelore Maes, Anna Kuchnio, Peter Carmeliet, and Patrizia Agostinis *Correspondence to: Patrizia Agostinis; Email: patrizia.agostinis@med.kuleuven; Hannelore Maes; Email: hannelore.maes@med.kuleuven.beSubmitted: 09/09/2014; Revised: 09/10/2014; Accepted: 09/10/2014 http://dx.doi.org/10.4161/23723548.2014.970097 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
Trends Mol Med 2013; 19(7): 428-46; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
Nat Rev Nephrol 2011; 7(12): 18-29; PMID:22009248; http://dx.doi.org/10.1038/nrneph.,OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
Cancer Cell 2014;26(2): 190-206; PMID:25117709; http://dx.doi.org/ 10.1016/j.ccr.2014.06.025 5.,Non-OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
Nat Rev Drug Discov 2011; 10(6): 417-27; PMID:21629292; http://dx.doi.org/10.1038/nrd3455 6.,Non-OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
72(11): 2791-801; PMID:22472122; http://dx.doi.org/10.1158/0008- 5472.CAN-12-0320 9.,Non-OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
Int J Radiat Oncol Biol Phys 2013; 87(4): 761-8; PMID:24138918; http://dx.doi.org/ 10.1016/j.ijrobp.2013.07.024 10.,OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
Antioxid Redox Signal 2012; 16(11): 1264- 84; http://dx.doi.org/10.1089/ars.2011.4243 www.tandfonline.com e970097-3 Molecular & Cellular Oncology,Non-OADS,/arxiv_data1/oa_pdf/1e/77/kmco-03-01-970097.PMC4845249.pdf
"Details on the CSPPT study design,inclusion/exclusion criteria, and participant characteristics can be found online (http://clinicaltrials.gov, NCT00794885); the main results were recently published (Huo et al, JAMA, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e5/ab/JAH3-4-e002639.PMC4845256.pdf
"All analyses were performed using Empower (R) (www.empowerstats.com, X&Y Solutions, Inc, Boston, MA) and R (http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/e5/ab/JAH3-4-e002639.PMC4845256.pdf
Clinical Trial Registration- —URL: https://www.ClinicalTrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/97/2b/JAH3-4-e002859.PMC4845257.pdf
"An accompanying Appendix S1 is available at http://jaha.ahajournals.org/content/4/12/e002859/suppl/DC1 Presented as a Late Breaking Clinical Trial at the American Heart Association Scienti ﬁc Sessions November 7 –11, 2015 in Orlando, FL.",Non-OADS,/arxiv_data1/oa_pdf/97/2b/JAH3-4-e002859.PMC4845257.pdf
Available at: http://nhird.nhri.org.tw/en/Back- ground.html.,Non-OADS,/arxiv_data1/oa_pdf/31/88/JAH3-4-e002840.PMC4845258.pdf
Available at: https://mcia.mohw.gov.tw/openinfo/A100/A101- 1.aspx.,Non-OADS,/arxiv_data1/oa_pdf/31/88/JAH3-4-e002840.PMC4845258.pdf
"Accompanying Figures S1 and S2 are available at http://jaha.ahajour- nals.org/content/4/12/e002505/suppl/DC1 Correspondence to: Alessia Buglioni, MD, Cardiorenal Research Laboratory, Guggenheim 915, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905.E-mail: buglioni.alessia@mayo.edu Received September 1, 2015; accepted November 25, 2015.ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2f/49/JAH3-4-e002505.PMC4845260.pdf
Accompanying Tables S1 through S3 and Figures S1 through S5 are available at http://jaha.ahajournals.org/content/4/12/e002540/suppl/DC1*Dr Bajaj and Dr Arora contributed equally to the preparation of this manuscript.,Non-OADS,/arxiv_data1/oa_pdf/8b/87/JAH3-4-e002540.PMC4845262.pdf
Webpage accessed on June 2015; Available at: https://clinicaltrials.gov/ct2/show/ NCT01740479.,Non-OADS,/arxiv_data1/oa_pdf/8b/87/JAH3-4-e002540.PMC4845262.pdf
"Accompanying Tables S1 through S4 are available at http://jaha.ahajournals.org/content/4/12/e002613/suppl/DC1Correspondence to: Erik B. Schelbert, MD, MS, Cardiovascular Magnetic Resonance Center, Heart and Vascular Institute, UPMC, Medicine and Clinical and Translational Science, University of Pittsburgh School of Medicine, 200 Lothrop Street, PUH A349, Pittsburgh, PA 15101.",Non-OADS,/arxiv_data1/oa_pdf/d7/7a/JAH3-4-e002613.PMC4845263.pdf
"Accompanying Tables S1 through S5 are available at http://jaha.ahajour- nals.org/content/4/12/e002290/suppl/DC1 Correspondence to: Anna Graipe, MD, Lignells v €ag 43, 831 42 €Ostersund, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/a3/49/JAH3-4-e002290.PMC4845264.pdf
"In 1998, coverage increased to 58 hospitals, and by 2007, 74 of 77 hospitals were participating, covering almost 100% of Swedish CCU admissions (detailed information and the complete protocol are available online at http://www.ucr.uu.se).",Non-OADS,/arxiv_data1/oa_pdf/a3/49/JAH3-4-e002290.PMC4845264.pdf
Clinical Trial Registration- —URL: http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/c3/fb/JAH3-4-e002524.PMC4845267.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/content/4/12/e002524/suppl/DC1Correspondence to: Marco Valgimigli, MD, PhD, FESC, Swiss Cardiovascular Center Bern, Bern University Hospital, CH-3010 Bern, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/c3/fb/JAH3-4-e002524.PMC4845267.pdf
"Accompanying Figures S1 and S2 are available at http://jaha.ahajour- nals.org/content/4/12/e002481/suppl/DC1 Correspondence to: Rachelle H. Crosbie-Watson, PhD, Department of Integrative Biology and Physiology, Department of Neurology, University of California Los Angeles, Center for Duchenne Muscular Dystrophy, 610 Charles E. Young Drive E, Terasaki Life Sciences Building Room 1121, LosAngeles, CA 90095.",Non-OADS,/arxiv_data1/oa_pdf/c9/1f/JAH3-4-e002481.PMC4845268.pdf
"In contrast to the readmission rate for our intervention group, the 30-day all-cause readmission rate for HF patients at Herman Memorial Hospital at the Texas Medical Center was 22.1% during the same time period (https://data.medicare.gov/data/archives//hospital-com- pare).",Non-OADS,/arxiv_data1/oa_pdf/74/55/JAH3-4-e002296.PMC4845270.pdf
Clinical Trial Registration- —URL: https://Clinicaltrials.Gov/.,Non-OADS,/arxiv_data1/oa_pdf/fc/4f/JAH3-4-e002340.PMC4845271.pdf
"Using these data, risk models have been devel-oped and validated for heart valve operations, and online risk calculators are available for predicting a patient ’s operative risks based on individual clinical and demographic data (Online STS Adult Cardiac Surgery Risk Calculator, http:// riskcalc.sts.org; European System for Cardiac Operative Risk Evaluation, http://www.euroscore.org/).",Non-OADS,/arxiv_data1/oa_pdf/5e/dd/JAH3-4-e002424.PMC4845273.pdf
"Factors Contributing to Prohibitive Risk for Mitral Valve Surgery High 30-day predicted operative mortality risk Online STS Adult Cardiac Surgery Risk Calculator, http://riskcalc.sts.org/ European System for Cardiac Operative Risk Evaluation, http://www.euroscore.org/ Cardiopulmonary comorbidites High risk of internal mammary artery injury in reoperative surgeryRight ventricular dysfunction with severe tricuspid regurgitationSevere pulmonary hypertension ( >2/3 systemic pressure) Ascending aortic disease Extensive calcification (porcelain aorta) Mobile atheroma “Hostile ”chest Prior mediastinitisPostradiation mediastinumTwo or more prior cardiac operations Aorta adherent to posterior sternal table Other comorbidities Severe liver disease or cirrhosis (Child-Pugh class B or C)Major bleeding diathesisHigh risk of aspirationChemotherapy for malignancy Severe renal dysfunction (creatinine >2.5 mg/dL) Major organ system compromiseFrailty Cognitive impairmentSlow gait or poor ambulation Needing assistance with activities of daily living Table 3.",Non-OADS,/arxiv_data1/oa_pdf/5e/dd/JAH3-4-e002424.PMC4845273.pdf
"Accompanying Figure S1 and Table S1 are available at http://jaha.ahajour- nals.org/content/4/12/e002321/suppl/DC1 Correspondence to: Alan T. Hirsch, MD, Cardiovascular Division, Vascular Medicine, Quality Outcomes and Population Health, MMC 508, 420 DelawareSt SE, Minneapolis, MN 55455.",Non-OADS,/arxiv_data1/oa_pdf/6d/6b/JAH3-4-e002321.PMC4845274.pdf
"”21A commitment to achieve these goals has improved risk factor control and lowered rates of cardiovascular events.22,23In 2011, the Minnesota Heart Disease and Stroke Prevention Plan included a goal to lower rates of a ﬁrst heart attack or stroke by fostering appropriate use of low-dose aspirin in the USPSTF target population (http://www.health.",Non-OADS,/arxiv_data1/oa_pdf/6d/6b/JAH3-4-e002321.PMC4845274.pdf
Available at: http://quickfacts.census.gov/qfd/states/ 27/2728790.html.,OADS,/arxiv_data1/oa_pdf/6d/6b/JAH3-4-e002321.PMC4845274.pdf
Available at: http://www.mnhospi- tals.org.,Non-OADS,/arxiv_data1/oa_pdf/6d/6b/JAH3-4-e002321.PMC4845274.pdf
Available at: http://www.health.state.m- n.us/divs/chs/annsum/.,Non-OADS,/arxiv_data1/oa_pdf/6d/6b/JAH3-4-e002321.PMC4845274.pdf
Available at: http://www.health.state.m- n.us/divs/chs/trends/.,Non-OADS,/arxiv_data1/oa_pdf/6d/6b/JAH3-4-e002321.PMC4845274.pdf
Available at: http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can- Trust.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6f/25/JAH3-4-e002315.PMC4845275.pdf
Available at: http://www.nice.org.uk/guidance/cg181.,Non-OADS,/arxiv_data1/oa_pdf/6f/25/JAH3-4-e002315.PMC4845275.pdf
Clinical Trial Registration- —URL: https://ClinicalTrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/6f/63/JAH3-4-e002015.PMC4845276.pdf
"Accompanying Tables S1 and S2 are available at http://jaha.ahajour- nals.org/content/4/12/e002346/suppl/DC1 Correspondence to: Anouk L. M. Eikendal, MD, Department of Radiology (E01.132), University Medical Center, Heidelberglaan 100, 3584 CX Utrecht,The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/f9/40/JAH3-4-e002346.PMC4845277.pdf
An accompanying Data S1 is available at http://jaha.ahajournals.org/con- tent/4/12/e002395/suppl/DC1 This manuscript was handled by N.A.,Non-OADS,/arxiv_data1/oa_pdf/86/0f/JAH3-4-e002395.PMC4845278.pdf
An accompanying Table S1 is available at http://jaha.ahajournals.org/con- tent/4/12/e002308/suppl/DC1 The content is solely the responsibility of the authors and does not necessarily represent the of ﬁcial views of the National Institutes of Health.,Non-OADS,/arxiv_data1/oa_pdf/79/e1/JAH3-4-e002308.PMC4845280.pdf
Available at: http://www.goldcopd.org/ uploads/users/ ﬁles/GOLD_Report_2015_Sept2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/79/e1/JAH3-4-e002308.PMC4845280.pdf
"An accompanying Data S1 is available at http://jaha.ahajournals.org/ content/4/12/e002567/suppl/DC1 Correspondence to: Adam S. Vaughan, MPH, MS, Department of Epidemi- ology, Rollins School of Public Health, Emory University, 1518 Clifton RoadNE, Atlanta, GA 30322.",Non-OADS,/arxiv_data1/oa_pdf/83/4a/JAH3-4-e002567.PMC4845281.pdf
"Data on hospitalization for gastrointestinal (GI) bleeding, AMI, and stroke subtype were obtained from the comprehensive Minnesota Hospital Association ’s administra-tive claims database (http://www.mnhospitals.org/data- reporting/data-products-services/administrative-claims-data- base).",OADS,/arxiv_data1/oa_pdf/a0/af/JAH3-4-e002320.PMC4845283.pdf
Available at: http://www.healthypeople.gov/ 2020/topicsobjectives2020/default.,Non-OADS,/arxiv_data1/oa_pdf/a0/af/JAH3-4-e002320.PMC4845283.pdf
"Accompanying Tables S1 through S4 are available at http://jaha.ahajournals.org/content/4/12/e002546/suppl/DC1Correspondence to: Sean van Diepen, MD, MSc, 2C2 Cardiology Walter MacKenzie Center, University of Alberta Hospital, 8440-11 St. Edmonton, Alberta, Canada T6G 2B7.",Non-OADS,/arxiv_data1/oa_pdf/ac/6b/JAH3-4-e002546.PMC4845287.pdf
"Mahaffey: all disclosures prior toAugust 1, 2013 available at www.dcri.org, and all disclosures afterward are available at https://med.stanford.edu/ proﬁles/kenneth-mahaffey.",OADS,/arxiv_data1/oa_pdf/ac/6b/JAH3-4-e002546.PMC4845287.pdf
Available at: http://atvb.ahajournals.org/content/28/ 6/e32.full.pdf+html.,Non-OADS,/arxiv_data1/oa_pdf/ac/6b/JAH3-4-e002546.PMC4845287.pdf
"Accompanying Appendices S1 and S2 are available at http://jaha.ahajour- nals.org/content/4/12/e002568/suppl/DC1 Correspondence to: Kai Jin, MN, BN, RN, Sydney Nursing School, Level 2, Charles Perkins Centre, University of Sydney, NSW 2006, Australia.",Non-OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
"Analyses were conducted using Comprehensive Meta-Analysis software, Version 2.0 (Biostat, Englewood, NJ; http://www.meta-analysis.com).",OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: http://www.abs.gov.au/ausstats/ abs@.nsf/Lookup/2071.0main+features902012-2013.,Non-OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: http://www.statcan.gc.ca/ tables-tableaux/sum-som/l01/cst01/demo24a-eng.htm.,OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: http://www.census.gov/con- tent/dam/Census/library/publications/2011/acs/acsbr10-16.pdf.,OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: http://www.cis.org/sites/cis.org/ ﬁles/ articles/2012/immigrants-in-the-uni ted-states-2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: https://www.dss.gov.au/sites/de- fault/ ﬁles/documents/02_2014/china.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: http://www.who.int/classi ﬁca- tions/icd/ICD10Volume2_en_2010.pdf?ua=1.,Non-OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: http://www.ohri.ca/pro- grams/clinical_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
Available at: http://handbook.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/56/a6/JAH3-4-e002568.PMC4845291.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/con- tent/4/12/e002443/suppl/DC1 Correspondence to: Timothy M. Olson, MD, Cardiovascular Genetics Research Laboratory, Stabile 5, 200 First St SW, Mayo Clinic, Rochester,MN 55905.",Non-OADS,/arxiv_data1/oa_pdf/4d/32/JAH3-4-e002443.PMC4845292.pdf
"Those below the size threshold were considered relevant if suf ﬁcient evidence supporting pathogenicity from Online Mendelian Inheritance in Man (OMIM) (http://ncbi.nlm.nih.gov/omim), PubMed (http:// ncbi.nlm.nih.gov/pubmed), or ClinGen Dosage Sensitivity Map (http://ncbi.nlm.nih.gov/projects/dbvar/clingen/index.",Non-OADS,/arxiv_data1/oa_pdf/4d/32/JAH3-4-e002443.PMC4845292.pdf
Reads were aligned to the hg19 reference genome with Novoalign (http://novocraft.com) followed by sorting and marking of duplicate reads using Picard (http:// picard.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/4d/32/JAH3-4-e002443.PMC4845292.pdf
"To determine rarity of variants, minor allele frequenciesfrom 3 publicly available databases were utilized, collectively comprised of WES or whole genome sequences (WGS) from 7664 individuals: 1000 Genomes, WGS data from 1092 individuals13; Exome Variant Server (EVS), WES data from 6503 individuals (http://evs.gs.washington.edu/EVS/); and Complete Genomics Genome (CG), WGS data from 69 individuals.14To exclude false positives, in-house WGS or WES data from 115 individuals not affected with DCM were utilized.",OADS,/arxiv_data1/oa_pdf/4d/32/JAH3-4-e002443.PMC4845292.pdf
"≤1 Node upstream of DCM genes A gene list comprised of 50 genes (45 on Partners Healthcare DCM gene panel [http://personalizedmedicine.partners.org], EYA4 ,TMPO ,PSEN1 ,PSEN2 , and SYNE1 )6–8associated with DCM was uploaded to Ingenuity Variant Analysis, and variants were ﬁltered to include those within genes either directly associated with disease or 1 node removed from an associated DCM gene.",OADS,/arxiv_data1/oa_pdf/4d/32/JAH3-4-e002443.PMC4845292.pdf
"Similarly, post-hoc analysis of DCM genes from GeneDx ’s DCM/LVNC (http://genedx.com/) and Ambry Genetics DCMNEXT panels (http://ambrygen.",OADS,/arxiv_data1/oa_pdf/4d/32/JAH3-4-e002443.PMC4845292.pdf
"Knockout of both mXinb/Xirp2 alleles in mice, however, leads to diastolic dysfunction and postnatal death before weaning.41In addition, mice fail to form mature ICDs, with myocardial mislocalization of N-cadherin and b-catenin.41,42Interestingly, mXinb/Xirp2 - null pups were found to have a signi ﬁcant delay in switching off slow skeletal troponin I, hypothesized to allow for increased Ca2+-activated myo ﬁlament tension.41 XIRP2 Is a Novel Candidate Modi ﬁer of TNNT2- Mediated DCM The human ortholog, hXinb/XIRP2 , encoding a 3549-amino- acid protein, was initially identi ﬁed as a gene coexpressed with 13 known cardiomyopathy-associated genes.43Analysis ofXIRP2 in the Exome Aggregation Consortium (ExAC)database (http://exac.broadinstitute.org) and with the genic intolerance program44reveals a relatively high frequency of natural, functional variation.",Non-OADS,/arxiv_data1/oa_pdf/4d/32/JAH3-4-e002443.PMC4845292.pdf
Available at: http://shareddeci-sions.mayoclinic.org/decision-aid-information/decision-aids-for-chronic-dis- ease/cardiovascular-prevention/.,Non-OADS,/arxiv_data1/oa_pdf/1b/a1/JAH3-4-e002927.PMC4845293.pdf
Available at: https://clinicaltrials.gov/ct2/show/NCT00135226?term=aspirin+pri- mary+prevention&rank=7.,Non-OADS,/arxiv_data1/oa_pdf/1b/a1/JAH3-4-e002927.PMC4845293.pdf
Available at: https://clinicaltrials.gov/ct2/show/NCT00501059?term=aspirin +primary+prevention&rank=9.,Non-OADS,/arxiv_data1/oa_pdf/1b/a1/JAH3-4-e002927.PMC4845293.pdf
Available at: https://clinicaltrials.gov/ct2/show/ NCT01709994?term=aspirin+primary+prevention&rank=10.,Non-OADS,/arxiv_data1/oa_pdf/1b/a1/JAH3-4-e002927.PMC4845293.pdf
"Accompanying Data S1 and Table S1 are available at http://jaha.ahajournals.org/content/4/12/e002136/suppl/DC1 Correspondence to: Jeremiah R. Brown, PhD, HB 7505, One Medical Center Drive, Lebanon, NH 03756.",Non-OADS,/arxiv_data1/oa_pdf/a1/4d/JAH3-4-e002136.PMC4845295.pdf
Analyses were conducted using R (library glmnet (http://cran.r-project.org/web/packages/glmnet/glmnet.pdf) and Stata.,OADS,/arxiv_data1/oa_pdf/a1/4d/JAH3-4-e002136.PMC4845295.pdf
Available at: http://www.Va.Gov/health/aboutvha.Asp.2014.,Non-OADS,/arxiv_data1/oa_pdf/be/be/JAH3-4-e002268.PMC4845296.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/4d/main.PMC4845387.pdf
"Histopathology on a CT gui- ded biopsy, obtained on day 2 of admission, demonstrated broadContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.03.002 2211-7539/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dc/4d/main.PMC4845387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/4d/main.PMC4845387.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Prefrontal cortexAmygdalaOxytocinMaternal behaviorParent-child relations 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.009 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
Advanced Normalization Tools (ANTS;http://stnava.github.io/ANTs/ ) was used to optimize alignment of functional data to the TT_N27 T1-weighted template.,OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
Inline Supplementary Table S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1007/s00429-005-0025-5 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1016/j.brainresrev.2004.02.004 .,OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1093/scan/nsn004 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2008.545 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1097/00004583-199704000-00018 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"23, 439 –452.http://dx.doi.org/10.1017/S0954579411000162 .",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1080/15374416.2012.703122 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1002/dev.20447 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1006/ cbmr.1996.0014 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1111/j.1469-7610.2006.01673.x .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"Psychoneuroendocrinology 36, 891 –897  .http://dx.doi.org/ 10.1016/j.psyneuen.2010.12.004 .",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1038/nrn3524 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1162/jocn.2008.20114 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"172, 83 –91.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1016/j.nicl.2013.11.009 .,OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"http://dx.doi.org/10.1093/cercor/bhl041 .Larsen, J.T., Norris, C.J., McGraw, A.P., Hawkley, L.C., Cacioppo, J.T., 2009.",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1080/02699930801994054 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/ 10.1093/scan/nsu133 .,OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"19, 394 –403.http://dx.doi.org/ 10.1037/0893-3200.19.3.394 .",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1017/ S0954579410000799 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"8, 21. http://dx.doi.org/10.3389/fnbeh.2014.00021 .",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1001/archpsyc.65.5.568.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"11, 170. http://dx.doi.org/10.1186/1471-2288-11-170 .",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.05.028 .,OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1177/ 014662167700100306 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/ 10.1016/S1359-1789(01)00078-7 .,OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5587-06.2007 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1017/S0033291712000207 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1093/scan/nst175 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1002/jclp.20593 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1111/1469-7610.00037 .,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
"7, 23 –34.http://dx.doi.org/ 10.1093/scan/nsr049 .",Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/e3/76/main.PMC4845388.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: AnisotropyDiffusion magnetic resonance imaging (dMRI)PrematurityReadingWhite matter 1.,Non-OADS,/arxiv_data1/oa_pdf/e6/44/main.PMC4845391.pdf
http://dx.doi.org/10.1016/j.nicl.2016.04.0032213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/44/main.PMC4845391.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/44/main.PMC4845391.pdf
"Diffusion MR images were pre-processed with open-source soft- ware, mrDiffusion ( http://white.stanford.edu/newlm/index.php/ MrDiffusion ) implemented in MATLAB R2012a (Mathworks, Natick, MA).",OADS,/arxiv_data1/oa_pdf/e6/44/main.PMC4845391.pdf
"Fiber tracking and segmentation Fiber tracking and tract segmentation were performed using open source software, Automated Fiber Quanti ﬁcation (AFQ; https://github.jyeatman/AFQ ) implemented in MATLAB R2012a (Mathworks, Natick, MA).",OADS,/arxiv_data1/oa_pdf/e6/44/main.PMC4845391.pdf
"Copyright © 2016 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN   | Available on www .jocr.co.in | doi: 2321-3817 10.13107/jocr .2250-0685.360 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Open access, copyright and licensing: basics for open access publishers The purpose of this editorial is to cover as succinctly as possible the basics of copyright and licensing that open access publishers need to  know, and to provide some guidance in making decisions in this area.",Non-OADS,/arxiv_data1/oa_pdf/d8/9a/JOCR-6-1.PMC4845398.pdf
Retrieved from  http://creativecommons.org/licenses/ 3.,Non-OADS,/arxiv_data1/oa_pdf/d8/9a/JOCR-6-1.PMC4845398.pdf
Considerations for licensors and  licensees.Retrieved fromhttps://wiki.creativecommons.org/wiki/Considerations_for_licensors_and_lice nsees#Specify_precisely_what_it_is_you_are_licensing.,Non-OADS,/arxiv_data1/oa_pdf/d8/9a/JOCR-6-1.PMC4845398.pdf
"P.  114. http://www.uofrpress.ca/publications/Free-Knowledge  How to C ite thi s Article Morrison H, Desautels L. Open access, copyright and licensing:  basics for open access publishers.",Non-OADS,/arxiv_data1/oa_pdf/d8/9a/JOCR-6-1.PMC4845398.pdf
"E-mail: cankay adeniz78@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.364 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 11-13 Case Report Introduction:  Peripr osthetic fractur es of the femur are uncommon, but at times may lead to complications especially in  elderly patients.",Non-OADS,/arxiv_data1/oa_pdf/6f/3d/JOCR-6-11.PMC4845399.pdf
"Email: drabhishekv aish@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.365 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 14-16 Case Report Introduction:  The cyst of anterior cruciate ligament (ACL) is a known clinical entity , but its association with knee synovitis and melon or rice bodies is not  documented.",Non-OADS,/arxiv_data1/oa_pdf/ac/99/JOCR-6-14.PMC4845400.pdf
"E-Mail: manish.diw akar@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.366 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 17-19 Case Report Introduction:  Synovial chondromatosis is a rare intraarticular benign condition arising from the synovial membrane of the joints, synovial sheaths or bursae  around the joints.",Non-OADS,/arxiv_data1/oa_pdf/12/d2/JOCR-6-17.PMC4845401.pdf
"Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.367 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 20-22 Case Report Introduction:  Giant cell tumor accounts for 5 to 9 percent of all primary bony tumors.",Non-OADS,/arxiv_data1/oa_pdf/95/5a/JOCR-6-20.PMC4845402.pdf
"Email: b_tadros@y ahoo.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.368 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 23-25 Case Report Introduction:  Tuberculosis (TB) still remains a common problem in the UK and, with the increasing number of patients being offered arthroplasties;  periprosthetic involvement is not uncommon anymore.",Non-OADS,/arxiv_data1/oa_pdf/bf/9d/JOCR-6-23.PMC4845403.pdf
"E-Mail: dr_ranjit53@rediffmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.369 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 26-28 Case Report Introduction:  Ilizarov technique yields satisfactory results in difficult situations.",Non-OADS,/arxiv_data1/oa_pdf/eb/52/JOCR-6-26.PMC4845404.pdf
"Email : chaturv edi.hemant26@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.370 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 29-32 Case Report Introduction:  Tumors of the medial malleolus are rare.",Non-OADS,/arxiv_data1/oa_pdf/17/66/JOCR-6-29.PMC4845405.pdf
"Parchi Domenico  Paolo Copyright © 2016 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN   | Available on www .jocr.co.in | doi: 2321-3817 10.13107/jocr .2250-0685.361 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Author’s Photo Gallery Access this article online Website: www .jocr.co.in DOI: 2250-0685.3611 Department of Orthopaedic and Traumatology Unit Univ ersity of Pisa.",Non-OADS,/arxiv_data1/oa_pdf/81/41/JOCR-6-3.PMC4845406.pdf
"Email: aleemi@mcmaster.ca Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.371 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 33-36 Case Report Introduction:  Periprosthetic fractures of the femur after total hip arthroplasty are increasing in frequenc y.",Non-OADS,/arxiv_data1/oa_pdf/53/61/JOCR-6-33.PMC4845407.pdf
"Email – saurav.scb@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.372 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 37-39 Case Report Introduction:  Isolated coracoid fractures are rare and few scattered cases are reported in literature.",Non-OADS,/arxiv_data1/oa_pdf/2a/aa/JOCR-6-37.PMC4845408.pdf
"Email: mark.g@mdresearch.com.au Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.373 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 40-43 Case Report Introduction:  This is a report of a mechanical failure of an S-ROM revision total knee prosthesis.",Non-OADS,/arxiv_data1/oa_pdf/e1/6a/JOCR-6-40.PMC4845409.pdf
"Email: jw a.fletcher@doctors.net.uk Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.374 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 44-47 Case Report Introduction:  Pelvic injuries are common in high energy trauma.",Non-OADS,/arxiv_data1/oa_pdf/c1/0f/JOCR-6-44.PMC4845410.pdf
"Email Id: joergmika@y ahoo.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.362 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 5-7 Case Report Introduction: Only two cases of an isolated compartment syndrome of the extensor carpi ulnaris have been described previously [1,2].",Non-OADS,/arxiv_data1/oa_pdf/6c/da/JOCR-6-5.PMC4845412.pdf
"Email - pravinjadhav99@y ahoo.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.376 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 52-54 Case Report Introduction:  Osteochondr omas are benign tumour s of the skeletal system.",Non-OADS,/arxiv_data1/oa_pdf/7f/01/JOCR-6-52.PMC4845413.pdf
"Email: bkavy a96@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.377 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 55-57 Case Report Introduction:  Vascular complications post-operative to a total hip arthroplasty are a very rare phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/d8/cf/JOCR-6-55.PMC4845414.pdf
"Email: mahdikhalfaoui@nhs.net Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.378 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 58-60 Case Report Introduction:  Acute patellar dislocation is a common injur y usually associat ed with a signif icant traumatic mechanism  resulting in lateral displacement.",Non-OADS,/arxiv_data1/oa_pdf/bf/36/JOCR-6-58.PMC4845415.pdf
"Email: vikram1065@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.379 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 61-62 Case Report Introduction:  Tuber culosis of calcaneum is a rare entity .",Non-OADS,/arxiv_data1/oa_pdf/99/f5/JOCR-6-61.PMC4845416.pdf
"Email: drnavin_ortho@y ahoo.co.in Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.381 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 65-68 Case Report Introduction:  Subtr ochant eric fractures have a bimodal age distribution.",Non-OADS,/arxiv_data1/oa_pdf/c7/d2/JOCR-6-65.PMC4845418.pdf
"Email: odanisa@y ahoo.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.383 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 72-75 Case Report Introduction:  Pelvic sarcoma presenting with neur ologic symptoms is rare.",Non-OADS,/arxiv_data1/oa_pdf/80/4c/JOCR-6-72.PMC4845420.pdf
"Email :  vikram1065@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.384 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 76-78 Case Report Introduction:  Tuber culosis of Navicular bone is a rare entity .",Non-OADS,/arxiv_data1/oa_pdf/44/9e/JOCR-6-76.PMC4845421.pdf
"Email : xraydesai@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.385 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 79-81 Case Report Introduction:  Melor heost osis is a benign bone dysplasia affecting predominantly the appendicular skeleton and adjoining soft  tissues.",Non-OADS,/arxiv_data1/oa_pdf/4e/65/JOCR-6-79.PMC4845422.pdf
"E-mail: kun_bansal@y ahoo.co.in Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.363 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2016 Jan-Mar: 6(1):Page 8-10 Case Report Introduction:  Spinal cord injury in children frequently occurs without fracture or dislocation.",Non-OADS,/arxiv_data1/oa_pdf/84/5a/JOCR-6-8.PMC4845423.pdf
"Copyright © 2016 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN   | Available on www .jocr.co.in | doi: 2321-3817 10.13107/jocr .2250-0685.386 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Training by Publication: Can Journal be mentors Medical education specifically Surgical Training has been under scrutiny and various loop holes have been  identified [1,2].",Non-OADS,/arxiv_data1/oa_pdf/18/11/JOCR-6-82.PMC4845424.pdf
2016 Feb;96(1):71-88.4. http://jbstjournal.com/oncomedia-sep-dec-2015/ 5.,Non-OADS,/arxiv_data1/oa_pdf/18/11/JOCR-6-82.PMC4845424.pdf
"Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN   | Available on www .jocr.co.in | doi: 2321-3817 10.13107/jocr .2250-0685.330 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Predatory Journals: What are they?",Non-OADS,/arxiv_data1/oa_pdf/cf/ae/JOCR-5-1.PMC4845443.pdf
Available from link  https://web.facebook.com/groups/indian.ortho/ 2.  https://en.wikipedia.org/wiki/Jeffrey_Beall 3.,Non-OADS,/arxiv_data1/oa_pdf/cf/ae/JOCR-5-1.PMC4845443.pdf
[2015] Available on www.scholarlyoa.com from  l i n k  https://scholarlyoa.files.wordpress.com/2015/01/criteria- 2015.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/cf/ae/JOCR-5-1.PMC4845443.pdf
"E mail: Ganesangram@Y ahoo.Com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.333 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 10-13 Case Report Introduction:  Myositis ossif icans progressiv a is very rare with a worldwide prevalence of appr oximat ely 1 case in 2 million  individuals.",Non-OADS,/arxiv_data1/oa_pdf/c0/11/JOCR-5-10.PMC4845444.pdf
OMIM: Mendelian Inheritance in Man.[http://www.ncbi.nlm.nih.gov/omim].,Non-OADS,/arxiv_data1/oa_pdf/c0/11/JOCR-5-10.PMC4845444.pdf
"Orphanet Journal of Rare Diseases 2011,  6:80.http://www.ojrd.com/content/6/1/80.",Non-OADS,/arxiv_data1/oa_pdf/c0/11/JOCR-5-10.PMC4845444.pdf
"E mail – samarjit212@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.334 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/a0/3f/JOCR-5-14.PMC4845445.pdf
"Email: somanshardul@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.335 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 17-20 Case Report Introduction:  It is uncommon for hand surgeons to diagnose and treat persistent post-traumatic radius fracture on the lines of  tuber culosis infection even in developing countries especially when the clinical picture resembles more of a complex regional  pain syndr ome (CRPS).",Non-OADS,/arxiv_data1/oa_pdf/b8/e9/JOCR-5-17.PMC4845446.pdf
"Email: cankay adeniz78@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.336 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 21-23 Case Report Introduction:  Fracture of the femoral stem following hip arthroplasty has become very rare since the developments in modern  prosthe tic designs.",Non-OADS,/arxiv_data1/oa_pdf/0e/4b/JOCR-5-21.PMC4845447.pdf
"E mail- drmaulikpatel137@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.337 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/33/e9/JOCR-5-24.PMC4845448.pdf
"Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.338 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 27-29 Case Report Introduction:  Vascular injur y associat ed withclosed posterior elbow dislocations is rare and it usually occur s along with open  dislocation, ant erior dislocation, pene trating injuries, dislocations associat ed with fracture.",Non-OADS,/arxiv_data1/oa_pdf/c4/3f/JOCR-5-27.PMC4845449.pdf
"E mail – jitendranathpal@gmail.com  Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.331 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 3-6 Case Report Introduction:  Solitar y exostosis is common at the metaph ysis of long bones, and rarely may it develop in the lower pole of the  patella.",Non-OADS,/arxiv_data1/oa_pdf/c8/a2/JOCR-5-3.PMC4845450.pdf
"Email: anoopd_7@y ahoo.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.339 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 30-33 Case Report Introduction:  'Vanishing Bone Disease' or Gorham's disease is a very rare form of primar y idiopathic osteolysis with only around  200 cases being repor ted till date.",Non-OADS,/arxiv_data1/oa_pdf/43/b4/JOCR-5-30.PMC4845451.pdf
"E-mail:orthojar@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.340 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 34-35 Case Report Introduction:  Anterior dislocation of hip associat ed with fracture of proximal femur is an uncommon injur y.",Non-OADS,/arxiv_data1/oa_pdf/88/3e/JOCR-5-34.PMC4845452.pdf
"Email – dr.vikramkandhari@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.341 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 36-39 Case Report Introduction:  Chances of avascular necrosis of acetabulum are rare as it enjoys a rich blood supply .",Non-OADS,/arxiv_data1/oa_pdf/8f/21/JOCR-5-36.PMC4845453.pdf
"Address of Correspondence Dr. Sanjeev P atnaik , Senior Consultant Orthopaedics, Apollo Hospital, Bhubanesw ar, Odisha, India P IN- 751005 E mail – sportho1973@y ahoo.co.in Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.342 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/07/40/JOCR-5-40.PMC4845454.pdf
"E mail – dr.rajatjangir@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.343 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/8e/f0/JOCR-5-44.PMC4845455.pdf
"2 General practitioner, Gulf Medical College hospital, Ajman, U AE Address of Correspondence Dr. Sangeet Gangadharan 403, D-16, Shanti V ihar, Mira Road, Thane 401107, Maharashtra E mail – drsangeetgangadharan@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.344 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/31/b8/JOCR-5-47.PMC4845456.pdf
2010  Sep 7 [cited 2014 Sep 23]; Available from:  http://www.slackinc.com/doi/resolver.asp?doi=10.3928/01477447-20100722-04 10.,OADS,/arxiv_data1/oa_pdf/31/b8/JOCR-5-47.PMC4845456.pdf
"E mail – orthoseenu@y ahoo.com   Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.345 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/69/b0/JOCR-5-50.PMC4845457.pdf
"Dr. Ashish Gulia Dr. Ajay Puri Dr. Bharat Rekhi Dr. Nitin Shetty Dr. Siddhartha Laskar Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.346 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/4b/JOCR-5-54.PMC4845458.pdf
"Address of Correspondence Dr. Seema Sharma, H No 23,Type 5,Block B, Dr Rajendra Prasad Govt Medical College, T anda ,H P, INDI, E-mail : seema406@rediffmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.347 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/0e/ac/JOCR-5-57.PMC4845459.pdf
"Email: orthokunal@y ahoo.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.348 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 61-63 Case Report Introduction:  Shoulder joint is the most frequently dislocat ed joint.",Non-OADS,/arxiv_data1/oa_pdf/ea/45/JOCR-5-61.PMC4845460.pdf
"E-mail : mihirrdesai@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.349 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr.",Non-OADS,/arxiv_data1/oa_pdf/85/ed/JOCR-5-64.PMC4845461.pdf
"Email: luithderek@y ahoo.co.uk Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.350 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 68-70 Case Report Introduction:  Giant cell tumor of the tendon sheath is most commonly found in the flexor aspect of hand and wrist and is rare in  the foot and ankle.",Non-OADS,/arxiv_data1/oa_pdf/29/f7/JOCR-5-68.PMC4845462.pdf
"Email: mnpatil@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.332 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 7-9 Case Report Introduction:  Birth injuries are common phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/ee/67/JOCR-5-7.PMC4845463.pdf
"Email: drv arunchouhan@y ahoo.co.in Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.351 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 71-72 Case Report Introduction:  Obturat or internus hemat oma(OIH) is a very rare entity .",Non-OADS,/arxiv_data1/oa_pdf/41/9c/JOCR-5-71.PMC4845464.pdf
"Email: luithderek@y ahoo.co.uk Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | p ISSN  2250-0685 | e ISSN  2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.352 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 73-76 Case Report Introduction:  Eckert and Davis grade 3 superior peroneal retinaculum injur y is rare and the optimal treatment is not yet  determined.",Non-OADS,/arxiv_data1/oa_pdf/4a/b6/JOCR-5-73.PMC4845465.pdf
"Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.353 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 77-78 Case Report Introduction:  Symptomatic adrenal adenoma usually presents with systemic symptoms.",Non-OADS,/arxiv_data1/oa_pdf/8b/ce/JOCR-5-77.PMC4845466.pdf
"E-mail: rajendra.orthopaedics@gmail.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.354 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 79-81 Case Report Introduction:  Thumb carpome tacar pal dislocation is a rare injur y with many treatment options described in literature.",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/JOCR-5-79.PMC4845467.pdf
"E mail – drnavin_ortho@y ahoo.co.in Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.355 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 82-84 Case Report Introduction:  Established non-unions  pose a real nightmare for even the most accom plished surgeon.The variations in  anat omy due to extensiv e fibrous tissue growth, soft tissue contractures around the fracture site and bony alterations like  smoo thening and scler osis of  the fracture ends must each be addressed as a whole if good outcome is to be expect ed.",Non-OADS,/arxiv_data1/oa_pdf/f0/01/JOCR-5-82.PMC4845468.pdf
"Email: drrksharma50@y ahoo.com Copyright © 2015 by Journal of Orthpaedic Case Reports Journal of Orthopaedic Case Reports | pISSN 2250-0685 | eISSN 2321-3817 | A vailable on www .jocr.co.in | doi: 10.13107/jocr .2250-0685.356 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dr Yadwinder Singh  SohalDr Rajesh Kapila Dr Dhalwinder Singh Dr. Rakesh Sharma AbstractJournal of Orthopaedic Case Reports 2015 Oct-Dec: 5(4):Page 85-87 Case Image Introduction:  Aneurysmal Bone Cyst (ABC) is a benign expansile cystic blood filled reactive lesion of the bone, most common in the first 2  decades of life.",Non-OADS,/arxiv_data1/oa_pdf/84/10/JOCR-5-85.PMC4845469.pdf
Methods and Data All data used here have been released to the public and are available through the Planetary Data System (https://pds.nasa.gov) and other sources.2.2.1.,OADS,/arxiv_data1/oa_pdf/7c/54/JGRE-121-75.PMC4845591.pdf
Primary data used here are publically availablethrough the NASA Planetary DataSystem (https://pds.nasa.gov); addi- tional data are in the supporting infor- mation and from the authors.,OADS,/arxiv_data1/oa_pdf/7c/54/JGRE-121-75.PMC4845591.pdf
Available  from: http://www.globocan.iarc.fr/Pages/fact_sheets_cancer.,Non-OADS,/arxiv_data1/oa_pdf/30/4d/SAJC-5-12.PMC4845597.pdf
Available from: https://www.nrdo.gov.sg/uploadedFiles/NRDO/Cancer_ Trends_Report_08-12_website.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/4d/SAJC-5-12.PMC4845597.pdf
Available from: http://www.iccp -portal.org/sites/default/files/plans/ Publication_Cancer_Strategy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/4d/SAJC-5-12.PMC4845597.pdf
Available  from: http://www.globocan.iarc.fr/Pages/fact_sheets_cancer.,Non-OADS,/arxiv_data1/oa_pdf/96/53/SAJC-5-14.PMC4845598.pdf
Available from: https://www.nrdo.gov.sg/uploadedFiles/NRDO/Cancer_ Trends_Report_08-12_website.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/53/SAJC-5-14.PMC4845598.pdf
Available from: http://www.iccp -portal.org/sites/default/files/plans/ Publication_Cancer_Strategy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/53/SAJC-5-14.PMC4845598.pdf
Available from: http://www.oralcancerfoundation.org/facts/rare/om/.,Non-OADS,/arxiv_data1/oa_pdf/dc/3e/SAJC-5-29.PMC4845605.pdf
Available from: http://www.oralcancerfoundation.org/facts/rare/om/.,Non-OADS,/arxiv_data1/oa_pdf/82/22/SAJC-5-32.PMC4845607.pdf
"The diﬀerent total cross sections relative to water, carbon monoxide, carbon dioxide, and molecular oxygenaretakenfromthePHIDRATESdatabase(seehttp://phidrates.space.swri.edu/)whichisbasedontheworkofHuebnerandMukherjee [2015].ThesolarUVﬂuxismostlyabsorbedinthespectralrangebetween60 and 100 nm with an absorption average of about 12.5% between the top of the atmosphere and at 10 kmabove the comet, with a maximum at 90 nm with 17% of absorbed ﬂux.",Non-OADS,/arxiv_data1/oa_pdf/06/86/JGRA-121-804.PMC4845638.pdf
All Rosetta/ROSINAdata are available on request untilthey are released to the PSA archive of ESA (www.rssd.esa.int/PSA) and to the PDS archive of NASA.The solar UV ﬂux data wereobtained from the LISIRD database (http://lasp.colorado.edu/lisird/ssi/).,OADS,/arxiv_data1/oa_pdf/06/86/JGRA-121-804.PMC4845638.pdf
"The cross-sections data usedin this paper can be obtainedfrom the PHIDRATES database (http://phidrates.space.swri.edu/), a n df r o mt h eA T M O C I A Dd a t a b a s ewhich is available from theauthors upon request (Guillaume.",OADS,/arxiv_data1/oa_pdf/06/86/JGRA-121-804.PMC4845638.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 5, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2015.0095 427",Non-OADS,/arxiv_data1/oa_pdf/d9/4f/aid.2015.0095.PMC4845676.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 19, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0039 81",Non-OADS,/arxiv_data1/oa_pdf/1b/86/pop.2015.0039.PMC4845678.pdf
2003. http://store.samhsa.gov/product/ Achieving-the-Promise-Transforming-Mental-Health-Care- in-America-Executive-Summary/SMA03-3831.,Non-OADS,/arxiv_data1/oa_pdf/1b/86/pop.2015.0039.PMC4845678.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.POPULATION HEALTH MANAGEMENT Volume 19, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/pop.2015.0030 88",Non-OADS,/arxiv_data1/oa_pdf/87/17/pop.2015.0030.PMC4845682.pdf
"Youth Risk Behavior Surveillance—United States, 2011. http://www.cdc.gov/ mmwr/preview/mmwrhtml/ss6104a1.htm.",Non-OADS,/arxiv_data1/oa_pdf/87/17/pop.2015.0030.PMC4845682.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787",Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"S. pyogenes was a monoculture in the pus of two patients; S. constellatus and F. necrophorum were each a single organism in the pus culture of one patient.Microbiology of peritonsillar abscess in Estonia Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787",Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"Patient culture results and their locations.Microbiology of peritonsillar abscess in Estonia Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787",Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"These data were not included in the table since no MIC cut-off valuesexist for R. mucilaginosa susceptibility and resistance.Microbiology of peritonsillar abscess in Estonia Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.1016/j.amjoto.2008.12.003 4.,OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.3109/00016489.2014.905702 6.,Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.1093/jac/dkt128 7.,Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.1007/ s10096-010-1130-9 9.,Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.1007/ s10096-008-0583-6 10.,Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.1007/s10096-010-1114-9 11.,Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
Available from: http://www.eucast.,Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
doi: http://dx.doi.org/10.1177/1074248411423023Risto Vaikja ¨rv et al.,OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2016, 27: 27787 - http://dx.doi.org/10.3402/mehd.v27.27787",Non-OADS,/arxiv_data1/oa_pdf/eb/7d/MEHD-27-27787.PMC4845694.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2016, 11: 31258 - http://dx.doi.org/10.3402/ljm.v11.31258 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/44/LJM-11-31258.PMC4845695.pdf
"2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31258 - http://dx.doi.org/10.3402/ljm.v11.31258",Non-OADS,/arxiv_data1/oa_pdf/c7/44/LJM-11-31258.PMC4845695.pdf
"aCollected in 174 children.Vitamin D status in Tunisian children Citation: Libyan Journal of Medicine 2016, 11: 31258 - http://dx.doi.org/10.3402/ljm.v11.31258 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/44/LJM-11-31258.PMC4845695.pdf
"4 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31258 - http://dx.doi.org/10.3402/ljm.v11.31258",Non-OADS,/arxiv_data1/oa_pdf/c7/44/LJM-11-31258.PMC4845695.pdf
"Plasma 25-hydroxyvitamin D and multi-adjusted odd-ratios for vitamin D deﬁciency/insufﬁciency in children according to confounding variables Plasma 25-OHD, mg/L Vitamin D deficiencyaVitamin D insufficiencyb N Mean (SD) % OR (IC a ` 95%)c% OR (IC a ` 95%)c Maturity status Pre-PHV Around/post-PHV194 3114.195.25 13.594.0740.7 41.2/C1 1.89 (0.54 /C16.67)83.0 97.1/C1 6.76 (0.89 /C151.2) Body mass Normal-weight Overweight/obesity105 12013.894.79 14.395.3840.0 41.7/C1 1.34 (0.50 /C13.64)89.5 80.8/C1 3.09 (0.81 /C111.8) Adiposity No Yes86 13913.794.52 14.495.3939.3 41.0/C1 0.81 (0.29 /C12.24)91.7 80.6/C1 4.41 (0.97 /C118.1) Insulin resistance No Yes111 11414.295.25 13.994.9739.8 41.6/C1 1.07 (0.47 /C12.45)83.2 86.7/C1 1.82 (0.60 /C15.66) Skin color Fair Dark59 16615.995.19 13.394.88***25.8 46.4/C1 1.40 (0.60 /C13.25)77.4 88.0/C1 1.89 (0.66 /C15.44) Vitamin D intake ]8.34 mg/day B8.34 mg/day85 8915.395.29 14.794.9031.8 36.0/C1 2.63 (1.06 /C16.51)*81.2 82.0/C1 1.45 (0.50 /C14.22) Milk intake ]500 ml/day B500 ml/day87 8712.894.25 17.194.97***19.5 48.3/C1 3.32 (1.32 /C17.90)**69.0 94.3/C1 5.83 (1.75 /C119.4)** Red meat intake ]100 g/week B100 g/week86 8813.394.76 16.794.87***22.1 45.5/C1 3.42 (1.46 /C18.01)**73.3 89.8/C1 3.63 (1.23 /C110.7)* Fish intake ]100 g/week B100 g/week84 9012.794.53 17.494.51***13.1 53.3/C1 6.23 (2.64 /C114.7)***70.2 92.2/C1 5.93 (1.87 /C118.7)** Egg intake ]50 g/day B50 g/day73 10113.394.37 17.295.12***17.8 45.5/C1 2.94 (1.25 /C16.92)*68.5 91.1/C1 3.74 (1.27 /C111.0)* PHV, pick of high velocity; OR, odd-ratio; 95% CI, 95% confidence interval; 25-OHD, 25-hydroxyvitamin D;a25-OH D B12mg/L; b25-OHD B20mg/L;cadjusted for maturation status, BMI, skin color, fat mass, HOMA-IR, and intake of vitamin D, milk, red meat, fish, and eggs; * pB0.05; ** pB0.01; *** pB0.001.Vitamin D status in Tunisian children Citation: Libyan Journal of Medicine 2016, 11: 31258 - http://dx.doi.org/10.3402/ljm.v11.31258 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/44/LJM-11-31258.PMC4845695.pdf
"6 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2016, 11: 31258 - http://dx.doi.org/10.3402/ljm.v11.31258",Non-OADS,/arxiv_data1/oa_pdf/c7/44/LJM-11-31258.PMC4845695.pdf
"2011; 141: 290 /C15.Vitamin D status in Tunisian children Citation: Libyan Journal of Medicine 2016, 11: 31258 - http://dx.doi.org/10.3402/ljm.v11.31258 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/44/LJM-11-31258.PMC4845695.pdf
"All CMIP5 data used in this study were downloaded through theEarth System Grid data portal of theProgram for Climate Model Diagnosis and Intercomparison (PCMDI), U.S. Department of Energy (DOE) (http://pcmdi9.llnl.gov/).",OADS,"/arxiv_data1/oa_pdf/61/97/GRL-42-10,876.PMC4845713.pdf"
"The TwentiethCentury Reanalysis Project (20CR) Version 2c used in this study was downloaded from the NOAA ’s Earth System Research Laboratory data portal,http://www.esrl.noaa.gov/psd/data/ 20thC_Rean/.",OADS,"/arxiv_data1/oa_pdf/61/97/GRL-42-10,876.PMC4845713.pdf"
"In this pro- cess, the capacity of the HDL particle to promote cholesterol  Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.116.307385Objective—Patients with type 2 diabetes mellitus (T2D) have an increased risk of cardiovascular disease, the mechanism of  which is incompletely understood.",Non-OADS,/arxiv_data1/oa_pdf/47/49/atv-36-787.PMC4845764.pdf
"The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.116.307385/-/DC1.Correspondence to Johanna Apro, C2-84, Karolinska University Hospital Huddinge, S-141 86 Stockholm, Sweden.",Non-OADS,/arxiv_data1/oa_pdf/47/49/atv-36-787.PMC4845764.pdf
"Available April 20, 2015from: http://www.pauldickman.com/survival/strs.",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/sjph-2016-0012.PMC4845767.pdf
"Available September 10,  2015 from: http://www.codexalimentarius.org/input/download/standards/291/CXS_118e_2015.pdf.",Non-OADS,/arxiv_data1/oa_pdf/05/80/sjph-2016-0013.PMC4845768.pdf
Available May 10 2014 from: http://consultgerirn.org/uploads/File/trythis/try_this_2.pdf 29.,Non-OADS,/arxiv_data1/oa_pdf/98/dc/sjph-2016-0015.PMC4845770.pdf
"Available April 5, 2015 from: http://www.drtraycehansen.com/Media/Dissertation.pdf.",Non-OADS,/arxiv_data1/oa_pdf/ee/09/sjph-2016-0017.PMC4845772.pdf
ST designations were assigned by the MLST database (available from: http://www.mlst.net).,OADS,/arxiv_data1/oa_pdf/bb/17/sjph-2016-0018.PMC4845773.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ciw072.PMC4845786.pdf
"A copy of the survey can be accessed in Appendix A, http://links.lww.com/MD/A899.",Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
"ISBN 978-1-905813-63-6. http://www.sign.ac.uk/guidelines/fulltext/118/.Accessed June 04, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
http://www.qualityforum.org/News_An- d_Resources/Press_Releases/2012/NQF_Endorses_Neurology_Mea-sures.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
http://www.jointcommission.org/specifi-cations_manual_for_national_hospital_inpatient_quality_measure-s.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
"Guidance on engagement of institutions in human subject research, section III, B, 7, datedOctober 16, 2008. http://www.hhs.gov/ohrp/policy/engage08.html.Accessed May 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
"http://www.cms.gov/Regula- tions-and-Guidance/Legislation/CFCsAndCoPs/Hospitals.html.Accessed June 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
2014;22:145–147http://www.ncbi.nlm.nih.gov/ pubmed/25330701.,Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
2004http://www.nber.org/papers/w10424.,Non-OADS,/arxiv_data1/oa_pdf/d6/5f/medi-95-e3206.PMC4845814.pdf
"Therefore, we further analyzed the risk of osteoporosis between the PUD and non-PUD cohorts stratified by various subtypes of comorbidity and presented the risk of osteoporosisin patients with PUD and relevant comorbidities in Supple-mentary Tables, http://links.lww.com/MD/A901.",Non-OADS,/arxiv_data1/oa_pdf/aa/9b/medi-95-e3309.PMC4845819.pdf
"Supplementary Table S1, http://links.lww.com/MD/A901, shows the results of a comorbidity-stratified analysis of osteo- porosis risk.",Non-OADS,/arxiv_data1/oa_pdf/aa/9b/medi-95-e3309.PMC4845819.pdf
"Supplementary Table S2, http://links.lww.com/MD/A901, shows the effects of PUD and comorbidities on the risk ofosteoporosis development.",Non-OADS,/arxiv_data1/oa_pdf/aa/9b/medi-95-e3309.PMC4845819.pdf
"2014. http://aids.gov/federal-resources/national-hiv-aids-strategy/doj-hiv-criminal-law-best-prac-tices-guide.pdf Published July 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
"2015, http://www.hivlawand policy.org/sites/www.hivlawandpolicy.org/files/HIV%20Crim%20Manual%20%28updated%205.4.15%29.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
"Department of Justice, U.S. ‘‘The Attorney General’s Report on Criminal History Background Checks.’’ http://www.bjs.gov/content/pub/pdf/ag_bgchecks_report.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
"Washington, DC: Bureau of Justice Statistics;2013:http://www.bjs.gov/index.cfm?ty=pbdetail&iid=4843.",OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
http://www.cdc.gov/nchs/data/nhanes/nhanes_13_14/2013–14_overview_brochure.pdf.2015.,OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
2007. http://doi.org/10.3886/ICPSR02598.v1.,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
2012.http://doi.org/10.3886/ICPSR04359.v2.,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
1999.http://doi.org/10.3886/ICPSR06858.v1.,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
Minneapolis: University of Minnesota; 2015:https://cps.ipums.org/cps/intro.shtml.,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
2016. http://www.research.uci.edu/compliance/human-research-protections/researchers/levels-of-review.html.,OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
http://www.cdc.gov/hiv/statistics/basics/ataglan-ce.html.,Non-OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
http://www3.norc.org/GSS+Website/Data+A- nalysis/.,OADS,/arxiv_data1/oa_pdf/f9/9f/medi-95-e3352.PMC4845822.pdf
"This work was supported by AP-HP (Assist- ance Publique des Ho ˆpitaux de Paris), Fondation FondaMental (RTRS Sante ´Mentale) http://www.fondation-fondamental.org/ and by INSERM (Institut National de la Sante ´et de la Recherche Me´dicale).",Non-OADS,/arxiv_data1/oa_pdf/0c/43/medi-95-e3366.PMC4845824.pdf
2014http://www.ofdt.fr/BDD/publica tions/docs/eisxfbv4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/43/medi-95-e3366.PMC4845824.pdf
2012. http://www.ofdt.fr/pub- lications/collections/rapports/ouvrages-collectifs/cocaine-donnees-essentielles/.,Non-OADS,/arxiv_data1/oa_pdf/0c/43/medi-95-e3366.PMC4845824.pdf
"Data management and all analyses were performed using R software program, version 3.0.0 (http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/96/9b/medi-95-e3456.PMC4845851.pdf
"Correlation Analyses Relationship Between FC Concentrations and HRQoL in the Whole Study Population For both CD and UC, only very weak negative correlations were found between FC concentrations and SIBDQ scores,including all FC values determined within 30 days of ques-tionnaire completion (Tables 3 and 4; Supplemental digital content 2, Figure, http://links.lww.com/MD/A914).",OADS,/arxiv_data1/oa_pdf/fe/a2/medi-95-e3477.PMC4845856.pdf
"Relationship Between FC Concentrations and HRQoL in the FC ( /C63d) Subgroups Repeating the analyses using only FC values collected within 3 days of questionnaire completion resulted in strongercorrelations between FC concentrations and SIBDQ scores in both CD and UC (Tables 3 and 4; Supplemental digital content 2, Figure, http://links.lww.com/MD/A914).",OADS,/arxiv_data1/oa_pdf/fe/a2/medi-95-e3477.PMC4845856.pdf
"Supplementaldigital content 3 (Table, http://links.lww.com/MD/A914) illus- trates how correlation coefficients changed depending on the time frame between questionnaire completion and FCmeasurement.",OADS,/arxiv_data1/oa_pdf/fe/a2/medi-95-e3477.PMC4845856.pdf
"Cor- respondingly, UC patients with FC ( /C63d) concentrations <200 mg/g (n ¼20) had a significantly higher median SIBDQ score (56, IQR 46 –62) than those with FC concentrations /C21200mg/g (n¼23, 40 [IQR 36 –57]) ( P¼0.02; Figure 1B).Among SIBDQ subscores, FC concentrations ( /C63d) of CD patients correlated best with the subscore of systemic symp-toms, while FC concentrations ( /C63d) of UC patients correlated only with the subscores of bowel symptoms and social function (Supplemental digital content 4, Table, http://links.lww.com/MD/A914).TABLE 1.",Non-OADS,/arxiv_data1/oa_pdf/fe/a2/medi-95-e3477.PMC4845856.pdf
"Supplemental digital content 5 (Table, http://links.lww.com/MD/A914) shows how potential confounders identified using multiple logisticregression analyses influenced the results of correlation analyses between FC and SIBDQ.",OADS,/arxiv_data1/oa_pdf/fe/a2/medi-95-e3477.PMC4845856.pdf
Numerous studies thathave applied data from the NHIRD data sets have been pub-lished (http://w3.nhri.org.tw/nhird/talk_07.htm).,OADS,/arxiv_data1/oa_pdf/43/cb/medi-95-e3481.PMC4845858.pdf
"In addition, we found the trend is similar after using the Longi- tudinal Health Insurance Database 2000, a database containingthe claims data from 1996 to 2011 for 1 million peoplerandomly sampled from 2000 NHIRD enrollment records, to do the same analysis (Appendix Table 1, http://links.lww.com/ MD/A915).",OADS,/arxiv_data1/oa_pdf/43/cb/medi-95-e3481.PMC4845858.pdf
"Comorbid conditions, assessed using the diagnosiscodes of the International Classification of Diseases, NinthRevision, Clinical Modification (supplementary Table A1, http://links.lww.com/MD/A917) were considered to be present if the diagnosis codes were recorded on /C211 inpatient claim or 2 million subjects randomly selected from among the total Taiwan popula/g415on in 2008 Admission within 1  year (n=8511, 19.1%)Excluding subjects: 1. hospitalized within 6  months before the index  date (date of ﬁrst visit)  (n=21364); or 2. who had missing  informa/g415on on  sociodemographic variables (n=515)Outpa/g415ent cohort, including subjects: 1. who had at least 1 outpa/g415ent visit in 2008  (n=1670701); and  2. were 65 years or older in 2008 (n=200165) Final Outpa/g415ent  cohort  (n=178286) Development  (n=133726)Valida/g415on (n=44560) Admission within 1  year (n=25541, 19.1%)Excluding subjects who:1. died or withdrew from NHI program  at discharge of the index admission  (n=2337); or 2. had missing informa/g415on on  sociodemographicvariables (n=99)Inpa/g415ent cohort, including subjects:1. who had hospital admission in 2008 for  which the principal discharge diagnosis was  not cancer; and  2. were 65 years or older at the ﬁrst admission  (the index admission) in 2008  (n=41586) Final Inpa/g415ent cohort ( n=39156) Development ( n=29351) Valida/g415on (n=9805) Admission within 1  month(n=4265, 14.5%)Admission within 1  month (n=1458 , 14.9%) FIGURE 1.",Non-OADS,/arxiv_data1/oa_pdf/54/50/medi-95-e3484.PMC4845859.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8d/1a/ccid-9-089.PMC4845892.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/8d/1a/ccid-9-089.PMC4845892.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).clinical, cosmetic and investigational Dermatology 2016:9 89–93submit your manuscript | www.dovepress.co m Dove press  89 http: //dx.doi.org/10.2147/CCID.S10099 9improved patient satisfaction using ingenol  mebutate gel 0.015% for the treatment of facial  actinic keratoses: a prospective pilot study Joanna emilio1 Michelle schwartz2–4 eleanor Feldman2–4 amy Kalowitz Bieber2–4 amanda Bienenfeld2–4 Min-Kyung Jung1 Daniel M siegel2,3 Orit Markowitz2–4 1Department of Dermatology, nYiT  college of Osteopathic Medicine,   Old Westbury, 2Department of  Dermatology, sUnY Downstate  Medical center, 3Department of  Dermatology, nY harbor healthcare  system, Brooklyn, 4Department of  Dermatology, Mount sinai Medical  center, new Y ork, nY, Usa correspondence: Orit Markowitz   Department of Dermatology, Mount sinai  Medical center, 5 east 98th street, 5th  Floor, new Y ork, nY 10029, Usa   T el +1 212 241 9728   Fax +1 212 978 1197   email omarkowitz@gmail.co mAbstract:  Actinic keratoses (AKs), especially on areas of the face, have a negative impact on a  patient’ s quality of life (QoL).",Non-OADS,/arxiv_data1/oa_pdf/8d/1a/ccid-9-089.PMC4845892.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/8d/1a/ccid-9-089.PMC4845892.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/1a/ccid-9-089.PMC4845892.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/42/89/ccid-9-079.PMC4845893.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).clinical, cosmetic and investigational Dermatology 2016:9 79–87submit your manuscript | www.dovepress.co m Dove press  79 http: //dx.doi.org/10.2147/CCID.S8848 5a population-based study of the stratum corneum  moisture Thiago de Farias Pires1 ana Paula azambuja2 andrea roseli Vançan  russo horimoto1 Mary sanae nakamura2 rafael de Oliveira alvim1 José eduardo Krieger1 alexandre costa Pereira1 1laboratory of genetics and  Molecular cardiology, heart institute,   University of são Paulo Medical  school, 2natura innovation and  Product T echnology ltd., cajamar,   sP , Brazil correspondence: Thiago de Farias Pires;  alexandre costa Pereira   laboratory of genetics and Molecular  cardiology, heart institute, University  of são Paulo Medical school,  a venida  Doutor enéas de carvalho aguiar,   44, são Paulo, sP 05403-900, Brazil   T el +55 11 2661 5993   email thiagofp@usp.b r; alexandre.",Non-OADS,/arxiv_data1/oa_pdf/42/89/ccid-9-079.PMC4845893.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/42/89/ccid-9-079.PMC4845893.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/89/ccid-9-079.PMC4845893.pdf
Available  from: http://linkinghub.elsevier.com/retrieve/pii/S1568461X0180053 3.,Non-OADS,/arxiv_data1/oa_pdf/42/89/ccid-9-079.PMC4845893.pdf
"6, 787 –798 http://dx.doi.org/10.1080/15384101.2016.1138184",Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Mol Cell Biol 2003; 23:5706-15; PMID:12897142; http://dx.doi.org/10.1128/MCB.23.16.5706-5715.2003 [2] Chapman JR, Taylor MR, Boulton SJ.",Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Mol Cell 2012; 47:497-510; PMID:22920291; http://dx.doi.org/10.1016/j.molcel.2012.07.029 [3] Bekker-Jensen S, Mailand N. The ubiquitin- and SUMO-dependent signaling response to DNA double-strand breaks.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"FEBS Lett 2011; 585:2914-9; PMID:21664912; http://dx.doi.org/10.1016/j.febslet.2011.05.056 [4] Ciccia A, Elledge SJ.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Genes Dev 2011; 25:409-33; PMID:21363960; http://dx.doi.org/10.1101/gad.2021311 [6] Perry JJ, Tainer JA, Boddy MN.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Trends Biochem Sci 2008; 33:201-8; PMID:18403209; http://dx.doi.org/10.1016/j.tibs.2008.02.001 [7] Vyas R, Kumar R, Clermont F, Helfricht A, Kalev P, Sotiropoulou P, Hendriks IA, Radaelli E, Hochepied T, Blanpain C, et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Cell Death and Differ 2013; 20:490-502; PMID:23197296; http://dx.doi.org/10.1038/ cdd.2012.145 [8] Poulsen SL, Hansen RK, Wagner SA, van Cuijk L, van Belle GJ, Streicher W, Wikstrom M, Choudhary C, Houtsmuller AB, Marteijn JA, et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"J Cell Biol 2013; 201:797-807;PMID:23751493; http://dx.doi.org/10.1083/jcb.201212075 [9] Yin Y, Seifert A, Chua JS, Maure JF, Golebiowski F, Hay RT.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Genes Dev 2012; 26:1196-208; PMID:3371408; http://dx.doi.org/10.1101/gad.189274.112 [10] Luo KT, Zhang HX, Wang LW, Yuan J, Lou ZK.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
EMBO J 2012; 31:3008-19; PMID:22635276; http://dx.doi.org/10.1038/emboj.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Sci Signal 2012;5:ra88; PMID:23211528; http://dx.doi.org/10.1126/scisignal.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"J Biol Chem 2014; 289(30):20757-72; PMID:24907272; http://dx.doi.org/10.1074/jbc.M114.555672 [14] Gibbs-Seymour I, Oka Y, Rajendra E, Weinert Brian T, Passmore Lori A, Patel Ketan J, Olsen Jesper V, Choudhary C, Bekker-JensenS, Mailand N. Ubiquitin-SUMO circuitry controls activated fanconianemia ID complex dosage in response to DNA damage.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Mol Cell 2015; 57:150-64; PMID:25557546; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"J Clin Invest 2015; 125:1523-32; PMID:25751062; http://dx.doi.org/10.1172/JCI79325 [16] Luo K, Deng M, Li Y, Wu C, Xu Z, Yuan J, Lou Z. CDK-mediated RNF4 phosphorylation regulates homologous recombination in S- phase.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Nucleic Acids Res 2015; 43:5465-75; PMID:25948581; http://dx.doi.org/10.1093/nar/gkv434 [17] Cheng C-T, Kuo C-Y, Ann DK.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"World J Biol Chem 2014; 5:308-20; PMID:25225599; http://dx.doi.org/10.4331/wjbc.v5.i3.308 [18] White DE, Negorev D, Peng H, Ivanov AV, Maul GG, Rauscher FJ, 3rd.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Cancer Res 2006; 66:11594-9; PMID:17178852; http://dx.doi.org/10.1158/0008-5472.CAN-06-4138 [19] Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz DC, Lukas J, Bekker-Jensen S, Bartek J, Shiloh Y. Chromatin relaxation inresponse to DNA double-strand breaks is modulated by a novelATM and KAP-1 dependent pathway.",Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Nat Cell Biol 2006; 8:870- U142; PMID:16862143; http://dx.doi.org/10.1038/ncb1446 [20] Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lobrich M, Jeggo PA. ATM signaling facilitates repair of DNA double-strandbreaks associated with heterochromatin.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Mol Cell 2008; 31:167-77; PMID:18657500; http://dx.doi.org/10.1016/j.molcel.2008.05.017 [21] Noon AT, Shibata A, Rief N, Lobrich M, Stewart GS, Jeggo PA, Goodarzi AA.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Nat Cell Biol 2010; 12:177-84; PMID:20081839; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"EMBO J 2009; 28:3413-27; PMID:2752027; http://dx.doi.org/10.1038/emboj.2009.276 [23] Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A, Kakarougkas A, Meek K, Taucher-Scholz G, Lobrich M, et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"EMBO J 2011; 30:1079-92; PMID:3061033; http://dx.doi.org/ 10.1038/emboj.2011.27 [24] Kakarougkas A, Ismail A, Klement K, Goodarzi AA, Conrad S, Freire R, Shibata A, Lobrich M, Jeggo PA.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Nucleic Acids Res 2013; 41:9719-31; PMID:23969417; http://dx.doi.org/10.1093/nar/gkt729 [25] Goodarzi AA, Noon AT, Jeggo P. The impact of heterochromatin on DSB repair.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Biochem Soc Trans 2009; 37:569-76; PMID:19442252; http://dx.doi.org/10.1042/BST0370569 [26] Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle.",Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
PLoS Genet 2008; 4:e1000110; PMID:18584027; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Cytometry Part A 2012; 81A:922-8; PMID:22893507; http://dx.doi.org/10.1002/cyto.a.22155 [31] Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, Baer R, Lukas J, Jackson SP.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Nature 2007; 450:509-14; PMID:17965729; http://dx.doi.org/ 10.1038/nature06337 [32] Forget AL, Kowalczykowski SC.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Trends Cell Biol 2010; 20:269-76; PMID:2862779; http://dx.doi.org/10.1016/j.tcb.2010.02.004 [33] Haaf T, Golub EI, Reddy G, Radding CM, Ward DC.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Curr Biol 2000;10:886-95; PMID:10959836; http://dx.doi.org/10.1016/S0960-9822(00)00610-2 [35] Lin Y-H, Yuan J, Pei H, Liu T, Ann DK, Lou Z. KAP1 Deacetylation by SIRT1 Promotes Non-Homologous End-Joining Repair.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"PLoS ONE 2015; 10:e0123935; PMID:25905708; http://dx.doi.org/10.1371/journal.pone.0123935 [36] Bunting SF, Callen E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Cell 2010; 141:243-54; PMID: 20362325; http://dx.doi.org/10.1016/j.cell.2010.03.012 [37] Chapman JR, Barral P, Vannier JB, Borel V, Steger M, Tomas-Loba A, Sartori AA, Adams IR, Batista FD, Boulton SJ.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Mol Cell 2013; 49:858-71; PMID:23333305; http://dx.doi.org/10.1016/j.molcel.2013.01.002 [38] Escribano-Diaz C, Orthwein A, Fradet-Turcotte A, Xing M, Young JT, Tkac J, Cook MA, Rosebrock AP, Munro M, Canny MD, et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Mol Cell 2013;49:872-83; PMID:23333306; http://dx.doi.org/10.1016/j.molcel.2013.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Mol Cell Biol 1999; 19:4366-78; PMID:10330177; http://dx.doi.org/10.1128/MCB.19.6.4366 [40] Baldeyron C, Soria G, Roche D, Cook AJ, Almouzni G. HP1alpha recruitment to DNA damage by p150CAF-1 promotes homologous recombination repair.",Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
J Cell Biol 2011; 193:81-95; PMID:3082177;http://dx.doi.org/10.1083/jcb.201101030CELL CYCLE 797,Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Mol Cancer Res 2012; 10:401-14; PMID:22205726; http://dx.doi.org/10.1158/1541-7786.,Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Cell Cycle 2013; 12:422-9; PMID:23287531; http://dx.doi.org/10.4161/cc.23215 [43] Lee YH, Kuo CY, Stark JM, Shih HM, Ann DK.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Nucleic Acids Res 2013; 41:5784-98; PMID:23589625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Genes Dev 2013; 27:2259-73; PMID: 24142876; http://dx.doi.org/10.1101/gad.223180.113 [45] Davis EJ, Lachaud C, Appleton P, Macartney TJ, N €athke I, Rouse J. DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage.",Non-OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Nat Struct Mol Biol 2012; 19:1093-100; PMID:23042607; http://dx.doi.org/10.1038/nsmb.2394 [46] Meerang M, Ritz D, Paliwal S, Garajova Z, Bosshard M, Mailand N, Janscak P, Hubscher U, Meyer H, Ramadan K. The ubiquitin-selec- tive segregase VCP/p97 orchestrates the response to DNA double-strand breaks.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Nat Cell Biol 2011; 13:1376-82; PMID:22020440;http://dx.doi.org/10.1038/ncb2367 [47] Mosbech A, Gibbs-Seymour I, Kagias K, Thorslund T, Beli P, Povl- sen L, Nielsen SV, Smedegaard S, Sedgwick G, Lukas C, et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Nat Struct Mol Biol 2012; 19:1084-92; PMID:23042605; http://dx.doi.org/10.1038/ nsmb.2395 [48] Nie M, Aslanian A, Prudden J, Heideker J, Vashisht AA, Wohlschle- gel JA, Yates JR, 3rd, Boddy MN.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"J Biol Chem 2012; 287:29610-9; PMID:22730331; http://dx.doi.org/10.1074/jbc.M112.379768 [49] Kalousi A, Hoffbeck A-S, Selemenakis Platonas N, Pinder J, Sav- a g eK i e n a nI ,K h a n n aK u mK ,B r i n oL ,D e l l a i r eG ,G o r g o u l i s Vassilis G, Soutoglou E. The Nuclear Oncogene SET ControlsDNA Repair by KAP1 and HP1 Retention to Chromatin.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Cell Rep 2015; 11:149-63; PMID:25818296; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Cell Cycle 2012; 11:2643-9; PMID:22732494; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Science 2012; 335:1499-502; PMID:22442485; http://dx.doi.org/10.1126/science.1216154 [52] Santoni de Sio FR, Massacand J, Barde I, Offner S, Corsinotti A, Kapopoulou A, Bojkowska K, Dagklis A, Fernandez M, Ghia P, et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"Blood 2012; 119:4675-85; PMID:22452978; http://dx.doi.org/10.1182/blood-2011-12-401117 [53] Santoni de Sio FR, Barde I, Offner S, Kapopoulou A, Corsinotti A, Bojkowska K, Genolet R, Thomas JH, Luescher IF, Pinschewer D,et al.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"FASEB J 2012; 26:4561-75; PMID:22872677; http://dx.doi.org/10.1096/fj.12-206177 [54] Hakli M, Karvonen U, Janne OA, Palvimo JJ.",OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Exp CellRes 2005; 304:224-33; PMID:15707587; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
Am J Pathol 2006; 168:1452-63;PMID:16651613; http://dx.doi.org/10.2353/ajpath.2006.050782798 C.-Y.,OADS,/arxiv_data1/oa_pdf/fa/09/kccy-15-06-1138184.PMC4845925.pdf
"6, 799 –811 http://dx.doi.org/10.1080/15384101.2016.1138187",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"The ﬁxed cells were incubated with RNase for 10 minutes to digest RNA, and stained with propi-dium iodide (cycleTEST PLUS DNA Reagent Kit, BD Biosciences,http://www.bdbiosciences.com /dna-reagent-kit/p/340242).",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"RNA interference and overexpression For Kv10.1 knockdown experiments in HeLa cells, a validated Kv10.1 siRNA sequence TACAGCCATCTTGGTCCCTTA(Quiagen) 11and the non-targeting siRNA control sequence (Ambion, https://www.thermo ﬁsher.com/catalog/product/ AM4635) were transfected at 30 nM ﬁnal concentration using Lipofectamine RNAiMAX (Invitrogen) following the indica-tions of the manufacturer.",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"For immu- noprecipitation, pre-cleared chromatin was incubated with 10 mg of anti-E2F1 rabbit antibody (Cell Signaling Technology http://www.cellsignal.com/antibody/3742) at 4/C14C with constant rotation overnight.",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Ten mg Normal Rabbit IgG (Cell Signaling Technology http://www.cellsignal.com/rabbit-igg/2729) wereadded to negative control samples.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Immunocomplexes were isolated using 30 mL of ChIP- Grade Protein G Magnetic Beads (Cell Signaling Technology http://www.cellsignal.com/products//9006) at 4 /C14C for 2 h with constant rotation.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"700 mg of total protein precleared for 1 hour at 4/C14C with protein G Magnetic Beads (New England BioLabs https://www.neb.com/products/s1430s)were incubated for 1 hour with 3 mg anti-Kv10.1 monoclonal antibody (Kv10.1 –33.mAb; 4 /C14C), and the complexes were pulled down by incubation with 30 mL protein G magnetic beads for 1 hour.",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"Cells were washed 3 times with PBS containing 0.05 % Tween 20 (Sigma), blocked with 10 % BSA (Sigma) inPBS-T for 1 hour, and incubated with primary antibodiesmouse anti- Kv10.1 (1:1000, 10and rabbit anti-Cyclin B1 (1:100; Cell Signaling http://www.cellsignal.com/antibody/4138) over-night at 4 /C14C.",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"Secondary antibody Alexa Fluor 488 anti-rabbit (1:1000; Thermo ﬁsher https://www.thermo ﬁsher.com/Second ary-Antibody-Polyclonal/A-11008) and Alexa Fluor 546 anti- mouse (1:1000; Thermo ﬁsher https://www.thermo ﬁsher.com/ Secondary-Antibody-Polyclonal/A-11003) incubation was per-formed at room temperature for 1 h. Nuclei were counter-stained with 1:1000 dilution of TO-PRO-3 (Invitrogen) in PBS-T. For immunohistochemistry, tissue sections were deparaf- ﬁned in xylene and rehydrated by ethanol series (100, 90, 70, and 0 %) for 5 minutes each step.",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"The tissue sections were incubated over-n i g h ta t4 /C14C with primary antibodies mouse anti-Kv10.1 dilution 1:100,10and rabbit anti-Cyclin B1 (1:200; Acris https://www.acris-antibodies.com/cyclin-b1-ta590439.htm).",Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"Secondary antibodies were Alexa Fluor 488 anti-rabbit(1:1000; Thermo ﬁsher https://www.thermo ﬁsher.com/Second ary-Antibody-Polyclonal/A-11008) and Alexa Fluor 546 anti- mouse (1:1000; Thermo ﬁsher https://www.thermo ﬁsher.com/ Secondary-Antibody-Polyclonal/A-11003) (1 hour at RT).Confocal images were taken using a LSM 510 Meta laser scan-ning confocal microscope (Zeiss), ZEN (Zeiss) software wasused for image acquisition, and imaging processing was doneusing the image analysis software FIJI (Schindelin 2008).",OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Cell 2011; 144:646 –74; PMID:21376230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Chromosome Res 2011; 19:291 –306; PMID:21194009; http://dx.doi.org/10.1007/s10577-010-9178-z.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Genes Cancer 2010; 1:1124 –31; PMID:21779436; http://dx.doi.org/10.1177/1947601910392989.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Genetics 2014; 196:65 –90; PMID: 24395825; http://dx.doi.org/10.1534/genetics.113.152595.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Philos Trans R Soc Lon- don Ser B 2014; 369:20130094; http://dx.doi.org/10.1098/rstb.2013.0094.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Nat Rev Cancer 2014; 14:39 –48; PMID:24336491; http://dx.doi.org/10.1038/ nrc3635.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Cell Cycle 2009; 8:3519 –28; http://dx.doi.org/10.4161/cc.8.21.9888.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Genes Dev2012; 26:1780 –96; http://dx.doi.org/10.1101/gad.193789.112.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Science 2015; 349:873 –6; PMID:26293964; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Mol Cancer 2006; 5:41; PMID:17022810; http://dx.doi.org/10.1186/1476-4598-5-41.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
J Biol Chem 2006; 281:13030 –7; PMID:16537547; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
J Cell Physiol 2012;227:3837 –46; PMID:22495877; http://dx.doi.org/10.1002/jcp.24095.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Eag1 expression inter- feres with hypoxia homeostasis and induces angiogenesis in tumors.J Biol Chem 2008; 283:36234 –40; PMID:18927085; http://dx.doi.org/ 10.1074/jbc.M801830200.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
J Cell Physiol 2007;212:690 –701; PMID:17520698; http://dx.doi.org/10.1002/jcp.21065.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Cancer Res2009; 69:3300 –7; PMID:19351862; http://dx.doi.org/10.1158/0008- 5472.CAN-08-2036.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
PloS one 2011; 6: e20362; PMID:21655246; http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Mol Cell Biol 2001;21:4684 –99; PMID:11416145; http://dx.doi.org/10.1128/MCB.21.14.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Genes Dev 2002; 16:245 –56; PMID:11799067; http://dx.doi.org/10.1101/gad.949802.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
EMBO J 2004; 23:4615 –26; PMID: 15510213; http://dx.doi.org/10.1038/sj.emboj.7600459.CELL CYCLE 809,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
J Biol Chem 2001;276:44905 –11; PMID:11555648; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
EMBO J 1999; 18:5540 –7; PMID:10523298; http://dx.doi.org/10.1093/emboj/ 18.20.5540.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Transl Res 2010; 156:180 –7; PMID:20801415; http://dx.doi.org/10.1016/j.trsl.2010.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Nat Rev Cancer 2010; 10:550 –60; PMID: 20592731; http://dx.doi.org/10.1038/nrc2886.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Hum Mol Genet 2013; 22:2247 –62; PMID:23424202; http://dx.doi.org/10.1093/hmg/ddt076.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
J Mol Med (Berl)2012; 90:1173 –84; PMID:22466864; http://dx.doi.org/10.1007/ s00109-012-0893-0.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Neurosci Lett 2004; 368:249 –53; PMID:15364405; http://dx.doi.org/10.1016/j.neulet.2004.07.001.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
MolCancer 2006; 5:42; PMID:17022811; http://dx.doi.org/10.1186/1476- 4598-5-42.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Med Oncol 2007; 24:345 –50; PMID:17873312; http://dx.doi.org/ 10.1007/s12032-007-0015-y.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Dig Dis Sci 2008; 53:2039 –44; PMID: 18080766; http://dx.doi.org/10.1007/s10620-007-0116-7.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Diagn Pathol 2010; 5:78; PMID:21138547; http://dx.doi.org/10.1186/1746-1596-5-78.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Mol Cancer 2010; 9:18;PMID:20105281; http://dx.doi.org/10.1186/1476-4598-9-18.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Cancer Cell 2002; 2:103 –12; PMID:12204530; http://dx.doi.org/10.1016/ S1535-6108(02)00102-2.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Jpn J Cancer Res 2001; 92:285 –92; PMID: 11267938; http://dx.doi.org/10.1111/j.1349-7006.2001.tb01093.x.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Oncogene 2003; 22:8413 –21; PMID:14627982; http://dx.doi.org/ 10.1038/sj.onc.1206888.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Gas-troenterol 2011; 141:1091 –101; http://dx.doi.org/10.1053/j.gastro.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Cell Cycle 2010; 9:4153 –63; PMID:20948315; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Neuro-oncology2012; 14:870 –81; PMID:22711607; http://dx.doi.org/10.1093/ neuonc/nos114.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Mol Cell Biol 2000; 20:672 –83; PMID:10611246; http://dx.doi.org/10.1128/MCB.20.2.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
J Neurosci 2007; 27:12555 –64; PMID:18003834; http://dx.doi.org/10.1523/JNEUROSCI.3681-07.2007.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Biol 1998; 143:767 –75; PMID:9813096; http://dx.doi.org/10.1083/ jcb.143.3.767.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
J Cell Physiol 1995; 165:177 –85; PMID:7559799; http://dx.doi.org/10.1002/jcp.1041650121.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Proc Natl Acad Sci USA 2006; 103:2886 –91; PMID:16477030; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Nature2001; 413:323 –7; PMID:11565035; http://dx.doi.org/10.1038/ 35095083.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Genes Dev 1998; 12:95 –106; PMID:9420334; http://dx.doi.org/10.1101/gad.12.1.95.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
PloS one 2012; 7:e35839; PMID:22629304; http://dx.doi.org/10.1371/journal.pone.0035839.,Non-OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Genes Dev 2008; 22:2664 –76; PMID:18832071; http://dx.doi.org/10.1101/gad.1703008.,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
Methods 2001; 25:402 –8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262.CELL CYCLE 811,OADS,/arxiv_data1/oa_pdf/fd/4a/kccy-15-06-1138187.PMC4845928.pdf
"5, 689 –698 http://dx.doi.org/10.1080/15384101.2016.1147633",Non-OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Cell 2004; 0:281-97; PMID:14744438; http://dx.doi.org/ 10.1016/S0092-8674(04)00045-5 [2] Denli AM, Tops BBJ, Plasterk RHA, Ketting RF, Hannon GJ.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Nature 2004; 432:231-5; PMID:15531879; http://dx.doi.org/10.1038/ nature03049 [3] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Cell 1993; 75:843-54; PMID:8252621; http://dx.doi.org/10.1016/ 0092-8674(93)90529-Y [4] Van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Science 2007; 316:575-9; PMID:17379774; http://dx.doi.org/10.1126/science.1139089 [5] Xiao C, Calado DP, Galler G, Thai T-H, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 controls B cell differ- entiation by targeting the transcription factor c-Myb.",Non-OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Cell 2007;131:146-59; PMID:17923094; http://dx.doi.org/10.1016/j.cell.2007.07.021 [6] Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio M V, Visone R, Sever NI, Fabbri M, et al.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"N Engl J Med 2005; 353:1793-801; PMID:16251535; http://dx.doi.org/10.1056/NEJMoa050995 [7] Zabolotneva A, Tkachev V, Filatov F, Buzdin A.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Biol Direct 2010; 5:62; PMID:21059241; http://dx.doi.org/ 10.1186/1745-6150-5-62 [8] Hsu S-D, Tseng Y-T, Shrestha S, Lin Y-L, Khaleel A, Chou C-H, Chu C-F, Huang H-Y, Lin C-M, Ho S-Y, et al.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Nucleic Acids Res 2014; 42:D78-85; PMID:24304892;http://dx.doi.org/10.1093/nar/gkt1266 [9] Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N, Dalamagas T, HatzigeorgiouAG.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Nucleic Acids Res 2012; 40:D222-9; PMID:22135297; http://dx.doi.org/10.1093/nar/gkr1161 [10] Buzdin AA, Zhavoronkov AA, Korzinkin MB, Venkova LS, Zenin AA, Smirnov PY, Borisov NM.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
Front Genet 2014; 5:55; PMID:24723936; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Oncotarget 2014; 5:10198-205;PMID:25415353; http://dx.doi.org/10.18632/oncotarget.2548 [12] Khatri P, Sirota M, Butte AJ.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"PLoS Comput Biol 2012; 8:e1002375; PMID:22383865; http://dx.doi.org/10.1371/journal.pcbi.1002375 [13] Khatri P, Dr /C21aghici S. Ontological analysi s of gene expression data: cur- rent tools, limitations, and open problems.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Bioinformatics 2005; 21:3587-95; PMID:15994189; http://dx.doi.org/10.1093/bioinformatics/bti565 [14] Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Front Physiol 2013; 4:278;PMID:24133454; http://dx.doi.org/10.3389/fphys.2013.00278 [16] Afsari B, Geman D. Learning dysregulated pathways in cancers from differential variability analysis.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Bioinformatics 2008; 24:i390-8; PMID:18586739; http://dx.doi.org/10.1093/bioinformatics/btn142 [18] Eddy JA, Hood L, Price ND, Geman D. Identifying tightly regulated and variably expressed networks by Differential Rank Conservation(DIRAC).",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"PLoS Comput Biol 2010; 6:e1000792; PMID:20523739;http://dx.doi.org/10.1371/journal.pcbi.1000792 [19] Buzdin AA, Zhavoronkov AA, Korzinkin MB, Roumiantsev SA, Aliper AM, Venkova LS, Smirnov PY, Borisov NM.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Front Mol Biosci 2014; 1:8; PMID:25988149; http://dx.doi.org/10.3389/fmolb.2014.00008 [20] Makarev E, Fortney K, Litovchenko M, Braunewell KH, Zhavor- onkov A, Atala A. Quantifying sig naling pathway activation to monitor the quality of induced pluripotent stem cells.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Oncotarget 2015; 6:23204-12; PMID:26327604; http://dx.doi.org/10.18632/oncotarget.4673 [21] Lezhnina K, Kovalchuk O, Zhavoronkov AA, Korzinkin MB, Zabo- lotneva AA, Shegay P V, Sokov DG, Gaifullin NM, Rusakov IG, Aliper AM, et al.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Oncotarget2014; 5:9022-32; PMID:25296972; http://dx.doi.org/10.18632/ oncotarget.2493 [22] Spirin PV, Lebedev TD, Orlova NN, Gornostaeva AS, Prokofjeva MM, Nikitenko NA, Dmitriev SE, Buzdin AA, Borisov NM, AliperCELL CYCLE 697",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Silencing AML1-ETO gene expression leads to simulta- neous activation of both pro-apoptotic and proliferation signaling.Leukemia 2014; 28:2222-8; PMID:24727677; http://dx.doi.org/10.1038/leu.2014.130 [23] Aliper AM, Frieden-Korovkina VP, Buzdin A, Roumiantsev SA, Zhavoronkov A. Interactome anal ysis of myeloid-derived sup- pressor cells in murine models of colon and breast cancer.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Onco- target 2014; 5:11345-53; PMID:25294811; http://dx.doi.org/ 10.18632/oncotarget.2489 [24] Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A, Zhavoronkov A.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"CA Cancer J Clin 55:74-108; PMID:15761078; http://dx.doi.org/10.3322/canjclin.55.2.74 [27] Kim W-J, Bae S-C. Molecular biomarkers in urothelial bladder can- cer.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Cancer Sci 2008; 99:646-52; PMID:18377416; http://dx.doi.org/10.1111/j.1349-7006.2008.00735.x [28] Majewski T, Lee S, Jeong J, Yoon D-S, Kram A, Kim M-S, Tuziak T, Bondaruk J, Lee S, Park W-S, et al.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Lab Investig 2008; 88:694-721; PMID:18458673; http://dx.doi.org/10.1038/labinvest.2008.27[29] S /C19anchez-Carbayo M, Cordon-Cardo C. Applications of array technol- ogy: identi ﬁcation of molecular targets in bladder cancer.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Br J Cancer 2003; 89:2172-7; PMID:14676790; http://dx.doi.org/10.1038/sj.bjc.6601406 [30] Zabolotneva AA, Zhavoronkov A, Garazha A V, Roumiantsev SA, Buzdin AA.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Front Genet 2012; 3:310; PMID:23316212; http://dx.doi.org/10.3389/fgene.2012.00310 [31] Zabolotneva AA, Zhavoronkov AA, Shegay P V, Gaifullin NM, Alekseev BY, Roumiantsev SA, Garazha A V, Kovalchuk O, AravinA, Buzdin AA.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Front Genet 2013; 4:247; PMID:24298280; http://dx.doi.org/10.3389/fgene.2013.00247 [32] Zhavoronkov A, Buzdin AA, Garazha A V. Borisov NM, Moskalev AA.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Front Genet 2014; 5:49; PMID:24624136; http://dx.doi.org/10.3389/fgene.2014.00049 [33] Andreev DE, O ’Connor PB, Fahey C, Kenny EM, Terenin IM, Dmitriev SE, Cormican P, Morris DW, Shatsky IN, Baranov PV.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Elife 2015; 4:e03971; PMID:25621764; http://dx.doi.org/10.7554/eLife.03971 [34] Langmead B, Trapnell C, Pop M, Salzberg SL.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"Genome Biol 2009; 10:R25; PMID:19261174; http://dx.doi.org/10.1186/gb-2009-10-3-r25 [35] Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The Sequence Alignment/Map format andSAMtools.",OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
Bioinformatics 2009; 25:2078-9; PMID:19505943; http://dx.doi.org/10.1093/bioinformatics/btp352698 A. V. ARTCIBASOVA ET AL.,OADS,/arxiv_data1/oa_pdf/c3/c7/kccy-15-05-1147633.PMC4845938.pdf
"5, 699 –710 http://dx.doi.org/10.1080/15384101.2016.1148837",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Mol Cell 1998; 2:305-16; PMID:9774969; http://dx.doi.org/10.1016/S1097-2765(00)80275-0 [2] Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bon- danza S, Ponzin D, McKeon F, De Luca M. p63 identi ﬁes keratino- cyte stem cells.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cell 2007; 129:523-36; PMID:17482546; http://dx.doi.org/10.1016/j.cell.2007.02.045 [5] Keyes WM, Pecoraro M, Aranda V, Vernersson-Lindahl E, Li W, Vogel H, Guo X, Garcia EL, Michurina TV, Enikolopov G, et al.DNp63 ais an oncogene that targets chromatin remodeler lsh to drive skin stem cell proliferation and tumorigenesis.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cell Stem Cell 2011; 8:164-76; PMID:21295273; http://dx.doi.org/10.1016/j.stem.2010.12.009 [6] Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, et al.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"p63 is essential for regen- erative proliferation in limb, craniofacial and epithelial development.Nature 1999; 398:714-8; PMID:10227294; http://dx.doi.org/10.1038/19539 [7] Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis.Nature 1999; 398:708-13; PMID:10227293; http://dx.doi.org/ 10.1038/19531 [8] Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, New- bury-Ecob R, Hennekam RC, Van Buggenhout G, van Haeringen A,et al.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cell 1999; 99:143-53; PMID:10535733; http://dx.doi.org/10.1016/S0092-8674(00)81646-3 [9] Brunner HG, Hamel BC, Van Bokhoven H. The p63 gene in EEC and other syndromes.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
J Med Gen 2002; 39:377-81; PMID:12070241; http://dx.doi.org/10.1136/jmg.39.6.377 [10] Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas.,Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Nature 2015; 517:576- 82; PMID:25631445; http://dx.doi.org/10.1038/nature14129 [11] Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D. AIS is an oncogene ampli ﬁed in squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Mol Cell Biol 2005; 25:6077-89; PMID:15988020; http://dx.doi.org/10.1128/MCB.25.14.6077-6089.2005 [13] Kurata S, Okuyama T, Osada M, Watanabe T, Tomimori Y, Sato S, Iwai A, Tsuji T, Ikawa Y, Katoh I. p51/p63 Controls subunit alpha3 of the major epidermis integrin anchoring the stem cells to the niche.J Biol Chem 2004; 279:50069-77; PMID:15361520; http://dx.doi.org/10.1074/jbc.M406322200 [14] Koster MI, Dai D, Marinari B, Sano Y, Costanzo A, Karin M, Roop DR. p63 induces key target genes required for epidermal morpho-genesis.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Nat Cell Biol 2006; 8:551-61;PMID:16715076; http://dx.doi.org/10.1038/ncb1420 [16] Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, Tanaka T, Imai K, Nakamura Y, Tokino T. The p53 Family MemberGenes Are Involved in the Notch Signal Pathway.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
J Biol Chem 2002; 277:719-24; PMID:11641404; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"J Investig Dermatol 2005; 125:52-60; PMID:15982302; http://dx.doi.org/10.1111/j.0022-202X.2005.23801.x [18] Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Fed- erschneider JM, Peters R, McKeon FD, et al.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Gynecol Oncol 2001;80:24-9; PMID:11136565; http://dx.doi.org/10.1006/gyno.2000.5953[19] Massion PP, Ta ﬂan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP,et al.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
J Invest Dermatol 1999; 113:1099-105; PMID:10594758; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Oncogene 2015; PMID:26119942; http://dx.doi.org/10.1038/onc.2015.230 [24] Higashikawa K, Yoneda S, Tobiume K, Taki M, Shigeishi H, Kamata N. Snail-Induced Down-Regulation of {Delta}Np63{alpha} AcquiresInvasive Phenotype of Human Squamous Cell Carcinoma.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"CancerRes 2007; 67:9207-13; PMID:17909026; http://dx.doi.org/10.1158/ 0008-5472.CAN-07-0932 [25] Fukunishi N, Katoh I, Tomimori Y, Tsukinoki K, Hata R, Nakao A, Ikawa Y, Kurata S. Induction of DeltaNp63 by the newly identi ﬁed keratinocyte-speci ﬁc transforming growth factor beta Signaling Path- way with Smad2 and IkappaB Kinase alpha in squamous cell carci- noma.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Neoplasia 2010; 12:969-79; PMID:21170261; http://dx.doi.org/10.1593/neo.101054 [26] Barbieri CE, Tang LJ, Brown KA, Pietenpol JA.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cancer Res 2006; 66:7589-97; PMID:16885358; http://dx.doi.org/10.1158/0008-5472.CAN- 06-2020 [27] Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Oncogene 2006; 25:7531-7; PMID:17143297;http://dx.doi.org/10.1038/sj.onc.1210059 [28] Kan Z, Zheng H, Liu X, Li S, Barber TD, Gong Z, Gao H, Hao K, Willard MD, Xu J, et al.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Genome Res 2013; 23:1422-33; PMID:23788652; http://dx.doi.org/10.1101/ gr.154492.113 [29] Yeang C-H, McCormick F, Levine A. Combinatorial patterns of somatic gene mutations in cancer.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"FASEB J 2008; 22:2605-22; PMID:18434431; http://dx.doi.org/10.1096/fj.08-108985 [30] Patturajan M, Nomoto S, Sommer M, Fomenkov A, Hibi K, Zangen R, Poliak N, Califano J, Trink B, Ratovitski E, et al.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cancer Cell 2002; 1:369-79; PMID:12086851; http://dx.doi.org/10.1016/S1535- 6108(02)00057-0 [31] Drewelus I, Gopfert C, Hippel C, Dickmanns A, Damianitsch K, Pieler T, Dobbelstein M. p63 antagonizes Wnt-induced transcription.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cell Cycle (Georgetown, Tex) 2010; 9:580-87; PMID:20107313; http://dx.doi.org/10.4161/cc.9.3.10593 [32] Atcha FA, Syed A, Wu B, Hoverter NP, Yokoyama NN, Ting JH, Munguia JE, Mangalam HJ, Marsh JL, Waterman ML.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Mol Cell Biol 2007; 27:8352-63; PMID:17893322; http://dx.doi.org/10.1128/MCB.02132-06 [33] Perez CA, Pietenpol JA.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cell Cycle (Georgetown, Tex)2007; 6:246-54; PMID:17297308; http://dx.doi.org/10.4161/cc.6.3.3801 [34] Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
Nat Rev Mol Cell Biol 2008; 9:402-12;PMID:18431400; http://dx.doi.org/10.1038/nrm2395CELL CYCLE 709,Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Mol Biol Cell 2009; 20:870-81; PMID:19056683; http://dx.doi.org/10.1091/mbc.E08-07-0671 [38] Lim X, Tan SH, Koh WLC, Chau RMW, Yan KS, Kuo CJ, van Amer- ongen R, Klein AM, Nusse R. Interfollicular Epidermal Stem Cells Self-Renew via Autocrine Wnt Signaling.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Science 2013; 342:1226-30; PMID:24311688; http://dx.doi.org/10.1126/science.1239730 [39] Takeda K, Yasumoto K, Takada R, Takada S, Watanabe K, Udono T, Saito H, Takahashi K, Shibahara S. Induction of melanocyte-speci ﬁc microphthalmia-associated transcription factor by Wnt-3a.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"J Biol Chem 2000; 275:14013-6; PMID:10747853; http://dx.doi.org/10.1074/jbc.C000113200 [40] Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. b-Catenin Regu- lates the Expression of the Matrix Metalloproteinase-7 in HumanColorectal Cancer.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Am J Pathol 1999; 155:1033-8; PMID:10514384;http://dx.doi.org/10.1016/S0002-9440(10)65204-2 [41] Huang W, Chang HY, Fei T, Wu H, Chen YG.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN.Oncogene 2007; 26:2471-82; PMID:17043650; http://dx.doi.org/10.1038/sj.onc.1210033 [42] Lambertini E, Franceschetti T, Torreggiani E, Penolazzi L, Pastore A, Pelucchi S, Gambari R, Piva R. SLUG: a new target of lymphoidenhancer factor-1 in human osteoblasts.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"BMC Mol Biol 2010; 11:13; PMID:20128911; http://dx.doi.org/10.1186/1471-2199-11-13 [43] Patturajan M, Nomoto S, Sommer M, Fomenkov A, Hibi K, Zangen R, PoliakN,CalifanoJ, TrinkB, RatovitskiE,etal.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cancer Cell 2002; 1:369-79; PMID:12086851;http://dx.doi .org/10.1016/S1535-6108(02)00057-0 [44] el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Nat Genet 1992; 1:45-9;PMID:1301998; http://dx.doi.org/10.1038/ng0492-45 [45] Berglind H, Pawitan Y, Kato S, Ishioka C, Soussi T. Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell linecross-contamination.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Cancer Biol Ther 2008; 7:699-708; PMID:18277095; http://dx.doi.org/10.4161/cbt.7.5.5712 [46] Tomimori Y, Katoh I, Kurata S, Okuyama T, Kamiyama R, Ikawa Y. Evolutionarily conserved expression pattern and trans-regulatingactivity of Xenopus p51/p63.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
Biochem Biophys Res Commun 2004; 313:230-6; PMID:14684151; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Biochem Biophys Res Commun 2013; 431:274-9;PMID:23291185; http://dx.doi.org/10.1016/j.bbrc.2012.12.118 [48] Austinat M, Dunsch R, Wittekind C, Tannapfel A, Gebhardt R, Gaunitz F. Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellularcarcinoma.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Science 2008; 321:1086-8; PMID:18719284; http://dx.doi.org/10.1126/ science.1155546 [50] Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KWY.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Nat Genet 2009; 41:1068-75;PMID:19718027; http://dx.doi.org/10.1038/ng.431 [52] Hatzis P, van der Flier LG, van Driel MA, Guryev V, Nielsen F, Denissov S, Nijman IJ, Koster J, Santo EE, Welboren W, et al.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Mol Cell Biol 2008; 28:2732-44;PMID:18268006; http://dx.doi.org/10.1128/MCB.02175-07 [53] Bottomly D, Kyler SL, McWeeney SK, Yochum GS.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Nucl Acids Res 2010; 38:5735-45; PMID:20460455; http://dx.doi.org/ 10.1093/nar/gkq363 [54] Cadigan KM, Waterman ML.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Oncogene 2011; 30:4656-65; PMID:21643019; http://dx.doi.org/10.1038/ onc.2011.171 [56] Yamashita K, Azumano I, Mai M, Okada Y.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Int J Cancer 1998; 79:187-94; http://dx.doi.org/10.1002/(SICI)1097-0215(19980417)79:2%3c187::AID- IJC15%3e3.0.CO;2-7 [57] Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H. Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tis-sue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implica- tions and Clinical Signi ﬁcance for Invasion and Metastasis.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Clin Cancer Res 2006; 12:6998-7003; PMID:17145820; http://dx.doi.org/10.1158/1078-0432.CCR-06-1626 [58] Jho E-H, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F. Wnt/b-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway.",Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"Mol Cell Biol 2002;22:1172-83; PMID:11809808; http://dx.doi.org/10.1128/ MCB.22.4.1172-1183.2002 [59] Wu Z-Q, Brabletz T, Fearon E, Willis AL, Hu CY, Li X-Y, Weiss SJ.",OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
The Latency-associated nuclear anti- gen of kaposi ’s sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3 b. J Virol 2003; 77:8019-30; PMID:12829841; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/65/kccy-15-05-1148837.PMC4845946.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/93/af/pgpm-9-031.PMC4846041.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Potential utility of precision medicine for older  adults with polypharmacy: a case series study Joseph Finkelstein1 Carol Friedman1 George Hripcsak1 Manuel Cabrera2 1Department of Biomedical  Informatics, 2Department of Medicine,   Columbia University, New Y ork, NY,   USA Correspondence: Joseph Finkelstein   622 West 168th Street, PH-20,  Room 401A, New Y ork, NY 10032, USA   T el +1 917 477 3909   Email jf193@cumc.columbia.ed uAbstract:  Pharmacogenomic (PGx) testing has been increasingly used to optimize drug  regimens; however, its potential in older adults with polypharmacy has not been systemati - cally studied.",Non-OADS,/arxiv_data1/oa_pdf/93/af/pgpm-9-031.PMC4846041.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/93/af/pgpm-9-031.PMC4846041.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/93/af/pgpm-9-031.PMC4846041.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b3/5b/copd-11-809.PMC4846042.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 809–822International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  809RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S9607 9Do telemedical interventions improve quality of  life in patients with COPD?",Non-OADS,/arxiv_data1/oa_pdf/b3/5b/copd-11-809.PMC4846042.pdf
"Applying these technologies to patients with COPD has Correspondence: Charlotte Suppli Ulrik Department of Pulmonary Medicine,   Hvidovre Hospital, Kettegård Alle 30,  DK-2650 Hvidovre, Denmark email csulrik@dadlnet.d k Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Gregersen et al Running head recto: Telehealth care and quality of life in COPD DOI: http://dx.doi.org/10.2147/COPD.S96079",Non-OADS,/arxiv_data1/oa_pdf/b3/5b/copd-11-809.PMC4846042.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b3/5b/copd-11-809.PMC4846042.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/5b/copd-11-809.PMC4846042.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/b7/idr-9-047.PMC4846043.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Daptomycin: an evidence-based review of its role  in the treatment of Gram-positive infections Armando Gonzalez-Ruiz1 R Andrew Seaton2 Kamal Hamed3 1Darent Valley Hospital, Dartford,   UK; 2Queen Elizabeth University  Hospital, Glasgow, UK; 3Novartis  Pharmaceuticals Corporation, East  Hanover, NJ, USA Correspondence: Kamal Hamed   Novartis Pharmaceuticals Corporation,  1 Health Plaza, East Hanover, NJ 07936,  USA  T el +1 862 778 4780   Fax +1 973 781 5987   Email kamal.hamed@novartis.co mAbstract:  Infections caused by Gram-positive pathogens remain a major public health burden  and are associated with high morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/ff/b7/idr-9-047.PMC4846043.pdf
Available from: http://www.who.int/drugresistance/documents/ surveillancereport /en/.,OADS,/arxiv_data1/oa_pdf/ff/b7/idr-9-047.PMC4846043.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/ff/b7/idr-9-047.PMC4846043.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/b7/idr-9-047.PMC4846043.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/92/43/ott-9-2287.PMC4846044.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2287–2295OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2287Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9758 3clinicopathological characteristics of patients  with HER2-positive breast cancer and the efficacy  of trastuzumab in the People’s republic of china Ping Zhou1–3 Yi-Zhou Jiang4 Xin hu4 Wei sun4 Yi-rong liu4 Fang liu5 rong-cheng luo1,* Zhi-Ming shao4,* 1Department of Oncology, TcM- integrated cancer center of southern  Medical University, southern Medical  University, guangzhou, guangdong,   2Department of Breast surgery, The  Third hospital of nanchang, 3Jiangxi  Provincial Key laboratory for Breast  Diseases, Jiangxi, 4Department  of Breast surgery, Fudan University  shanghai cancer center/ cancer  institute, shanghai, 5Department  of Pathophysiology, Foshan University,   guangdong, People’s republic  of china *These authors contributed equally  to this workObjective:  The aim of this study was to describe the clinical features and outcomes of Chinese  patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/92/43/ott-9-2287.PMC4846044.pdf
"Keywords:  breast cancer, trastuzumab, HER2,  disease-free survival, chemotherapy Introduction Amplification of the human epidermal growth factor receptor 2 (HER2) is observed  in 15%–20% of all the patients with breast cancer.1,2 In the era prior to the availabil - ity of HER2-directed therapy, patients with HER2-positive (HER2 +) breast cancer  were observed to have more aggressive disease, poorer prognosis, and shorter overall  survival (OS) than patients with other subtypes of breast cancer.3,4 In 1998, trastu - zumab was approved for use, either alone or in combination with chemotherapy, for  the treatment of metastatic HER2 + disease based on the results of a pivotal study  conducted by Slamon et al.5,6 Trastuzumab, the first biological agent developed and  approved for use in breast cancer, is a humanized monoclonal antibody against HER2  that has been shown to improve disease-free survival (DFS) after chemotherapy in correspondence: rong-cheng luo Department of Oncology, TcM- integrated cancer center of southern  Medical University, 13 shi liugang road,  guangzhou, guangdong 510315, People’s  republic of china Tel +86 20 6165 0001 Fax +86 20 6165 0009 email luorc01@163.co m  Zhi-Ming shao Department of Breast surgery, Fudan  University shanghai cancer center/ cancer institute, 270 Dong-an road,  shanghai 200032, People’s republic of  china Tel +86 21 6417 5590 Fax +86 21 6443 8653 email zhiminqshao@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original research Y ear: 2016 Volume: 9 Running head verso: Zhou et al Running head recto: Clinicopathological characteristics of patients with HER2 + breast cancer DOI: http://dx.doi.org/10.2147/OTT.S97583",Non-OADS,/arxiv_data1/oa_pdf/92/43/ott-9-2287.PMC4846044.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/92/43/ott-9-2287.PMC4846044.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/43/ott-9-2287.PMC4846044.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/53/fc/copd-11-799.PMC4846045.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 799–807International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  799OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10237 5high-dose oral N-acetylcysteine fails to improve  respiratory health status in patients with chronic  obstructive pulmonary disease and chronic  bronchitis: a randomized, placebo-controlled trial Kara Johnson1,2 Charlene e Mcevoy3 sakina naqvi1,4 Chris Wendt1 ronald a reilkoff4,5 Ken M Kunisaki1 erin e Wetherbee1 David nelson6 rabindra Tirouvanziam7 Dennis e niewoehner1 1Pulmonary section, Minneapolis V a  health Care system, Minneapolis,   Mn, 2sanford health, Fargo, nD,   3Pulmonary section, healthPartners  research Foundation, st Paul,   4healtheast Maplewood Clinic,   Maplewood, 5Pulmonary section,   University of Minnesota Medical  Center, 6Center for Chronic Disease  Outcomes research, Minneapolis  Va health Care system, Minneapolis,   Mn, 7Center for Cystic Fibrosis and  airways Disease research, emory  University school of Medicine,   atlanta, ga, UsaBackground:  Clinical outcomes are worse in patients with COPD and chronic bronchitis.",Non-OADS,/arxiv_data1/oa_pdf/53/fc/copd-11-799.PMC4846045.pdf
"In the majority of patients, these classes  of drugs fail to confer improvements in the St George’s Respiratory Questionnaire  (SGRQ) that are considered clinically significant.2,3 Chronic bronchitis, traditionally defined as chronic cough and phlegm for at least  3 months a year for at least two consecutive years, is common among patients with Correspondence: Dennis e niewoehner Pulmonary section (111n), Minneapolis  Va health Care system, 1 Veterans  Drive, Minneapolis, Mn 55417, Usa Tel +1 612 467 4412 Fax +1 612 727 5634 email niewo001@umn.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Johnson et al Running head recto: Oral N-acetylcysteine for patients with COPD and chronic bronchitis DOI: http://dx.doi.org/10.2147/COPD.S102375",Non-OADS,/arxiv_data1/oa_pdf/53/fc/copd-11-799.PMC4846045.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/53/fc/copd-11-799.PMC4846045.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/53/fc/copd-11-799.PMC4846045.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/f1/ijgm-9-089.PMC4846046.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of General Medicine 2016:9 89–97International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  89OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S9240 4association between sarcopenia and quality of life  in quilombola elderly in Brazil   luiz sinésio silva neto1–3 Margô GO Karnikowski2 neila B Osório3 leonardo c Pereira2 Marcilio B Mendes1 Dayani Galato2 liana B Gomide Matheus4 João Paulo c Matheus2,4 1school of Medicine, Federal  University of T ocantins, Palmas,   T ocantins, 2Graduate Program in  health sciences and T echnology,   ceilândia college, University of  Brasilia, Federal District, 3Graduate  Program in education, Federal  University of T ocantins, Palmas,   T ocantins, 4school of Physiotherapy,   ceilândia college, University of  Brasília, Federal District, Brazil correspondence: luiz sinésio silva neto   school of Medicine, Federal University of  T ocantins/University of Maturidade,   109 norte, avenida ns 15 alcnO 14,  Bloco IV, University campus,   ceP 77001-090, Palmas, T ocantins, Brazil   T el +55 63 3232 8253   Fax +55 63 3232 8070   email luizneto@uft.edu.b rIntroduction:  Currently, there is no single consensual definition of sarcopenia in the literature.",Non-OADS,/arxiv_data1/oa_pdf/63/f1/ijgm-9-089.PMC4846046.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/63/f1/ijgm-9-089.PMC4846046.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/f1/ijgm-9-089.PMC4846046.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Prescription omega-3 fatty acid products:  considerations for patients with diabetes mellitus Nadeem Tajuddin1 Ali Shaikh2 Amir Hassan2 1Department of Internal Medicine,   Baylor College of Medicine, Houston,   TX, USA; 2Clinic of Endocrinology,   Houston, TX, USA Correspondence: Nadeem Tajuddin   Department of Internal Medicine, Baylor  College of Medicine, One Baylor Plaza,  Houston, TX 77030, USA   T el +1 281 922 4000   Fax +1 281 922 4242   Email nadeem.tajuddin@bcm.ed uAbstract:  Type 2 diabetes mellitus (T2DM) and metabolic syndrome contribute to hypertri­ glyceridemia, which may increase residual risk of cardiovascular disease in patients with elevated  triglyceride (TG) levels despite optimal low ­density lipoprotein cholesterol (LDL ­C) levels with  statin therapy.",Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
"Available from:  http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204977Orig1s000MedR.pd f. Accessed March 2, 2016.65 Abbreviations:  Apo B, apolipoprotein B; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein  cholesterol; TC, total cholesterol; TG, triglyceride; VLDL-C, very-low-density lipoprotein cholesterol.",Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
"Available from: http://health.gov/dietsupp/ch1.ht m. Accessed  March 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ nda/2014/204977Orig1s000MedR.pd f. Accessed March 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT001352 26?term=00135226&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
Available from: http://clinicaltrials.gov/ct2/show/   NCT02104817?term =strength+and+omega­3&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
Available from: http://clinicaltrials.gov/show/ NCT0149236 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer ­reviewed open ­access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/c5/dmso-9-109.PMC4846047.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dd/5a/ott-9-2181.PMC4846049.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2181–2192OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2181Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9476 1association between two interleukin-2  gene  polymorphisms and cancer susceptibility:  a meta-analysis Meng Zhang1,2,* Xiuxiu Tan1,* Junjie huang3,* lijuan Xie1 hao Wang1 Jizhou shi4 Wei lu1 Zhaojie lv1 hongbing Mei1 chaozhao liang2 1Department of Urology, shenzhen  second People’s hospital, clinical  Medicine of anhui Medical University,   2Department of Urology, the First  affiliated hospital of anhui Medical  University, hefei, 3Department  of hematology, shenzhen second  People’s hospital, the First affiliated  hospital of shenzhen University,   shenzhen, 4Department of Urology,   shengli Oilfield central hospital,   Dongying, Peoples republic of china *These authors contributed equally  to this workBackground:  Several epidemiological studies have illustrated that polymorphisms in  interleukin-2  (IL-2) were associated with diverse cancer types.",Non-OADS,/arxiv_data1/oa_pdf/dd/5a/ott-9-2181.PMC4846049.pdf
"IL-2 is an immunoregulatory cytokine produced by T helper type 1 cells when  they are stimulated by mitogens, antigens, or major histocompatibility complexes chaozhao liang Department of Urology, the First  Affiliated Hospital of AnhuiMedical  University, hefei, People’s republic of  china Tel +86 551 6292 3861;  email liang_chaozhao@163.co m  Zhaojie lv Department of Urology, shenzhen  second People’s hospital, clinical  Medicine of anhui Medical University,  shenzhen, People’s republic of china Tel +86 159 2000 6559 email 794225924@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Association between two polymorphisms of IL-2 gene DOI: http://dx.doi.org/10.2147/OTT.S94761",Non-OADS,/arxiv_data1/oa_pdf/dd/5a/ott-9-2181.PMC4846049.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/dd/5a/ott-9-2181.PMC4846049.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/5a/ott-9-2181.PMC4846049.pdf
Available from: http://www.ohri.ca/programs/ clinical_epidemiology/oxford.htm.,Non-OADS,/arxiv_data1/oa_pdf/dd/5a/ott-9-2181.PMC4846049.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/06/ott-9-2247.PMC4846051.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2247–2254OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2247Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10317 9esophageal cancer stem cells and implications  for future therapeutics Xia Qian* Cheng Tan* Feng wang* Baixia Yang Yangyang Ge Zhifeng Guan Jing Cai Department of Radiation Oncology,   Nantong Tumor Hospital, Affiliated  Tumor Hospital of Nantong  University, Nantong, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Esophageal carcinoma (EC) is a lethal disease with high morbidity and mortality  worldwide, and the incidence has been increasing in recent years.",Non-OADS,/arxiv_data1/oa_pdf/65/06/ott-9-2247.PMC4846051.pdf
"Recent studies have shown that many solid tumors contain a cell  subpopulation known as cancer stem cells (CSCs).5,6 CSCs, which are present in many  cancers, are thought to lead to aggressive tumor behavior and have exceedingly high Correspondence: Jing Cai Department of Radiation Oncology,  Nantong Tumor Hospital, Affiliated  Tumor Hospital of Nantong University,  Tong Yang Road, No 30, Nantong  226321, People’s Republic of China Tel +86 137 0629 9417 Fax +86 513 8657 1201 email cj7227@sina.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Qian et al Running head recto: ECSCs and implications for future therapeutics DOI: http://dx.doi.org/10.2147/OTT.S103179",Non-OADS,/arxiv_data1/oa_pdf/65/06/ott-9-2247.PMC4846051.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/65/06/ott-9-2247.PMC4846051.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/06/ott-9-2247.PMC4846051.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/ott-9-2203.PMC4846052.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2203–2209OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2203Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10376 3short- and long-term outcomes of laparoscopic  surgery vs open surgery for transverse colon  cancer: a retrospective multicenter study Jong Wan Kim1 Jeong Yeon Kim1 Byung Mo Kang2 Bong hwa lee3 Byung chun Kim4 Jun ho Park5 1Department of surgery, Dongtan  sacred heart hospital, college  of Medicine, hallym University,   hwaseong si, 2Department of  surgery, chuncheon sacred heart  hospital, college of Medicine,   hallym University, chuncheon si,   3Department of surgery, hallym  sacred heart hospital, college of  Medicine, hallym University, anyang si,   4Department of surgery, Kangnam  sacred heart hospital, college of  Medicine, hallym University, seoul,   5Department of surgery, Kangdong  sacred heart hospital, college of  Medicine, hallym University, seoul,   republic of KoreaPurpose:  The purpose of the present study was to compare the perioperative and oncologic  outcomes between laparoscopic surgery and open surgery for transverse colon cancer.",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/ott-9-2203.PMC4846052.pdf
"Keywords:  transverse colon, colon cancer, laparoscopic surgery Introduction Laparoscopic colon surgery was first introduced in 1991, and laparoscopic surgery is  now widely performed for resecting colorectal cancer.1 A Cochrane review showed that  laparoscopic surgery was associated with similar oncologic outcomes and short-term  benefits, including shorter hospital stay, less postoperative pain, improved cosmesis,  and an earlier return to normal activity, as compared with open surgery.2,3 However, previous randomized controlled trials excluded patients with transverse  colon cancer because the surgical procedures used were dependent on the cancer  location, the variable anatomy of the middle colic vessels, which demand excellent  surgical skills, and the anatomical location of the transverse colon relative to major  organs, especially the pancreas, spleen, and duodenum.4–12 In recent years, with accumulating experience of performing laparoscopic surgery,  several studies have evaluated the safety and feasibility of laparoscopic resection of  transverse colon cancer.13–19 However, the results of these studies should be interpreted correspondence: Jun ho Park Department of surgery, Kangdong sacred  heart hospital, college of Medicine,  hallym University, 150 seongan-ro, 445  gil-1-dong, gangdong-gu, 134-701 seoul,  republic of Korea Tel +82 2 2224 2222 Fax +82 2 2224 1655 email zooono@hanmail.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Kim et al Running head recto: Laparoscopic surgery for transverse colon cancer DOI: http://dx.doi.org/10.2147/OTT.S103763",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/ott-9-2203.PMC4846052.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/ott-9-2203.PMC4846052.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/ott-9-2203.PMC4846052.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/copd-11-831.PMC4846053.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 831–838International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  831OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10310 5Prevention of COPD exacerbation by lysozyme:  a double-blind, randomized, placebo-controlled  study Y oshinosuke Fukuchi1 Koichiro Tatsumi2 hiromasa Inoue3 Yukinori sakata4 Kai shibata4 hideaki Miyagishi4 Yasuhiro Marukawa4 Masakazu Ichinose5 1Department of respiratory  Medicine, graduate school of  Medicine, Juntendo University, T okyo,   2Department of respirology, graduate  school of Medicine, Chiba University,   Chiba, 3Department of Pulmonary  Medicine, graduate school of Medical  and Dental sciences, Kagoshima  University, Kagoshima, 4eisai Co., ltd.,   T okyo, 5Department of respiratory  Medicine, Tohoku University graduate  school of Medicine, sendai, JapanBackground/aim:  Lysozyme (mucopeptide N-acetyl-muramyl hydrolase) is widely used as a  mucolytic and anti-inflammatory agent in Japan.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/copd-11-831.PMC4846053.pdf
"The causes of COPD exacerbation are worsening of airway inflammation and  increased sputum production.1 Moreover, the decline over time in airway obstruction  is higher in COPD patients with mucus hypersecretion than in those without it.2 Thus,  control of sputum production may be assumed to contribute to both resolution of  pathological conditions and prevention of exacerbation in patients with COPD.Correspondence: Yoshinosuke Fukuchi CrD laboratory, Department  of respiratory Medicine, graduate  school of Medicine, Juntendo University,  asakaze Bldg 9F, 2-9-8 hongo,  Bunkyo-ku, Tokyo, Japan Tel/fax +81 3 3812 8473 email yfukuchi@tea.ocn.ne.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Fukuchi et al Running head recto: Lysozyme for COPD DOI: http://dx.doi.org/10.2147/COPD.S103105",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/copd-11-831.PMC4846053.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6d/e4/copd-11-831.PMC4846053.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/e4/copd-11-831.PMC4846053.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/d1/ott-9-2305.PMC4846054.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2305–2315OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2305Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10185 3Microrna-145-5p inhibits gastric cancer  invasiveness through targeting n-cadherin and  ZeB2 to suppress epithelial–mesenchymal transition shi-Bin Jiang1,2,* Xu-Jun he1,3,* Ying-Jie Xia1,3 Wei-Jian hu2 Jun-gang luo1,2 Jun Zhang2,3 hou-Quan Tao1–3 1Department of surgery, Zhejiang  Provincial People’s hospital,   hangzhou, 2Wenzhou Medical  University, Wenzhou, 3Key laboratory  of gastroenterology of Zhejiang  Province, Zhejiang Provincial People’s  hospital, hangzhou, Zhejiang, People’s  republic of china *These authors contributed equally  to this workAbstract:  MicroRNA (miR)-145-5p has been reported to function as a suppressor of cancer and  plays an important role in cancer invasiveness.",Non-OADS,/arxiv_data1/oa_pdf/76/d1/ott-9-2305.PMC4846054.pdf
"MicroRNAs (miRs) are small noncoding RNAs, which act as posttranscriptional  regulators of gene expression during tumor development and carcinogenesis.4,5  A series of studies have shown that numerous miRs influence the capacity for invasion,  migration, and proliferation of cancer cells in GC.5,6 miR-145-5p has been reported as  a tumor suppressor in several types of tumors, such as colon,7,8 breast,9 and prostate  cancers.10 Furthermore, previous studies have shown that miR-145-5p is downregu - lated in GC and may function as a suppressor gene.11 However, the mechanisms by  which miR-145-5p inhibits GC, especially by suppressing epithelial–mesenchymal correspondence: Jun Zhang Key laboratory of gastroenterology of  Zhejiang Province, Zhejiang Provincial  People’s hospital, 158 shangtang road,  hangzhou 310014, Zhejiang, People’s  republic of china Tel +86 571 8589 3781 Fax +86 571 8513 1448 email 19587372@qq.co m  hou-Quan Tao Department of surgery, Zhejiang  Provincial People’s hospital, Zhejiang  Provincial People’s hospital, 158  shangtang road, hangzhou 310014,  Zhejiang, People’s republic of china Tel +86 571 8589 3781 Fax +86 571 8513 1448 email taohouquan2008@aliyun.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jiang et al Running head recto: miR-145-5p in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S101853",Non-OADS,/arxiv_data1/oa_pdf/76/d1/ott-9-2305.PMC4846054.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/76/d1/ott-9-2305.PMC4846054.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/d1/ott-9-2305.PMC4846054.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/8b/idr-9-059.PMC4846055.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Species-based comparison of disease severity and  risk factors for disseminated Candida  infections in  pediatric patients John J Hawkshead III1 Russell B Van Dyke2 Susan E Hassig3 Larry S Webber4 Rodolfo E Begue5 1Merck & Co, CORE Hospital  Specialty Group, Rahway, NJ,   2Department of Pediatrics, Tulane  University School of Medicine,   3Department of Epidemiology,   4Department of Biostatistics, T ulane  University School of Public Health  and Tropical Medicine, 5Department of  Pediatrics, Louisiana State University  Health Sciences Center, New Orleans,   LA, USA Correspondence: John J Hawkshead III   Merck & Co, CORE Hospital Specialty  Group, 126 East Lincoln Avenue, Mail stop  RY -32-211 Rahway, NJ 07065, USA   T el +1 732 594 2506   Email john.hawkshead.iii@merck.co m    Susan E Hassig   Department of Epidemiology, T ulane  University School of Public Health and  Tropical Medicine, New Orleans, LA, USA   T el +1 504 988 6454   Email shassig@tulane.ed uBackground:  Pediatric Candida  infections are associated with worse clinical outcomes and  increased costs.",Non-OADS,/arxiv_data1/oa_pdf/75/8b/idr-9-059.PMC4846055.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/75/8b/idr-9-059.PMC4846055.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/8b/idr-9-059.PMC4846055.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/71/ott-9-2237.PMC4846057.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2237–2245OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2237Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10095 2The important tumor suppressor role of PER1  in regulating the cyclin–cDK–cKi network in  scc15 human oral squamous cell carcinoma cells Xiao-Juan Fu han-Xue li Kai Yang Dan chen hong Tang Department of Oral and Maxillofacial  surgery, The First affiliated hospital  of chongqing Medical University,   chongqing, People’s republic of chinaBackground:  Accumulating evidence suggests that the abnormal expression of the circadian  clock gene PER1  is closely related to the development and progression of cancer.",Non-OADS,/arxiv_data1/oa_pdf/37/71/ott-9-2237.PMC4846057.pdf
"The periodic expression of intracellular circadian clock genes is responsible for  circadian rhythms.1–3,5 To date, 14 circadian clock genes have been reported, including  PER1 , PER2 , PER3 , CRY1 , CRY2 , CLOCK , BMAL1 , TIM, CK1ε, NPAS2 , REV -ERBs , correspondence: Kai Yang Department of Oral and Maxillofacial  Surgery, The First Affiliated Hospital of  chongqing Medical University, no 1,  Youyi road, Yuzhong District, chongqing  400016, People’s republic of china Tel/fax +86 23 8901 2569 email cqfyyk@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Fu et al Running head recto: PER1  plays an important inhibitor in OSCC DOI: http://dx.doi.org/10.2147/OTT.S100952",Non-OADS,/arxiv_data1/oa_pdf/37/71/ott-9-2237.PMC4846057.pdf
"Plasmid construction and identification Based on the mRNA sequence of the human PER1  gene  (GeneID: NM_002616) in the GenBank database ( http:// www.ncbi.nlm.nih.gov/genbank /) and siRNA design  principles,24 RNA interference target sequences in the PER1   gene were selected, and a BLAST genome homology analysis  was performed ( http://www.ncbi.nlm.nih.gov/BLAST /).",OADS,/arxiv_data1/oa_pdf/37/71/ott-9-2237.PMC4846057.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/37/71/ott-9-2237.PMC4846057.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/71/ott-9-2237.PMC4846057.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/3f/jir-9-039.PMC4846058.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Inflammation Research 2016:9 39–50submit your manuscript | www.dovepress.co m Dove press  39 http: //dx.doi.org/10.2147/JIR.S10094 0Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/2f/3f/jir-9-039.PMC4846058.pdf
"Or use: http://youtu.be/efVJFLs-s8 gGeneration and characterization of ixekizumab,   a humanized monoclonal antibody that   neutralizes interleukin-17A ling liu1 Jirong lu1 Barrett W allan2 Ying Tang2 Jonathan T etreault1 Chi-kin Chow1 Barbra Barmettler2 James Nelson2 Holly Bina1 Lihua Huang3 Victor J Wroblewski4 Kristine Kikly1 1Biotechnology Discovery Research,   Indianapolis, IN, 2applied Molecular  Evolution, Lilly Biotechnology Center,   San Diego, CA, 3Bioproduct Research  and Development, 4Drug Disposition,   Lilly Research Laboratories, Eli Lilly and  Company, Indianapolis, IN, USA Correspondence: Ling Liu   Biotechnology Discovery Research, Lilly  Research Laboratories, Lilly Corporate  Center, Drop Code 0444, Eli Lilly and  Company, Indianapolis, IN 46285, USA   T el +1 317 276 9312   Fax +1 317 277 2934   Email Liu_Ling@Lilly.co mAbstract:  Interleukin (IL)-17A exists as a homodimer (A/A) or as a heterodimer (A/F) with  IL-17F .",Non-OADS,/arxiv_data1/oa_pdf/2f/3f/jir-9-039.PMC4846058.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/2f/3f/jir-9-039.PMC4846058.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/3f/jir-9-039.PMC4846058.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/fc/ott-9-2297.PMC4846059.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2297–2304OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2297Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9887 5carvacrol suppresses proliferation and invasion  in human oral squamous cell carcinoma Wei Dai1,2 changfu sun1,2 shaohui huang1,2 Qing Zhou1,2 1Department of Oromaxillofacial- head and neck surgery, 2Department  of Oral and Maxillofacial surgery,   school of stomatology, china Medical  University, shenyang, liaoning,   People’s republic of chinaAbstract:  Carvacrol, a component of thyme oil, as a novel antitumor agent, has been implicated  in several types of cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/76/fc/ott-9-2297.PMC4846059.pdf
"The enzyme Cox2 is only  produced during inﬂammation, cell proliferation, and differentiation.21 Studies demon - strated that the decreased expression of Cox2 in cancer cell lines induced cancer cell correspondence: Wei Dai Department of Oromaxillofacial-head  and neck surgery, school of  stomatology, china Medical University,  no 117 nanjing north street, heping  District, shenyang 110002, liaoning,  People’s republic of china email cmudaiwei@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Dai et al Running head recto: Carvacrol suppresses proliferation DOI: http://dx.doi.org/10.2147/OTT.S98875",Non-OADS,/arxiv_data1/oa_pdf/76/fc/ott-9-2297.PMC4846059.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/76/fc/ott-9-2297.PMC4846059.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/fc/ott-9-2297.PMC4846059.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c1/46/ott-9-2365.PMC4846061.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2365–2375OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2365Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10058 1Vitamin D postpones the progression of epithelial  ovarian cancer induced by 7, 12-dimethylbenz [a]  anthracene both in vitro and in vivo lizhi liu1,* Zhiyong hu2,* hemei Zhang3 Y ongfeng hou1 Zengli Zhang4 guangming Zhou5 Bingyan li1,5 1school of Public health, Medical  college of soochow University,   suzhou, 2Department of chronic  Disease Management, lishui center  for Disease control and Prevention,   lishui, 3Department of chronic  Disease Management, Wenzhou  center for Disease control and  Prevention, Wenzhou, 4Department  of labor hygiene and environmental  health, school of Public health,   soochow University, suzhou, 5school  of radiation Medicine and Protection,   soochow University, suzhou, People’s  republic of china *These authors contributed equally  to this workPurpose:  Ovarian cancer is the most lethal malignancy of the female reproductive system, and  the prevention and treatment of ovarian carcinoma are still far from optimal.",Non-OADS,/arxiv_data1/oa_pdf/c1/46/ott-9-2365.PMC4846061.pdf
"Moreover,  there has been little change to the 5-year cumulative survival rate for epithelial ovar - ian carcinoma (EOC) since platinum-based treatment was universally introduced  more than 30 years ago.2 As a result of chemosensitivity in the treatment of patients correspondence: Bingyan li Medical college of soochow University,  199 ren’ai road, suzhou industrial  Park, suzhou 215123, People’s  republic of china Tel +86 512 6588 2636 Fax +86 512 6588 0070 email bingyanli@suda.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Vitamin D postpones the progression of epithelial ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S100581",Non-OADS,/arxiv_data1/oa_pdf/c1/46/ott-9-2365.PMC4846061.pdf
Available from: http://globocan.iarc.,Non-OADS,/arxiv_data1/oa_pdf/c1/46/ott-9-2365.PMC4846061.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c1/46/ott-9-2365.PMC4846061.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/46/ott-9-2365.PMC4846061.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/59/ijnrd-9-105.PMC4846062.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nephrology and Renovascular Disease 2016:9 105–109International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  105Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJNRD.S10225 7Angioplasty of forearm arteries as a finger salvage  procedure for patient with end-stage renal failure Yuk Law Yiu Che Chan stephen Wing-Keung Cheng Division of Vascular and endovascular  surgery, Department of surgery,   University of Hong Kong Medical  Centre, Queen Mary Hospital, Hong  Kong Correspondence: Yiu Che Chan   Division of Vascular and endovascular  surgery, Department of surgery,  University of Hong Kong Medical Centre,  south Wing, 14th Floor K Block, Queen  Mary Hospital, p okfulam Road, Hong  Kong  tel +852 2255 4962   Fax +852 2255 4961   email ycchan88@hkucc.hku.h kAbstract:  Due to the relatively low metabolic demand and extensive collaterals of the upper  limb, peripheral arterial disease seldom leads to tissue loss, except in patients with end-stage  renal failure (ESRF), rheumatologic diseases, Raynaud’ s disease, frostbites, or distal emboli.",Non-OADS,/arxiv_data1/oa_pdf/1a/59/ijnrd-9-105.PMC4846062.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/1a/59/ijnrd-9-105.PMC4846062.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/59/ijnrd-9-105.PMC4846062.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/a7/ott-9-2329.PMC4846063.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2329–2335OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2329Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9766 8comparison of KRAS and PIK3CA  gene status  between primary tumors and paired metastases  in colorectal cancer Qiong he1 Qi Xu1 Wei Wu1 lei chen1 Weijing sun2 Jieer Ying1 1Department of chemotherapy,   Zhejiang cancer hospital, hangzhou,   People’s republic of china;   2Department of gastrointestinal  Medical Oncology, school of Medicine,   University of Pittsburgh, Pittsburgh,   Pa, UsaPurpose:  In metastatic or recurrent colorectal cancer (MRCRC), the concordance of Kirsten rat  sarcoma viral oncogene homolog ( KRAS ) and phosphatidylinositol-4,5-bisphosphate 3-kinase  catalytic subunit alpha ( PIK3CA ) mutation status between the primary tumors and metastases is  still controversial.",Non-OADS,/arxiv_data1/oa_pdf/04/a7/ott-9-2329.PMC4846063.pdf
"As for approximately  60%–70% Kirsten rat sarcoma viral oncogene homolog ( KRAS ) wild-type MRCRC,  anti-epidermal growth factor receptor (anti-EGFR) inhibitors, such as cetuximab and correspondence: Jieer Ying Department of chemotherapy,  Zhejiang cancer hospital,   38 guangji road, hangzhou, 310022,  People’s republic of china Tel +86 571 138 5819 5803 Fax +86 571 8812 2012 email jieerying@aliyun.co m  Weijing sun Department of gastrointestinal  Medical Oncology, school of Medicine,  University of Pittsburgh, 1218 scaife  hall, 3550 Terrace street, Pittsburgh,  Pa 15261, Usa email sunw@upmc.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: He et al Running head recto: Comparison of KRAS  and PIK3CA  in colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S97668",Non-OADS,/arxiv_data1/oa_pdf/04/a7/ott-9-2329.PMC4846063.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/04/a7/ott-9-2329.PMC4846063.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/a7/ott-9-2329.PMC4846063.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/c5/ijwh-8-119.PMC4846064.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 119–123International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  119CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S10032 1Escalating placenta invasiveness: repeated placenta  accreta at the limit of viability Shirley Greenbaum1 Alla Khashper2 Elad Leron1 Eric Ohana1 Mihai Meirovitz1 Reli Hershkovitz1 Offer Erez1 1Department of Obstetrics and  Gynecology, 2Department of  Radiology, Soroka University Medical  Center, School of Medicine, Ben- Gurion University of the Negev,    Be’er Sheva, IsraelAbstract:  Placenta percreta is an obstetric condition in which the placenta invades through the  myometrium.",Non-OADS,/arxiv_data1/oa_pdf/95/c5/ijwh-8-119.PMC4846064.pdf
"Understanding the processes that influence the timing and  location of this life-threatening complication may set the basis for better diagnosis  and management protocols.Correspondence: Offer Erez Department of Obstetrics and  Gynecology, Soroka University  Medical Center, School of Medicine,   Ben-Gurion University of the Negev,  Rager Boulevard, POB 151, Be’er  Sheva 85025, Israel Tel +972 52 228 8800 Email erezof@bgu.ac.i l Journal name: International Journal of Women’s Health Article Designation: CASE REPORT Y ear: 2016 Volume: 8 Running head verso: Greenbaum et al Running head recto: Escalating placenta invasiveness DOI: http://dx.doi.org/10.2147/IJWH.S100321",Non-OADS,/arxiv_data1/oa_pdf/95/c5/ijwh-8-119.PMC4846064.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/95/c5/ijwh-8-119.PMC4846064.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/c5/ijwh-8-119.PMC4846064.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/13/ott-9-2349.PMC4846065.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2349–2358OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2349Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10161 5Massive chest wall resection and reconstruction  for malignant disease christophoros n Foroulis1 athanassios D Kleontas1 george Tagarakis1 chryssoula nana1 ioannis alexiou1 Vasilis grosomanidis1 Paschalis T ossios1 elena Papadaki2 ioannis Kioumis2 sofia Baka3 Paul Zarogoulidis2 Kyriakos anastasiadis1 1Department of cardiothoracic  surgery, aristotle University school of  Medicine, aheP a University hospital,   2Pulmonary Department-Oncology  Unit, “ g. Papanikolaou” general  hospital, aristotle University of  Thessaloniki, 3Oncology Department,   european interbalkan Medical center,   Thessaloniki, greeceObjective:  Malignant chest wall tumors are rare neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/ae/13/ott-9-2349.PMC4846065.pdf
"Papanikolaou” general hospital,  aristotle University of Thessaloniki,  exohi 1100, Thessaloniki 57010, greece Tel +30 69 7727 1974 Fax +30 2310 99 2424 email pzarog@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Foroulis et al Running head recto: Massive chest wall resection and reconstruction DOI: http://dx.doi.org/10.2147/OTT.S101615",Non-OADS,/arxiv_data1/oa_pdf/ae/13/ott-9-2349.PMC4846065.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ae/13/ott-9-2349.PMC4846065.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/13/ott-9-2349.PMC4846065.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/17/ott-9-2317.PMC4846067.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2317–2327OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2317Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9179 6integrin and gene network analysis reveals that  iTga5 and iTgB1 are prognostic in non-small-cell  lung cancer Weiqi Zheng caihui Jiang ruifeng li Department of radiation Oncology,   guangqian hospital, Quanzhou, Fujian,   People’s republic of chinaBackground:  Integrin expression has been identified as a prognostic factor in non-small-cell  lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/2c/17/ott-9-2317.PMC4846067.pdf
"A total of 18 alpha and eight beta subunits  with different functions are currently known.3 Integrin family members participate in a  variety of processes influencing the cell’s biological behavior, including cell adhesion,  recognition, immune response, metastasis of tumor cells as well as embryogenesis,  hemostasis, and tissue repair.4 Alterations in integrin expression levels can influence  cancer cell adhesion, polarity, and extracellular matrix assembly, which may result in  tumor metastasis.5 Integrins can also interact with tyrosine kinase receptors, such as  epidermal growth factor receptor (EGFR) and vascular EGFR (VEGFR), to promote  cancer cell proliferation, survival, and differentiation.6 EGFR mutations frequently correspondence: ruifeng li Department of radiation Oncology,  guangqian hospital, no 109,  West guangqian road, Meishan  Town, Quanzhou 362321, Fujian,  People’s republic of china Tel +86 595 8657 2018 Fax +86 595 8658 5153 email ah_kay_aqi@msn.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zheng et al Running head recto: ITGA5 and ITGB1 are prognostic in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S91796",Non-OADS,/arxiv_data1/oa_pdf/2c/17/ott-9-2317.PMC4846067.pdf
Materials and methods Patients Expression data of integrins and their associated genes and  relative clinical data of patients with NSCLC were available  in TCGA database provided on the website of the Cancer  Genomics Browser of the University of California Santa  Cruz ( https://genome-cancer.ucsc.edu /).,OADS,/arxiv_data1/oa_pdf/2c/17/ott-9-2317.PMC4846067.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2c/17/ott-9-2317.PMC4846067.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/17/ott-9-2317.PMC4846067.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/be/ott-9-2393.PMC4846068.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2393–2402OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2393Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9109 7rna interference-mediated silencing of speckle- type POZ protein promotes apoptosis of renal  cell cancer cells Xiaoxia liu guiling sun Xiuju sun Department of n ephrology,   affiliated hospital of Weifang  Medical University, Weifang,   People’s republic of chinaAbstract:  This study aimed to investigate the effects of silencing the speckle-type POZ protein  (SPOP ) gene on renal cell cancer (RCC) cells and to explore its possible mechanism.",Non-OADS,/arxiv_data1/oa_pdf/1c/be/ott-9-2393.PMC4846068.pdf
"However,  recurrence remains high even after a radical nephrectomy, or a radical nephrectomy  combined with immunotherapy and targeted therapy as adjunctive therapy.1 Therefore,  a broadened and deepened understanding of the molecular mechanisms underlying RCC  progression and a further exploration of novel biomarkers as well as novel therapeutic  targets for the diagnosis and prognosis of RCC are of high importance.correspondence: guiling sun Department of Nephrology, Affiliated  hospital of Weifang Medical University,  no 2428, Yuhe road, Kuiwen  District, 261031 Weifang, shandong,  People’s republic of china Tel/fax +86 536 825 7939 email guilingsungls@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: siRNA-SPOP and RCC cells DOI: http://dx.doi.org/10.2147/OTT.S91097",Non-OADS,/arxiv_data1/oa_pdf/1c/be/ott-9-2393.PMC4846068.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1c/be/ott-9-2393.PMC4846068.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/be/ott-9-2393.PMC4846068.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/61/dmso-9-119.PMC4846069.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 119–124Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  119Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S10187 7level of control among patients with type 2  diabetes mellitus attending diabetic clinic under  family medicine compared to diabetic clinic under  endocrinology Mohammed a alhabdan1 Mohammed a alateeq2 Fiasal i alJurbou1 1college of Medicine, King Saud Bin  abdul- aziz University for health  Sciences, 2Department of Family  Medicine and P hc, King abdul-aziz  Medical city, n ational guard health  affairs, riyadh, Kingdom of Saudi  arabia correspondence: Mohammed a alateeq   Department of Family Medicine and Phc ,  King abdul-aziz Medical city, national  guard health affairs, PO Box 22490,  riyadh 11426, Kingdom of Saudi arabia   T el +966 1 180 1111 ext 46585   email malateeq@hotmail.co mObjectives:  To assess and compare level of control among patients with type 2 diabetes  mellitus  attending diabetic clinic under family medicine service and patients attending diabetic clinics  under endocrinology service, and to explore the effect of different variables on the level of  control in both groups.",Non-OADS,/arxiv_data1/oa_pdf/7a/61/dmso-9-119.PMC4846069.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/7a/61/dmso-9-119.PMC4846069.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/61/dmso-9-119.PMC4846069.pdf
Available from: http://care.diabetesjournals.,Non-OADS,/arxiv_data1/oa_pdf/7a/61/dmso-9-119.PMC4846069.pdf
